<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Sci</journal-id>
<journal-id journal-id-type="publisher-id">brainsci</journal-id>
<journal-title-group>
<journal-title>Brain Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">2076-3425</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30104506</article-id>
<article-id pub-id-type="pmc">6120011</article-id>
<article-id pub-id-type="doi">10.3390/brainsci8080154</article-id>
<article-id pub-id-type="publisher-id">brainsci-08-00154</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pinares-Garcia</surname>
<given-names>Paulo</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-08-00154">1</xref>
<xref ref-type="aff" rid="af2-brainsci-08-00154">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stratikopoulos</surname>
<given-names>Marielle</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-08-00154">1</xref>
<xref ref-type="aff" rid="af2-brainsci-08-00154">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zagato</surname>
<given-names>Alice</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-08-00154">1</xref>
<xref ref-type="aff" rid="af3-brainsci-08-00154">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loke</surname>
<given-names>Hannah</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-08-00154">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4277-3680</contrib-id>
<name>
<surname>Lee</surname>
<given-names>Joohyung</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-08-00154">1</xref>
<xref ref-type="aff" rid="af2-brainsci-08-00154">2</xref>
<xref ref-type="corresp" rid="c1-brainsci-08-00154">*</xref>
</contrib>
</contrib-group>
<aff id="af1-brainsci-08-00154"><label>1</label>Brain and Gender laboratory, Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia; <email>paulo.pinares-garcia@hudson.org.au</email> (P.P.-G.); <email>mstr0005@student.monash.edu</email> (M.S.); <email>alice.zagato@hudson.org.au</email> (A.Z.); <email>hannah.loke@hudson.org.au</email> (H.L.)</aff>
<aff id="af2-brainsci-08-00154"><label>2</label>Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3168, Australia</aff>
<aff id="af3-brainsci-08-00154"><label>3</label>School of Life and Environmental Sciences, Deakin University, Burwood, Victoria 3125, Australia</aff>
<author-notes>
<corresp id="c1-brainsci-08-00154"><label>*</label>Correspondence: <email>joohyung.lee@hudson.org.au</email>; Tel.: +613-8572-2507</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2018</year>
</pub-date>
<volume>8</volume>
<issue>8</issue>
<elocation-id>154</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 by the authors.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Males and females sometimes significantly differ in their propensity to develop neurological disorders. Females suffer more from mood disorders such as depression and anxiety, whereas males are more susceptible to deficits in the dopamine system including Parkinson’s disease (PD), attention-deficit hyperactivity disorder (ADHD) and autism. Despite this, biological sex is rarely considered when making treatment decisions in neurological disorders. A better understanding of the molecular mechanism(s) underlying sex differences in the healthy and diseased brain will help to devise diagnostic and therapeutic strategies optimal for each sex. Thus, the aim of this review is to discuss the available evidence on sex differences in neuropsychiatric and neurodegenerative disorders regarding prevalence, progression, symptoms and response to therapy. We also discuss the sex-related factors such as gonadal sex hormones and sex chromosome genes and how these might help to explain some of the clinically observed sex differences in these disorders. In particular, we highlight the emerging role of the Y-chromosome gene, <italic>SRY,</italic> in the male brain and its potential role as a male-specific risk factor for disorders such as PD, autism, and ADHD in many individuals.</p>
</abstract>
<kwd-group>
<kwd>brain sex differences</kwd>
<kwd>estrogen</kwd>
<kwd>testosterone</kwd>
<kwd>
<italic>SRY</italic>
</kwd>
<kwd>gender-specific medicine</kwd>
<kwd>ADHD</kwd>
<kwd>Parkinson’s disease</kwd>
<kwd>Alzheimer’s disease</kwd>
<kwd>autism</kwd>
<kwd>schizophrenia</kwd>
<kwd>depression</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-brainsci-08-00154">
<title>1. Introduction</title>
<p>Sex is sometimes a significant variable in the prevalence and incidence of neurological disorders [<xref ref-type="bibr" rid="B1-brainsci-08-00154">1</xref>,<xref ref-type="bibr" rid="B2-brainsci-08-00154">2</xref>,<xref ref-type="bibr" rid="B3-brainsci-08-00154">3</xref>,<xref ref-type="bibr" rid="B4-brainsci-08-00154">4</xref>,<xref ref-type="bibr" rid="B5-brainsci-08-00154">5</xref>,<xref ref-type="bibr" rid="B6-brainsci-08-00154">6</xref>,<xref ref-type="bibr" rid="B7-brainsci-08-00154">7</xref>]. In addition, sexual differences also exist in the age-of-onset, progression, disease severity, underlying neuropathology and treatment response of neurological diseases [<xref ref-type="bibr" rid="B1-brainsci-08-00154">1</xref>,<xref ref-type="bibr" rid="B3-brainsci-08-00154">3</xref>,<xref ref-type="bibr" rid="B4-brainsci-08-00154">4</xref>,<xref ref-type="bibr" rid="B5-brainsci-08-00154">5</xref>,<xref ref-type="bibr" rid="B7-brainsci-08-00154">7</xref>,<xref ref-type="bibr" rid="B8-brainsci-08-00154">8</xref>,<xref ref-type="bibr" rid="B9-brainsci-08-00154">9</xref>]. Whilst this attention to sexual dimorphism has traditionally been stronger in fields like cancer, cardiovascular and endocrine disorders [<xref ref-type="bibr" rid="B10-brainsci-08-00154">10</xref>,<xref ref-type="bibr" rid="B11-brainsci-08-00154">11</xref>], accumulating evidence demonstrates significant sex differences in brain physiology and behavior throughout development and adulthood [<xref ref-type="bibr" rid="B1-brainsci-08-00154">1</xref>,<xref ref-type="bibr" rid="B4-brainsci-08-00154">4</xref>,<xref ref-type="bibr" rid="B12-brainsci-08-00154">12</xref>]. Indeed, girls are more likely to suffer from depression than boys, and following puberty this female susceptibility for anxiety increases to around twice that for males [<xref ref-type="bibr" rid="B13-brainsci-08-00154">13</xref>]. Males with ADHD tend to exhibit the hyperactive-impulsive subtype whereas females tend to exhibit the inattentive subtype [<xref ref-type="bibr" rid="B14-brainsci-08-00154">14</xref>]. Sex differences are also seen in neurodegenerative disorders as the male sex is a significant risk factor for Parkinson’s disease [<xref ref-type="bibr" rid="B15-brainsci-08-00154">15</xref>,<xref ref-type="bibr" rid="B16-brainsci-08-00154">16</xref>,<xref ref-type="bibr" rid="B17-brainsci-08-00154">17</xref>] and motor neuron disease [<xref ref-type="bibr" rid="B18-brainsci-08-00154">18</xref>,<xref ref-type="bibr" rid="B19-brainsci-08-00154">19</xref>], whilst females are more susceptible to Alzheimer’s disease [<xref ref-type="bibr" rid="B20-brainsci-08-00154">20</xref>,<xref ref-type="bibr" rid="B21-brainsci-08-00154">21</xref>] and multiple sclerosis [<xref ref-type="bibr" rid="B22-brainsci-08-00154">22</xref>,<xref ref-type="bibr" rid="B23-brainsci-08-00154">23</xref>] (Summarised in <xref ref-type="fig" rid="brainsci-08-00154-f001">Figure 1</xref>). Despite the well-established understanding that males and females differ in their predisposition to neurological diseases, gender is rarely considered when making diagnostic or treatment decisions. Hence, a better understanding of the molecular underpinnings behind these sex differences could help develop more targeted therapies with higher success rates, especially in diseases where sex differences are most prominent.</p>
<p>Significant increase in research efforts is now starting to unravel the biological mechanisms responsible for promoting sex-specific characteristics in the healthy and diseased brain [<xref ref-type="bibr" rid="B7-brainsci-08-00154">7</xref>,<xref ref-type="bibr" rid="B24-brainsci-08-00154">24</xref>,<xref ref-type="bibr" rid="B25-brainsci-08-00154">25</xref>,<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B27-brainsci-08-00154">27</xref>]. It is now well established that organizational and activational effects of sex steroid hormones play an important role in brain sex differentiation [<xref ref-type="bibr" rid="B7-brainsci-08-00154">7</xref>,<xref ref-type="bibr" rid="B28-brainsci-08-00154">28</xref>,<xref ref-type="bibr" rid="B29-brainsci-08-00154">29</xref>,<xref ref-type="bibr" rid="B30-brainsci-08-00154">30</xref>,<xref ref-type="bibr" rid="B31-brainsci-08-00154">31</xref>]. Indeed, neuroprotective actions of estrogen in females underlie sex differences in susceptibility to disorders such as PD and schizophrenia [<xref ref-type="bibr" rid="B7-brainsci-08-00154">7</xref>,<xref ref-type="bibr" rid="B32-brainsci-08-00154">32</xref>,<xref ref-type="bibr" rid="B33-brainsci-08-00154">33</xref>,<xref ref-type="bibr" rid="B34-brainsci-08-00154">34</xref>], whilst aberrant levels of fetal testosterone have been associated with male preponderance to neurodevelopmental disorders such as autism and ADHD [<xref ref-type="bibr" rid="B35-brainsci-08-00154">35</xref>,<xref ref-type="bibr" rid="B36-brainsci-08-00154">36</xref>]. In addition to the influence of gonadal hormones, accumulating evidence demonstrate that sex chromosome genes (i.e., X and Y-linked) can directly influence brain function in normal and pathological conditions [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B37-brainsci-08-00154">37</xref>,<xref ref-type="bibr" rid="B38-brainsci-08-00154">38</xref>]. The Y-chromosome gene, <italic>SRY</italic>, which directly exerts male-specific actions in adult dopamine neurons, may also underlie male preponderance to disorders such as PD and autism. Thus, it is likely that these sex differences in the healthy and diseased brain result from complex interactions between sex hormones, sex chromosomes and epigenetic factors.</p>
<p>In view of these findings, increasing our understanding regarding the molecular basis of sex differences in neurological disorders will be pivotal in identifying sex-specific risk or protective factors and in being able to develop more effective therapies for each sex. The current review will summarise the available evidence on sex differences in neuropsychiatric and neurodegenerative disorders regarding prevalence, progression, symptoms and response to therapy. We will then discuss the potential role of sex hormones and sex chromosome genes in contributing to these sex differences. </p>
</sec>
<sec id="sec2-brainsci-08-00154">
<title>2. Female-Biased Brain Disorders</title>
<sec id="sec2dot1-brainsci-08-00154">
<title>2.1. Female-Biased Neuropsychiatric Disorders</title>
<sec id="sec2dot1dot1-brainsci-08-00154">
<title>2.1.1. Anxiety Disorders</title>
<p>Anxiety disorders are a group of psychiatric disorders characterized by exaggerated feelings of anxiety and fear responses. These feelings can manifest as physical symptoms, such as increased heart rate, difficulty concentrating or mind going blank, irritability, muscle tension, lethargy, and sleep disturbance [<xref ref-type="bibr" rid="B39-brainsci-08-00154">39</xref>,<xref ref-type="bibr" rid="B40-brainsci-08-00154">40</xref>]. Most common types of anxiety disorders include generalized anxiety disorder, social anxiety disorder, post-traumatic stress disorder, obsessive compulsive disorder and panic disorder. People often have more than one type of anxiety disorder. Like depression, serotonin appears to be involved in the pathogenesis of anxiety disorders and thus therapeutics directed at enhancing synaptic levels of serotonin, such as serotonin-reuptake inhibitors (SSRIs) and serotonin/norepinephrine-reuptake inhibitors (SNRIs), ease symptoms associated with anxiety [<xref ref-type="bibr" rid="B41-brainsci-08-00154">41</xref>].</p>
<p>Almost all subtypes of anxiety are more likely to be diagnosed in women than in men [<xref ref-type="bibr" rid="B42-brainsci-08-00154">42</xref>,<xref ref-type="bibr" rid="B43-brainsci-08-00154">43</xref>]. Lifetime prevalence rates of the major anxiety disorders range between approximately 3 to 12% and are approximately two times greater among women than men [<xref ref-type="bibr" rid="B42-brainsci-08-00154">42</xref>]. Women seem to be more negatively affected by symptoms of anxiety disorders, often experiencing symptoms to a greater degree [<xref ref-type="bibr" rid="B42-brainsci-08-00154">42</xref>]. Data on the prevalence of affective disorders such as anxiety and depression mainly come from self-reports and it has been hypothesised that part of the high female prevalence may be due to the unwillingness for males to report their anxiety symptoms [<xref ref-type="bibr" rid="B43-brainsci-08-00154">43</xref>,<xref ref-type="bibr" rid="B44-brainsci-08-00154">44</xref>]. Another reason for the higher female prevalence of anxiety disorders has been thought to come from the difficulty men face in expressing their feelings due to masculine sex-role stereotypes [<xref ref-type="bibr" rid="B45-brainsci-08-00154">45</xref>]. Despite these sociological factors, overwhelming evidence demonstrate that actions of gonadal hormones on brain functions, such as hippocampal neurogenesis [<xref ref-type="bibr" rid="B46-brainsci-08-00154">46</xref>] and fear conditioning [<xref ref-type="bibr" rid="B47-brainsci-08-00154">47</xref>], play a significant role in the vulnerability of females to anxiety disorders. </p>
</sec>
<sec id="sec2dot1dot2-brainsci-08-00154">
<title>2.1.2. Depression</title>
<p>Depression is one of the most common and debilitating psychiatric disorders, with more than 300 million people affected worldwide [<xref ref-type="bibr" rid="B48-brainsci-08-00154">48</xref>]. Depression is a leading cause of suicide [<xref ref-type="bibr" rid="B49-brainsci-08-00154">49</xref>] characterized by symptoms of depressed mood, lack of drive, anhedonia, changes in appetite, sleep disturbances, feelings of guilt and concentration problems [<xref ref-type="bibr" rid="B50-brainsci-08-00154">50</xref>,<xref ref-type="bibr" rid="B51-brainsci-08-00154">51</xref>,<xref ref-type="bibr" rid="B52-brainsci-08-00154">52</xref>]. These symptoms are thought to largely arise from underactivation of the brain serotonin and norepinephrine transmitter systems [<xref ref-type="bibr" rid="B53-brainsci-08-00154">53</xref>], although deficiencies in neurotrophic and angiogenic factors [<xref ref-type="bibr" rid="B54-brainsci-08-00154">54</xref>] and glutamate metabolism [<xref ref-type="bibr" rid="B55-brainsci-08-00154">55</xref>] are also thought to contribute. Hence, anti-depressant medications such as SSRIs, SNRIs, and monoamine oxidase inhibitors act via enhancing serotonin and/or norepinephrine levels in the brain [<xref ref-type="bibr" rid="B56-brainsci-08-00154">56</xref>].</p>
<p>Depression is much more common among women than men, with female/male risk ratios roughly 2:1 [<xref ref-type="bibr" rid="B57-brainsci-08-00154">57</xref>]. This female-bias begins in adolescence and continues to midlife, approximating the span of the childbearing years in women [<xref ref-type="bibr" rid="B58-brainsci-08-00154">58</xref>]. Like anxiety disorders, sex differences in reporting of symptoms and differential persistence (e.g., sex-roles that create higher stress levels for women leading to higher rates of depression) may contribute to the higher female prevalence of depression [<xref ref-type="bibr" rid="B59-brainsci-08-00154">59</xref>]. However, increased incidence of depression in women during perimenopause and menopause, as well as following child-birth (i.e., post-partum depression) [<xref ref-type="bibr" rid="B43-brainsci-08-00154">43</xref>,<xref ref-type="bibr" rid="B44-brainsci-08-00154">44</xref>,<xref ref-type="bibr" rid="B60-brainsci-08-00154">60</xref>] suggests that fluctuating levels of sex hormones plays a significant role in female susceptibility to depression.</p>
</sec>
<sec id="sec2dot1dot3-brainsci-08-00154">
<title>2.1.3. Late-Onset Schizophrenia </title>
<p>Schizophrenia is a complex, chronic neuropsychiatric disorder that has a population frequency of approximately 1% [<xref ref-type="bibr" rid="B61-brainsci-08-00154">61</xref>,<xref ref-type="bibr" rid="B62-brainsci-08-00154">62</xref>,<xref ref-type="bibr" rid="B63-brainsci-08-00154">63</xref>]. Schizophrenia is characterized by distortions in thinking, perception, emotions, language, sense of self and behavior, manifested by a mixture of debilitating positive (hallucinations and delusions) and negative symptoms (depression, cognitive impairment, social withdrawal) [<xref ref-type="bibr" rid="B64-brainsci-08-00154">64</xref>]. Whilst the neuropathology underlying schizophrenia is unclear, most theories center on either an excess or a deficiency of neurotransmitters, including dopamine, serotonin, and glutamate [<xref ref-type="bibr" rid="B65-brainsci-08-00154">65</xref>,<xref ref-type="bibr" rid="B66-brainsci-08-00154">66</xref>,<xref ref-type="bibr" rid="B67-brainsci-08-00154">67</xref>]. Positive symptoms such as hallucinations and delusions, which are thought to result from excessive dopamine release in the prefrontal cortex [<xref ref-type="bibr" rid="B68-brainsci-08-00154">68</xref>,<xref ref-type="bibr" rid="B69-brainsci-08-00154">69</xref>] have been treated by dopamine antagonists such as haloperidol [<xref ref-type="bibr" rid="B70-brainsci-08-00154">70</xref>,<xref ref-type="bibr" rid="B71-brainsci-08-00154">71</xref>]. Other theories implicate aspartate, glycine, and gamma-aminobutyric acid (GABA) as part of the neurochemical imbalance of schizophrenia [<xref ref-type="bibr" rid="B72-brainsci-08-00154">72</xref>]. </p>
<p>Late-onset schizophrenia, which classifies individuals who are diagnosed at the age of 45 or older, are more common in women than men [<xref ref-type="bibr" rid="B73-brainsci-08-00154">73</xref>]. In contrast, early-onset schizophrenia, which refers to those diagnosed before the age of 18, are more common in males than females (discussed later in this review). Women have been shown to be more vulnerable to psychotic breakdown at times of estrogen withdrawal, i.e., menopause or just after giving birth [<xref ref-type="bibr" rid="B74-brainsci-08-00154">74</xref>]. Females more frequently exhibit depressive symptoms [<xref ref-type="bibr" rid="B73-brainsci-08-00154">73</xref>], whilst males tend to have a greater vulnerability to negative symptoms and traits of disorganization. However, studies have found premorbid functioning to be worse in men than in women, with late-onset schizophrenia generally found to have good premorbid competence [<xref ref-type="bibr" rid="B75-brainsci-08-00154">75</xref>,<xref ref-type="bibr" rid="B76-brainsci-08-00154">76</xref>,<xref ref-type="bibr" rid="B77-brainsci-08-00154">77</xref>]. Overall, the prognosis of the illness, the social functioning, and the response to treatment is generally better in female schizophrenic patients compared to males [<xref ref-type="bibr" rid="B73-brainsci-08-00154">73</xref>]. </p>
</sec>
</sec>
<sec id="sec2dot2-brainsci-08-00154">
<title>2.2. Female-Biased Neurodegenerative Disorders</title>
<sec id="sec2dot2dot1-brainsci-08-00154">
<title>2.2.1. Alzheimer’s Disease</title>
<p>Alzheimer’s disease (AD) is the most common neurodegenerative disorder, with an estimated worldwide prevalence of 24 million people [<xref ref-type="bibr" rid="B78-brainsci-08-00154">78</xref>]. AD sufferers exhibit gradual cognitive decline, often beginning with memory loss and extending to behavioural disturbances such as apathy and depression [<xref ref-type="bibr" rid="B79-brainsci-08-00154">79</xref>]. AD is characterized by the accumulation of intracellular hyperphosphorylated tau inclusions termed neurofibrillary tangles, extracellular plaques consisting of beta-amyloid aggregates, and brain atrophy caused by the progressive loss of cholinergic neurons [<xref ref-type="bibr" rid="B80-brainsci-08-00154">80</xref>,<xref ref-type="bibr" rid="B81-brainsci-08-00154">81</xref>,<xref ref-type="bibr" rid="B82-brainsci-08-00154">82</xref>,<xref ref-type="bibr" rid="B83-brainsci-08-00154">83</xref>,<xref ref-type="bibr" rid="B84-brainsci-08-00154">84</xref>]. The propagation of neuropathological changes in AD is highly characterized, beginning in the entorhinal cortex, before spreading to the hippocampus, basal forebrain, temporal and parietal lobes, and eventually the neocortex [<xref ref-type="bibr" rid="B85-brainsci-08-00154">85</xref>,<xref ref-type="bibr" rid="B86-brainsci-08-00154">86</xref>]. </p>
<p>The female sex is a significant risk factor for AD, as two-third of AD patients are women [<xref ref-type="bibr" rid="B21-brainsci-08-00154">21</xref>,<xref ref-type="bibr" rid="B87-brainsci-08-00154">87</xref>,<xref ref-type="bibr" rid="B88-brainsci-08-00154">88</xref>]. Moreover, women have a two-fold higher incidence in AD [<xref ref-type="bibr" rid="B89-brainsci-08-00154">89</xref>], and two-fold higher lifetime risk of AD compared to men [<xref ref-type="bibr" rid="B90-brainsci-08-00154">90</xref>,<xref ref-type="bibr" rid="B91-brainsci-08-00154">91</xref>]. This female-bias is not seen in any other types of dementias [<xref ref-type="bibr" rid="B92-brainsci-08-00154">92</xref>], although some have reasoned that it is a result of women living longer than men [<xref ref-type="bibr" rid="B93-brainsci-08-00154">93</xref>]. Women AD patients exhibit faster rate of hippocampal atrophy and greater neurofibrillary tangles than men with AD [<xref ref-type="bibr" rid="B94-brainsci-08-00154">94</xref>,<xref ref-type="bibr" rid="B95-brainsci-08-00154">95</xref>]. Women also show more rapid loss of autonomy, greater disability and more rapid cognitive decline whilst men have a higher mortality and comorbidity and later onset [<xref ref-type="bibr" rid="B79-brainsci-08-00154">79</xref>,<xref ref-type="bibr" rid="B96-brainsci-08-00154">96</xref>,<xref ref-type="bibr" rid="B97-brainsci-08-00154">97</xref>]. In particular, female AD patients exhibit a greater cognitive decline in areas of visuospatial abilities, verbal processing, and semantic and episodic memory than male AD patients [<xref ref-type="bibr" rid="B98-brainsci-08-00154">98</xref>,<xref ref-type="bibr" rid="B99-brainsci-08-00154">99</xref>,<xref ref-type="bibr" rid="B100-brainsci-08-00154">100</xref>,<xref ref-type="bibr" rid="B101-brainsci-08-00154">101</xref>]. Clinical and pre-clinical studies demonstrate conflicting evidence on sex differences in response to anticholinesterase medications, a widely used therapy for AD. Some studies have reported that females responded better than males in clinical [<xref ref-type="bibr" rid="B102-brainsci-08-00154">102</xref>] and in AD models [<xref ref-type="bibr" rid="B103-brainsci-08-00154">103</xref>], whilst recent meta-analysis study have no significant sex differences [<xref ref-type="bibr" rid="B104-brainsci-08-00154">104</xref>]. Overall, women show a greater rate of prevalence and incidence, increased cognitive decline and greater rate of neuropathological decline in AD compared to men. Given the differences in sex hormone levels in AD patients compared to controls, this suggests that biological factors could contribute to sex differences seen in AD. Further investigation into the underlying causes of sex differences in AD is a crucial step towards providing specific gender-based therapies and diagnosis. </p>
</sec>
<sec id="sec2dot2dot2-brainsci-08-00154">
<title>2.2.2. Multiple Sclerosis</title>
<p>Multiple Sclerosis (MS) is a neurodegenerative disease characterized by autoimmune demyelination of axons and plaque formation, eventually leading to CNS degeneration [<xref ref-type="bibr" rid="B105-brainsci-08-00154">105</xref>]. Disease course can be classified into 4 subtypes; relapsing-remitting (RR), primary progressive (PP), secondary progressive (SP), and primary relapsing (PR). RR-MS as the name suggests, is characterized by periods of acute disease followed by recovery [<xref ref-type="bibr" rid="B106-brainsci-08-00154">106</xref>]. RR-MS is the most common type accounting for 85–90% of cases, whilst 10–15% of cases are categorized as PP, where symptoms continually worsen with time [<xref ref-type="bibr" rid="B106-brainsci-08-00154">106</xref>]. The disease mainly affects young adults with peak symptom onset at 30 years of age [<xref ref-type="bibr" rid="B107-brainsci-08-00154">107</xref>]. MS symptoms have a wide range and severity, resulting from disparity in lesion development and progression. Most commonly reported are fatigue, visual or sensory impairment and cognitive deficits. Magnetic resonance imaging (MRI) is an essential technique for diagnosis and can be used to determine the presence of lesions, anatomically specific to MS whilst brain atrophy is associated with disease progression and cognitive impairment [<xref ref-type="bibr" rid="B107-brainsci-08-00154">107</xref>,<xref ref-type="bibr" rid="B108-brainsci-08-00154">108</xref>]. Unlike most neurodegenerative diseases, disease-modifying treatments are available for MS, although there is still no cure. Disease-modifying treatments, which are usually drugs that suppress or modulate the immune systems, are efficacious at slowing disease progression or reducing severity or frequency of attacks when implemented early [<xref ref-type="bibr" rid="B109-brainsci-08-00154">109</xref>].</p>
<p>There is a higher incidence of MS in females compared to males [<xref ref-type="bibr" rid="B22-brainsci-08-00154">22</xref>], with 3.6 females to 2.0 male cases per 100,000 [<xref ref-type="bibr" rid="B23-brainsci-08-00154">23</xref>]. RR-MS has approximately two-fold higher incidence in women over men [<xref ref-type="bibr" rid="B105-brainsci-08-00154">105</xref>]. Unaffected females that carry susceptibility genes are also more likely to transmit to children than males [<xref ref-type="bibr" rid="B110-brainsci-08-00154">110</xref>]. RR-MS, female sex and early age of onset are all associated with more benign disease course [<xref ref-type="bibr" rid="B111-brainsci-08-00154">111</xref>] whilst male sex, later age of onset and a high number of early attacks all associated with poorer prognosis [<xref ref-type="bibr" rid="B112-brainsci-08-00154">112</xref>,<xref ref-type="bibr" rid="B113-brainsci-08-00154">113</xref>]. Males with MS are prone to develop less inflammatory, but more destructive lesions than women [<xref ref-type="bibr" rid="B114-brainsci-08-00154">114</xref>]. Women have greater T-cell immunoreactivity to myelin protein than males in both MS cases and healthy controls [<xref ref-type="bibr" rid="B115-brainsci-08-00154">115</xref>]. Comparison of gene expression in inflammatory lesions suggests MS pathogenesis in males induces estrogen signalling pathways, whilst females exhibit an upregulation of progesterone pathways [<xref ref-type="bibr" rid="B116-brainsci-08-00154">116</xref>]. Interestingly, female disease incidence is rising, which may be due to an unknown environmental influence or gene-environment interaction [<xref ref-type="bibr" rid="B117-brainsci-08-00154">117</xref>,<xref ref-type="bibr" rid="B118-brainsci-08-00154">118</xref>,<xref ref-type="bibr" rid="B119-brainsci-08-00154">119</xref>,<xref ref-type="bibr" rid="B120-brainsci-08-00154">120</xref>,<xref ref-type="bibr" rid="B121-brainsci-08-00154">121</xref>,<xref ref-type="bibr" rid="B122-brainsci-08-00154">122</xref>,<xref ref-type="bibr" rid="B123-brainsci-08-00154">123</xref>].</p>
</sec>
</sec>
</sec>
<sec id="sec3-brainsci-08-00154">
<title>3. Male-Biased Disorders</title>
<sec id="sec3dot1-brainsci-08-00154">
<title>3.1. Male-Biased Neuropsychiatric Disorders</title>
<sec id="sec3dot1dot1-brainsci-08-00154">
<title>3.1.1. Autism </title>
<p>Autism, or autism spectrum disorders, is a set of heterogeneous neurodevelopmental conditions, characterized by early-onset difficulties in social communication and unusually restricted, repetitive behaviour and interests [<xref ref-type="bibr" rid="B124-brainsci-08-00154">124</xref>,<xref ref-type="bibr" rid="B125-brainsci-08-00154">125</xref>]. Symptoms manifest prior to the age of 3, although diagnosis doesn’t usually occur until 3–4 years of age [<xref ref-type="bibr" rid="B126-brainsci-08-00154">126</xref>] which is based primarily on the observation of behavioral problems and atypical language development [<xref ref-type="bibr" rid="B127-brainsci-08-00154">127</xref>]. Globally, autism is thought to affect around 25 million people as of 2015 [<xref ref-type="bibr" rid="B128-brainsci-08-00154">128</xref>]. The most recent report by the Centers for Disease Control and Prevention revealed a 15% increase in prevalence of autism in the United States from the previous two years [<xref ref-type="bibr" rid="B129-brainsci-08-00154">129</xref>]. The recent increase in the diagnosis of autism may be partly due to changes in diagnostic practice, although the question of whether actual rates have increased remains unclear [<xref ref-type="bibr" rid="B130-brainsci-08-00154">130</xref>]. Autism is thought to affect information processing in the brain by altering neuronal connectivity and organization during development [<xref ref-type="bibr" rid="B124-brainsci-08-00154">124</xref>,<xref ref-type="bibr" rid="B125-brainsci-08-00154">125</xref>], although how this occurs is not well understood. Evidence from clinical and animal research also suggests an imbalance in serotonin and dopamine [<xref ref-type="bibr" rid="B124-brainsci-08-00154">124</xref>,<xref ref-type="bibr" rid="B125-brainsci-08-00154">125</xref>]. Boys with autism have reduced serotonin synthesis and levels in the frontal cortex and thalamus [<xref ref-type="bibr" rid="B131-brainsci-08-00154">131</xref>,<xref ref-type="bibr" rid="B132-brainsci-08-00154">132</xref>], which may underlie impaired language production and sensory integration symptoms [<xref ref-type="bibr" rid="B131-brainsci-08-00154">131</xref>]. Studies have also shown that autism is a hyperdopaminergic condition, likely due to the atypical neural network between the amygdala and prefrontal cortex, which could underlie the social deficits in autism [<xref ref-type="bibr" rid="B133-brainsci-08-00154">133</xref>,<xref ref-type="bibr" rid="B134-brainsci-08-00154">134</xref>]. </p>
<p>Whilst the cause of autism remains unknown, it is likely to result from a combination of genetic and environmental factors such as prenatal infections, valproic acid or alcohol use during pregnancy [<xref ref-type="bibr" rid="B124-brainsci-08-00154">124</xref>,<xref ref-type="bibr" rid="B125-brainsci-08-00154">125</xref>]. Interestingly, one of the most consistent findings in autism research is the higher rate of diagnosis in males than females [<xref ref-type="bibr" rid="B124-brainsci-08-00154">124</xref>,<xref ref-type="bibr" rid="B125-brainsci-08-00154">125</xref>,<xref ref-type="bibr" rid="B135-brainsci-08-00154">135</xref>,<xref ref-type="bibr" rid="B136-brainsci-08-00154">136</xref>]. Autism is approximately four times more common among males than females [<xref ref-type="bibr" rid="B137-brainsci-08-00154">137</xref>], although this ratio is further increased to eleven males to one female in severe autism [<xref ref-type="bibr" rid="B138-brainsci-08-00154">138</xref>]. Aside from prevalence rates, males and females differ in the presentation of clinical symptoms [<xref ref-type="bibr" rid="B139-brainsci-08-00154">139</xref>]. Females with autism show less restricted and repetitive behaviours and interests compared to males and tend to have internalising symptoms such as depression and anxiety, whereas males tend to have more externalising symptoms such as aggression, and hyperactivity [<xref ref-type="bibr" rid="B140-brainsci-08-00154">140</xref>,<xref ref-type="bibr" rid="B141-brainsci-08-00154">141</xref>]. Several theories exist on the male preponderance of autism—such as a genetic protective effect in females [<xref ref-type="bibr" rid="B142-brainsci-08-00154">142</xref>,<xref ref-type="bibr" rid="B143-brainsci-08-00154">143</xref>] or the “extreme male brain” theory [<xref ref-type="bibr" rid="B144-brainsci-08-00154">144</xref>]—which will be discussed later in this review. </p>
</sec>
<sec id="sec3dot1dot2-brainsci-08-00154">
<title>3.1.2. Attention-Deficit Hyperactivity Disorder</title>
<p>Attention-deficit hyperactivity disorder (ADHD) is the most commonly diagnosed psychiatric disorder in children, affecting approximately 5% of children worldwide, particularly boys [<xref ref-type="bibr" rid="B145-brainsci-08-00154">145</xref>]. ADHD is characterized by symptoms of inattention and/or hyperactivity-impulsivity [<xref ref-type="bibr" rid="B146-brainsci-08-00154">146</xref>]. Symptoms typically appear the age of twelve years old, persist for more than six months, and cause disruptions in at least two settings (such as school, home, or recreational activities). Symptoms of ADHD have been primarily associated with the hypofunction of catecholamines dopamine and norepinephrine in the frontal-subcortical circuit (i.e., prefrontal cortex and striatum), which are involved in attention, reward and motor activity [<xref ref-type="bibr" rid="B146-brainsci-08-00154">146</xref>,<xref ref-type="bibr" rid="B147-brainsci-08-00154">147</xref>,<xref ref-type="bibr" rid="B148-brainsci-08-00154">148</xref>,<xref ref-type="bibr" rid="B149-brainsci-08-00154">149</xref>]. Thus, the most effective drugs used to treat ADHD, such as methylphenidate and d-amphetamine, are all stimulants, which increase levels of dopamine and norepinephrine to enhance catecholamine signalling in the brain [<xref ref-type="bibr" rid="B150-brainsci-08-00154">150</xref>,<xref ref-type="bibr" rid="B151-brainsci-08-00154">151</xref>].</p>
<p>Like autism, ADHD is a neurodevelopmental disorder with a strong male-bias, with a sex ratio of three males to every female [<xref ref-type="bibr" rid="B152-brainsci-08-00154">152</xref>,<xref ref-type="bibr" rid="B153-brainsci-08-00154">153</xref>,<xref ref-type="bibr" rid="B154-brainsci-08-00154">154</xref>,<xref ref-type="bibr" rid="B155-brainsci-08-00154">155</xref>,<xref ref-type="bibr" rid="B156-brainsci-08-00154">156</xref>]. Males are likely to exhibit all subtypes of ADHD [<xref ref-type="bibr" rid="B157-brainsci-08-00154">157</xref>], have higher ADHD symptom scores, and may present with externalising behaviours such as physical abuse, aggression and criminality [<xref ref-type="bibr" rid="B158-brainsci-08-00154">158</xref>]. On the other hand, females tend to exhibit the inattentive subtype and be at increased risk of developing co-morbid eating and anxiety disorders [<xref ref-type="bibr" rid="B14-brainsci-08-00154">14</xref>,<xref ref-type="bibr" rid="B159-brainsci-08-00154">159</xref>,<xref ref-type="bibr" rid="B160-brainsci-08-00154">160</xref>,<xref ref-type="bibr" rid="B161-brainsci-08-00154">161</xref>]. There is also some evidence for sex differences in brain activity in ADHD as electroencephalography (EEG) recordings revealed that girls exhibit abnormally elevated coherence in frontal and temporal regions and localised frontal theta enhancement, whereas boys show little evidence of systematic coherence development, and more widespread theta-wave enhancement [<xref ref-type="bibr" rid="B162-brainsci-08-00154">162</xref>,<xref ref-type="bibr" rid="B163-brainsci-08-00154">163</xref>,<xref ref-type="bibr" rid="B164-brainsci-08-00154">164</xref>]. These findings are in line with the notion of a more extensive and severe neurodevelopmental phenotype in males with ADHD. A recent genome-wide association study of ADHD patient samples from Psychiatric Genomics Consortium (PGC) and the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) revealed a greater familial burden of risk in female individuals with ADHD, although autosomal common variants did not explain the sex bias in ADHD prevalence [<xref ref-type="bibr" rid="B165-brainsci-08-00154">165</xref>]. Overall, sex differences observed in ADHD and autism may be partially accounted for by diagnostic and ascertainment biases, but are likely, in large part, to be due to biological differences between males and females. </p>
</sec>
<sec id="sec3dot1dot3-brainsci-08-00154">
<title>3.1.3. Tourette’s Syndrome</title>
<p>Tourette’s syndrome is a neuropsychiatric disorder characterised by recurring motor and phonic tics during childhood and adolescence [<xref ref-type="bibr" rid="B166-brainsci-08-00154">166</xref>]. Typical onset of Tourette’s syndrome occurs around 6 to 7 years old and one-third of Tourette’s affected children retain their symptoms into adulthood [<xref ref-type="bibr" rid="B167-brainsci-08-00154">167</xref>,<xref ref-type="bibr" rid="B168-brainsci-08-00154">168</xref>]. 90% of Tourette’s patients suffer from comorbid psychiatric conditions including ADHD, obsessive compulsive disorder (OCD), aggression and other impulse control disorders [<xref ref-type="bibr" rid="B169-brainsci-08-00154">169</xref>,<xref ref-type="bibr" rid="B170-brainsci-08-00154">170</xref>]. Neuroimaging and post-mortem studies have shown excessive activity and/or innervation of the cerebral cortex and basal ganglia of Tourette’s patients [<xref ref-type="bibr" rid="B171-brainsci-08-00154">171</xref>], which may reflect dysregulations in the dopaminergic system [<xref ref-type="bibr" rid="B172-brainsci-08-00154">172</xref>,<xref ref-type="bibr" rid="B173-brainsci-08-00154">173</xref>,<xref ref-type="bibr" rid="B174-brainsci-08-00154">174</xref>,<xref ref-type="bibr" rid="B175-brainsci-08-00154">175</xref>]. Treatment options for Tourette’s syndrome include drug treatments such as dopamine antagonists [<xref ref-type="bibr" rid="B176-brainsci-08-00154">176</xref>,<xref ref-type="bibr" rid="B177-brainsci-08-00154">177</xref>] or behavioural approaches such as habit reversal therapy [<xref ref-type="bibr" rid="B178-brainsci-08-00154">178</xref>,<xref ref-type="bibr" rid="B179-brainsci-08-00154">179</xref>].</p>
<p>Tourette’s syndrome is more common in boys with sex ratio of four boys to one girl [<xref ref-type="bibr" rid="B180-brainsci-08-00154">180</xref>], and is diagnosed earlier in males than females [<xref ref-type="bibr" rid="B181-brainsci-08-00154">181</xref>]. In males, onset of Tourette’s syndrome is characterised by anger-related manifestations and simple tics; conversely, females exhibit complex tics more often than males [<xref ref-type="bibr" rid="B181-brainsci-08-00154">181</xref>]. Furthermore, male TS patients exhibit significant deficits in cortical and callosal thickness, which are not observed in females [<xref ref-type="bibr" rid="B182-brainsci-08-00154">182</xref>,<xref ref-type="bibr" rid="B183-brainsci-08-00154">183</xref>,<xref ref-type="bibr" rid="B184-brainsci-08-00154">184</xref>]. Whilst males have increased vulnerability for tics in childhood, females have greater tic severity during adulthood [<xref ref-type="bibr" rid="B185-brainsci-08-00154">185</xref>].</p>
</sec>
<sec id="sec3dot1dot4-brainsci-08-00154">
<title>3.1.4. Early-Onset Schizophrenia</title>
<p>Although schizophrenia has a weak male bias on average (7 males: 5 females), this ratio is increased in younger males (&lt;20 years old) where two males to every female are affected [<xref ref-type="bibr" rid="B186-brainsci-08-00154">186</xref>,<xref ref-type="bibr" rid="B187-brainsci-08-00154">187</xref>,<xref ref-type="bibr" rid="B188-brainsci-08-00154">188</xref>,<xref ref-type="bibr" rid="B189-brainsci-08-00154">189</xref>]. Males also have an earlier age of onset of schizophrenia, between 18–25 years of age, compared with the female age of onset which is 25–35 years [<xref ref-type="bibr" rid="B73-brainsci-08-00154">73</xref>]. Males tend to have a greater vulnerability to negative symptoms and traits of disorganization, while females more frequently exhibit depressive symptoms [<xref ref-type="bibr" rid="B73-brainsci-08-00154">73</xref>].</p>
</sec>
</sec>
<sec id="sec3dot2-brainsci-08-00154">
<title>3.2. Male-Biased Neurodegenerative Disorders</title>
<sec id="sec3dot2dot1-brainsci-08-00154">
<title>3.2.1. Parkinson’s Disease</title>
<p>Parkinson’s disease (PD) is the second most common neurodegenerative disorder after AD, affecting nearly 10 million people worldwide. PD affects 2% of population over the age of 65, increasing to 5% over the age of 85 [<xref ref-type="bibr" rid="B190-brainsci-08-00154">190</xref>]. PD is characterized by the inability to initiate and maintain voluntary movement [<xref ref-type="bibr" rid="B190-brainsci-08-00154">190</xref>]. Motor symptoms of PD are associated with the loss of midbrain dopamine neurons [<xref ref-type="bibr" rid="B191-brainsci-08-00154">191</xref>]. Whilst current therapies based on DA replacement strategies effectively treat motor symptoms, they do not slow down or halt the progression of PD. Furthermore, their therapeutic benefit is eventually marred by the development of debilitating side effects known as dyskinesias [<xref ref-type="bibr" rid="B192-brainsci-08-00154">192</xref>]. Whilst the cause(s) of PD is unknown, PD is likely to arise from a complex interplay between genetic and environmental factors [<xref ref-type="bibr" rid="B193-brainsci-08-00154">193</xref>,<xref ref-type="bibr" rid="B194-brainsci-08-00154">194</xref>,<xref ref-type="bibr" rid="B195-brainsci-08-00154">195</xref>,<xref ref-type="bibr" rid="B196-brainsci-08-00154">196</xref>].</p>
<p>Aside from aging, the male-sex is the most significant risk factor for PD. Men are twice more likely to develop PD and also have an earlier age of onset and a faster rate of disease progression in PD than women [<xref ref-type="bibr" rid="B16-brainsci-08-00154">16</xref>,<xref ref-type="bibr" rid="B17-brainsci-08-00154">17</xref>,<xref ref-type="bibr" rid="B197-brainsci-08-00154">197</xref>,<xref ref-type="bibr" rid="B198-brainsci-08-00154">198</xref>]. Evidence from animal models of PD reproduce the sex differences observed in humans, as administration of equal doses of dopamine toxins produce greater motor deficits and nigrostriatal dopamine loss in male rodents and primates than their female counterparts [<xref ref-type="bibr" rid="B199-brainsci-08-00154">199</xref>,<xref ref-type="bibr" rid="B200-brainsci-08-00154">200</xref>]. Microarray analysis of single SNc dopamine neurons from healthy post-mortem SNc revealed that expression of genes implicated in PD pathogenesis (e.g., <italic>α-synuclein</italic>, <italic>PINK-1</italic>) was higher in men than in women [<xref ref-type="bibr" rid="B201-brainsci-08-00154">201</xref>], suggesting that nigral dopamine cells have intrinsic sex differences that may influence the pattern of gene expression, predisposing the male-sex to developing PD. There are also clear differences in expression and function of dopamine machinery genes between males and females. For instance, striatal D2R density and binding potential decline twice as fast with age in males compared to females [<xref ref-type="bibr" rid="B202-brainsci-08-00154">202</xref>], which is likely to reflect sex differences in symptom severity and response to medication in PD. Together, evidence from animal models and clinical studies suggests that sex differences in PD pathogenesis mechanisms and dopamine machinery genes are likely to contribute to sex differences in prevalence, symptoms severity and medication response in PD. </p>
</sec>
<sec id="sec3dot2dot2-brainsci-08-00154">
<title>3.2.2. Motor Neuron Disease</title>
<p>Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease, is a rapidly degenerative muscular disorder affecting over 2.7 per 100,000 people [<xref ref-type="bibr" rid="B203-brainsci-08-00154">203</xref>]. Although MND has &gt;99% fatality within 2–5 years [<xref ref-type="bibr" rid="B204-brainsci-08-00154">204</xref>], one of the most famous sufferer Stephen Hawking survived well over 50 years from his initial diagnosis. The pathological hallmark of MND is the presence of hyper phosphorylated and ubiquitinated aggregates of TAR DNA-binding protein 43 (TDP-43), a ubiquitously expressed nuclear protein involved in transcriptional repression and RNA splicing [<xref ref-type="bibr" rid="B205-brainsci-08-00154">205</xref>,<xref ref-type="bibr" rid="B206-brainsci-08-00154">206</xref>,<xref ref-type="bibr" rid="B207-brainsci-08-00154">207</xref>,<xref ref-type="bibr" rid="B208-brainsci-08-00154">208</xref>]. Whilst the pathogenic role of TDP-43 aggregates remains unclear, it is likely due to either a loss of function, toxic gain of function, or a combination of both [<xref ref-type="bibr" rid="B209-brainsci-08-00154">209</xref>]. Clinically there is a fast-focal onset but movement impairment eventually spreads all over the body [<xref ref-type="bibr" rid="B210-brainsci-08-00154">210</xref>], with phenotype heterogeneity attributed to variation in disease progression anatomically. </p>
<p>Around 95% of MND cases are idiopathic in nature, with the remaining 5–10% of cases attributed to familial genetic origins [<xref ref-type="bibr" rid="B211-brainsci-08-00154">211</xref>]. Males are at greater risk for MND with a sex ratio of 1.6 male: 1 female for prevalence and 1.4 male: 1 female for incidence [<xref ref-type="bibr" rid="B18-brainsci-08-00154">18</xref>,<xref ref-type="bibr" rid="B19-brainsci-08-00154">19</xref>,<xref ref-type="bibr" rid="B212-brainsci-08-00154">212</xref>,<xref ref-type="bibr" rid="B213-brainsci-08-00154">213</xref>]. The incidence ratio has been reported to be as high as four males: one female in the 20–29-year age of onset group [<xref ref-type="bibr" rid="B214-brainsci-08-00154">214</xref>]. Men also have an earlier age of onset for MND than women [<xref ref-type="bibr" rid="B215-brainsci-08-00154">215</xref>,<xref ref-type="bibr" rid="B216-brainsci-08-00154">216</xref>,<xref ref-type="bibr" rid="B217-brainsci-08-00154">217</xref>]. This male-bias is reflected in the superoxide dismutase 1 (SOD1) mouse model of MND as male SOD1 mice had an earlier disease onset than female counterparts [<xref ref-type="bibr" rid="B218-brainsci-08-00154">218</xref>]. There are sex differences in the clinical features of MND, with men more likely to have spinal onset MND (associated with limb muscle wasting), whereas bulbar onset MND (associated with dysarthria and dysphagia for solids or liquids) are more common in women [<xref ref-type="bibr" rid="B18-brainsci-08-00154">18</xref>].</p>
</sec>
</sec>
</sec>
<sec id="sec4-brainsci-08-00154">
<title>4. Role of Sex Hormones and Sex Chromosome Genes in Susceptibility to Neurological Disorders</title>
<p>Sex differences in brain and behaviour have been largely attributed to the effects of sex hormones, including permanent or “organizational” effects during development and reversible or “activational” effects during adulthood [<xref ref-type="bibr" rid="B219-brainsci-08-00154">219</xref>]. However, it is becoming increasingly clear that brain sex differences are also mediated by the complement of genes encoded on the sex chromosomes, which are expressed in a sex-specific manner that is independent of the effects of sex hormones [<xref ref-type="bibr" rid="B3-brainsci-08-00154">3</xref>,<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B37-brainsci-08-00154">37</xref>,<xref ref-type="bibr" rid="B38-brainsci-08-00154">38</xref>]. Indeed, sex chromosome gene expression is sexually dimorphic in the brain in a region-specific, cell type-specific, and time-specific manner [<xref ref-type="bibr" rid="B220-brainsci-08-00154">220</xref>,<xref ref-type="bibr" rid="B221-brainsci-08-00154">221</xref>,<xref ref-type="bibr" rid="B222-brainsci-08-00154">222</xref>,<xref ref-type="bibr" rid="B223-brainsci-08-00154">223</xref>,<xref ref-type="bibr" rid="B224-brainsci-08-00154">224</xref>,<xref ref-type="bibr" rid="B225-brainsci-08-00154">225</xref>,<xref ref-type="bibr" rid="B226-brainsci-08-00154">226</xref>,<xref ref-type="bibr" rid="B227-brainsci-08-00154">227</xref>,<xref ref-type="bibr" rid="B228-brainsci-08-00154">228</xref>]. Here, we will discuss the relative contribution of sex-hormones and sex-chromosome complement genes in the susceptibility to neurodegenerative and neuropsychiatric disorders.</p>
<sec id="sec4dot1-brainsci-08-00154">
<title>4.1. Influence of Sex Hormones </title>
<sec id="sec4dot1dot1-brainsci-08-00154">
<title>4.1.1. Estrogen and Estrogen Signalling</title>
<p>Compelling evidence demonstrate that estrogen exerts neuroprotective actions in females [<xref ref-type="bibr" rid="B7-brainsci-08-00154">7</xref>]. For instance, post-menopausal women also have an increased disease risk of PD and AD as they have the lowest concentrations of circulating estrogen, even lower than males [<xref ref-type="bibr" rid="B92-brainsci-08-00154">92</xref>]. Similarly, symptoms worsen in female PD or MS patients with the onset of menopause or before the onset of menses during the menstrual cycle [<xref ref-type="bibr" rid="B229-brainsci-08-00154">229</xref>,<xref ref-type="bibr" rid="B230-brainsci-08-00154">230</xref>]. Furthermore, early initiation of estrogen replacement therapy at menopause appears to lower the risk of developing AD [<xref ref-type="bibr" rid="B79-brainsci-08-00154">79</xref>,<xref ref-type="bibr" rid="B231-brainsci-08-00154">231</xref>], whilst post-menopausal estrogen treatment has been associated with reduced risk of developing PD [<xref ref-type="bibr" rid="B232-brainsci-08-00154">232</xref>] and reduced symptom severity in female PD patients [<xref ref-type="bibr" rid="B233-brainsci-08-00154">233</xref>,<xref ref-type="bibr" rid="B234-brainsci-08-00154">234</xref>]. Likewise, increased levels of estrogen produced during pregnancy are associated with reduced severity of MS [<xref ref-type="bibr" rid="B230-brainsci-08-00154">230</xref>,<xref ref-type="bibr" rid="B235-brainsci-08-00154">235</xref>]. Studies in animal models recapitulate these clinical findings as treatment with estrogen or estradiol attenuates neuropathology and symptoms in animal models of PD [<xref ref-type="bibr" rid="B199-brainsci-08-00154">199</xref>,<xref ref-type="bibr" rid="B200-brainsci-08-00154">200</xref>,<xref ref-type="bibr" rid="B236-brainsci-08-00154">236</xref>], MS [<xref ref-type="bibr" rid="B237-brainsci-08-00154">237</xref>], and AD [<xref ref-type="bibr" rid="B238-brainsci-08-00154">238</xref>,<xref ref-type="bibr" rid="B239-brainsci-08-00154">239</xref>]. Estrogen exerts its protective effects by mediating mitochondrial function [<xref ref-type="bibr" rid="B240-brainsci-08-00154">240</xref>], anti-apoptotic mechanisms [<xref ref-type="bibr" rid="B240-brainsci-08-00154">240</xref>] and immune responses [<xref ref-type="bibr" rid="B230-brainsci-08-00154">230</xref>], as well as reducing beta amyloid neurotoxicity [<xref ref-type="bibr" rid="B241-brainsci-08-00154">241</xref>].</p>
<p>Estrogen also plays a significant role in sex differences in susceptibility, symptom severity and treatment response to affective disorders and neuropsychiatric disorders. Women may have a higher risk for developing anxiety disorders, or exacerbation of their present symptoms, during different phases of their reproductive lives, such as puberty, menses, pregnancy, postpartum, and menopause [<xref ref-type="bibr" rid="B242-brainsci-08-00154">242</xref>,<xref ref-type="bibr" rid="B243-brainsci-08-00154">243</xref>,<xref ref-type="bibr" rid="B244-brainsci-08-00154">244</xref>,<xref ref-type="bibr" rid="B245-brainsci-08-00154">245</xref>,<xref ref-type="bibr" rid="B246-brainsci-08-00154">246</xref>], whilst depressed women have significantly lower circulating levels of estrogen [<xref ref-type="bibr" rid="B247-brainsci-08-00154">247</xref>]. Additionally, depressed women had more favorable response to sertraline than to imipramine and the reverse was found with men [<xref ref-type="bibr" rid="B52-brainsci-08-00154">52</xref>]. Given that the female response was primarily in premenopausal women, this suggested that female sex hormones may enhance response to SSRIs or inhibit response to tricyclics [<xref ref-type="bibr" rid="B248-brainsci-08-00154">248</xref>]. Similar to PD, the incidence of schizophrenia in post-menopausal females is higher compared to pre-menopausal females [<xref ref-type="bibr" rid="B249-brainsci-08-00154">249</xref>]. Women have been shown to be more vulnerable to psychotic breakdown at times of estrogen withdrawal, for example just after giving birth and at menopause [<xref ref-type="bibr" rid="B74-brainsci-08-00154">74</xref>]. Conversely, increased levels of estrogen during the menstrual cycle is associated with an improvement of schizophrenic symptoms and therapeutic response to treatments [<xref ref-type="bibr" rid="B250-brainsci-08-00154">250</xref>,<xref ref-type="bibr" rid="B251-brainsci-08-00154">251</xref>]. In support, a clinical study of female schizophrenic patients demonstrated that estrogen or estradiol treatment with antipsychotic drugs led to significant improvements in acute and severe psychotic symptoms when compared to antipsychotic drugs given alone [<xref ref-type="bibr" rid="B252-brainsci-08-00154">252</xref>,<xref ref-type="bibr" rid="B253-brainsci-08-00154">253</xref>]. </p>
<p>Whilst the effects of estrogen on neurodegeneration and cognition are well established, the roles of the estrogen receptors alpha (ERα) and beta (ERβ) are less clear. In the brain, ERα mRNA is abundantly expressed in the hypothalamus and amygdala [<xref ref-type="bibr" rid="B254-brainsci-08-00154">254</xref>,<xref ref-type="bibr" rid="B255-brainsci-08-00154">255</xref>,<xref ref-type="bibr" rid="B256-brainsci-08-00154">256</xref>], whilst ERβ mRNA is highly expressed in the hippocampus and entorhinal cortex [<xref ref-type="bibr" rid="B254-brainsci-08-00154">254</xref>,<xref ref-type="bibr" rid="B255-brainsci-08-00154">255</xref>,<xref ref-type="bibr" rid="B256-brainsci-08-00154">256</xref>]. In line with the brain distribution pattern, female ERβ knockout (KO) mice exhibited spatial learning and memory deficits compared to wild-type controls [<xref ref-type="bibr" rid="B257-brainsci-08-00154">257</xref>], which was not observed in the ERα KO mice [<xref ref-type="bibr" rid="B258-brainsci-08-00154">258</xref>]. Moreover, treatment with the ERβ (but not ERα) agonist in ovariectomized mice improved performance in spatial memory tasks [<xref ref-type="bibr" rid="B259-brainsci-08-00154">259</xref>], suggesting a role ERβ in memory and cognitive processing. In contrast, ERα, but not ERβ, agonist exerted neuroprotective effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of PD [<xref ref-type="bibr" rid="B260-brainsci-08-00154">260</xref>]. Furthermore, ERα KO mice exhibited greater vulnerability to MPTP-induced DA depletion compared to WT mice, which was not observed in the ERβ KO mice [<xref ref-type="bibr" rid="B261-brainsci-08-00154">261</xref>]—suggesting a role for ERα in estrogen-mediated neuroprotection. Taken together, greater understanding of the nature of ER selective ligands and the function of ERα and ERβ subtypes in different brain regions may lead to optimal therapies for neurodegenerative and neuropsychiatric diseases.</p>
</sec>
<sec id="sec4dot1dot2-brainsci-08-00154">
<title>4.1.2. Testosterone</title>
<p>Prenatal testosterone plays a crucial role in masculinising the developing male brain [<xref ref-type="bibr" rid="B219-brainsci-08-00154">219</xref>]. Testosterone activates the androgen receptor to mediate the masculinization of the male brain during the perinatal period to induce male-typical behaviours such as aggression and sexual behavior in male adult rodents [<xref ref-type="bibr" rid="B262-brainsci-08-00154">262</xref>,<xref ref-type="bibr" rid="B263-brainsci-08-00154">263</xref>]. Thus, exposure to aberrant levels of prenatal testosterone may influence susceptibility to neurodevelopmental disorders, [<xref ref-type="bibr" rid="B264-brainsci-08-00154">264</xref>,<xref ref-type="bibr" rid="B265-brainsci-08-00154">265</xref>]. </p>
<p>In 2002, Baron-Cohen proposed the so-called “extreme male brain theory” [<xref ref-type="bibr" rid="B144-brainsci-08-00154">144</xref>] which hypothesizes that abnormally high levels of foetal testosterone may underlie the cognitive and emotional profile of people with autism, as well as the higher prevalence of autism in males compared with females. In one study, researchers found that girls who had been exposed to high levels of foetal testosterone in the womb had a more male-typical play style [<xref ref-type="bibr" rid="B266-brainsci-08-00154">266</xref>], whilst another study found a positive relationship between fetal testosterone levels and number of autistic traits in children [<xref ref-type="bibr" rid="B267-brainsci-08-00154">267</xref>]. Along these lines, males diagnosed with ADHD or autism have lower finger-length ratios [<xref ref-type="bibr" rid="B35-brainsci-08-00154">35</xref>,<xref ref-type="bibr" rid="B36-brainsci-08-00154">36</xref>], a proxy measure of high levels of prenatal testosterone exposure [<xref ref-type="bibr" rid="B268-brainsci-08-00154">268</xref>].</p>
<p>On the other hand, testosterone and its metabolites have been shown to possess anxiolytic properties, reducing anxiety behaviors and enhancing cognition in male rodents [<xref ref-type="bibr" rid="B269-brainsci-08-00154">269</xref>,<xref ref-type="bibr" rid="B270-brainsci-08-00154">270</xref>,<xref ref-type="bibr" rid="B271-brainsci-08-00154">271</xref>]. Testosterone has shown to influence the severity of tics, as anabolic androgens worsen tic severity in males with Tourette’s syndrome [<xref ref-type="bibr" rid="B272-brainsci-08-00154">272</xref>], whilst treatment with the 5α-reductase inhibitor, finasteride, decreased tic severity and compulsive symptoms in adult men with Tourette’s syndrome [<xref ref-type="bibr" rid="B273-brainsci-08-00154">273</xref>]. Depletion of endogenous testosterone levels in male rodents, via castration, induced neuronal cell loss in animal models of MS [<xref ref-type="bibr" rid="B274-brainsci-08-00154">274</xref>] and PD [<xref ref-type="bibr" rid="B275-brainsci-08-00154">275</xref>], suggesting that testosterone may be neuroprotective in males. </p>
<p>In summary, oestrogen exerts neuroprotective effects in females, which may underlie the reduced (or increased) incidence of neurological disorders in females throughout development and adulthood. Exposure to prenatal testosterone appears to be critical for the masculinization of the male brain and hence exposure to abnormal levels of testosterone may contribute to susceptibility of males to neurodevelopmental disorders such as autism and Tourette’s syndrome.</p>
</sec>
</sec>
<sec id="sec4dot2-brainsci-08-00154">
<title>4.2. Influence of Sex Chromosome Genes</title>
<p>In addition to the well-established actions of sex hormones on brain sex differences, accumulating evidence demonstrate that sex chromosomes genes (X-linked or Y-linked) can directly influence brain function [<xref ref-type="bibr" rid="B3-brainsci-08-00154">3</xref>,<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B37-brainsci-08-00154">37</xref>,<xref ref-type="bibr" rid="B38-brainsci-08-00154">38</xref>]. Whilst small in number, X- and Y-linked genes are proportionally abundant in the brain and have been shown to influence neural development and function [<xref ref-type="bibr" rid="B276-brainsci-08-00154">276</xref>,<xref ref-type="bibr" rid="B277-brainsci-08-00154">277</xref>]. For instance, genes on the sex chromosome may influence neurological diseases by altering the basic differentiation process of the neurons [<xref ref-type="bibr" rid="B278-brainsci-08-00154">278</xref>], encoding proteins [<xref ref-type="bibr" rid="B279-brainsci-08-00154">279</xref>], neurotransmitter biosynthesis [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B280-brainsci-08-00154">280</xref>] and synaptic transmission [<xref ref-type="bibr" rid="B281-brainsci-08-00154">281</xref>]. Moreover, sex chromosome abnormalities can influence neurodevelopment and often result in impairments in attention, working memory, verbal skills and executive function [<xref ref-type="bibr" rid="B282-brainsci-08-00154">282</xref>]. Therefore, the study of sex chromosomes in brain disorders may provide a new angle to understand the sex differences in the pathogeneses of neurodevelopmental and degenerative diseases. To better understand the relative contribution of sex chromosome complement on sex-bias in preponderance to neurological disorders, we will highlight three distinct genetic mechanisms: (i) X-linked dosage effects, (ii) X-linked imprinting effects, and (iii) Y-chromosome effects.</p>
<sec id="sec4dot2dot1-brainsci-08-00154">
<title>4.2.1. X-Linked Dosage Effects</title>
<p>As females have two X chromosomes, one of the copies of the X chromosome present in females is inactivated in process known as X-inactivation [<xref ref-type="bibr" rid="B283-brainsci-08-00154">283</xref>], equalizing the gene products of sex chromosomes between the sexes. However, approximately 15–20% of X-linked genes consistently escape X-inactivation [<xref ref-type="bibr" rid="B284-brainsci-08-00154">284</xref>], and therefore may be expressed higher in females than males. For instance, X-inactivation gene escapees, <italic>Utx</italic> and <italic>Usp9x</italic>, have higher expression in XX mice brains compared to XY, regardless of their gonadal phenotype [<xref ref-type="bibr" rid="B285-brainsci-08-00154">285</xref>,<xref ref-type="bibr" rid="B286-brainsci-08-00154">286</xref>]. Whilst the significance of X-inactivation gene escapee expression in brain function remains to be fully elucidated, it may potentially mask any gain or loss of function in females [<xref ref-type="bibr" rid="B9-brainsci-08-00154">9</xref>]. For instance, females with Turner syndrome (also known as 45, XO), a condition in which a female is partly or completely missing an X chromosome, have increased vulnerability to neurodevelopmental disorders such as ADHD [<xref ref-type="bibr" rid="B287-brainsci-08-00154">287</xref>], autism [<xref ref-type="bibr" rid="B288-brainsci-08-00154">288</xref>] and potentially schizophrenia [<xref ref-type="bibr" rid="B289-brainsci-08-00154">289</xref>]. Similarly, 39, XO mice (female mice with only one X-chromosome) exhibit attention deficits compared to 40, XX mice [<xref ref-type="bibr" rid="B290-brainsci-08-00154">290</xref>]. These attention deficits were rescued in 40, XY*<sup>X</sup> mice (39, XO mice with a small number of pseudoautosomal and X-linked genes on the Y*<sup>X</sup> chromosome), suggesting a protective role for X-chromosome genes in attentional and cognitive processes [<xref ref-type="bibr" rid="B290-brainsci-08-00154">290</xref>]. Deletions and frameshift mutations of <italic>NLGN4X</italic>, an X-inactivation gene escapee involved in formation and remodeling of synapses, were identified in boys with autism [<xref ref-type="bibr" rid="B291-brainsci-08-00154">291</xref>,<xref ref-type="bibr" rid="B292-brainsci-08-00154">292</xref>,<xref ref-type="bibr" rid="B293-brainsci-08-00154">293</xref>]. Polymorphism in the promoter region of <italic>MAOA</italic>, a X-linked gene involved in catecholamine metabolism, have been associated with increased risk of males to autism [<xref ref-type="bibr" rid="B294-brainsci-08-00154">294</xref>,<xref ref-type="bibr" rid="B295-brainsci-08-00154">295</xref>,<xref ref-type="bibr" rid="B296-brainsci-08-00154">296</xref>] and ADHD [<xref ref-type="bibr" rid="B297-brainsci-08-00154">297</xref>]. Thus, the extra dose of X-chromosome may have a protective effect in females, reducing the vulnerability to neurodevelopmental disorders such as autism and ADHD. On the other hand, individuals with an additional X-chromosome (e.g., 47, XXX and 47, XXY) exhibit global intellectual impairment [<xref ref-type="bibr" rid="B298-brainsci-08-00154">298</xref>] and show increased risk of ADHD and autism [<xref ref-type="bibr" rid="B299-brainsci-08-00154">299</xref>,<xref ref-type="bibr" rid="B300-brainsci-08-00154">300</xref>], suggesting that over dosage of X chromosomes can also be detrimental to brain development.</p>
</sec>
<sec id="sec4dot2dot2-brainsci-08-00154">
<title>4.2.2. X-Linked Imprinting Effects</title>
<p>Imprinted genes are solely expressed by one allele in a parent-of-origin dependent manner [<xref ref-type="bibr" rid="B9-brainsci-08-00154">9</xref>,<xref ref-type="bibr" rid="B301-brainsci-08-00154">301</xref>]. Although small in number, high proportion of imprinted genes are expressed in the brain and postulated to have role in neurodevelopment, brain function and behaviour [<xref ref-type="bibr" rid="B276-brainsci-08-00154">276</xref>]. Given the unique inheritance pattern of the X chromosome—maternal X can be inherited to male or female offspring, whilst paternal X only goes to female offspring—imprinted genes on the X chromosome could potentially influence sex-bias in vulnerability to neurodevelopmental disorders. For instance, any protective function of paternally expressed X-linked imprinted genes will be passed only to the female offspring. Indeed, females with Turner’s syndrome (45, XO) who inherited the paternal X chromosome (45, X<sup>p</sup>O) had superior verbal and higher-order executive function skills compared to females that inherited the maternal X chromosome (45, X<sup>m</sup>O). In view of these findings, they suggested that a genetic locus for social cognition is imprinted on the paternal X-chromosome, which could contribute to the higher incidence of autism seen in 45, X<sup>m</sup>O females, and males [<xref ref-type="bibr" rid="B302-brainsci-08-00154">302</xref>]. Bishop, et al. [<xref ref-type="bibr" rid="B303-brainsci-08-00154">303</xref>] assessed verbal and visuospatial memory in females with a single paternal X chromosome (45, X<sup>p</sup>O) and those with a single maternal X (45, X<sup>m</sup>O). Their findings revealed that 45, X<sup>m</sup>O females showed enhanced verbal forgetting relative to controls, whilst 45, X<sup>p</sup>O females showed disproportionate visuospatial memory loss relative to controls. In view of their results, Bishop and colleagues postulated the existence of one or more imprinted genes involved in memory function on both the maternal and paternal X chromosome Bishop, Canning, Elgar, Morris, Jacobs and Skuse [<xref ref-type="bibr" rid="B303-brainsci-08-00154">303</xref>], which could contribute to sex differences seen in memory-associated neurological disorders. To better understand the role of X-linked genes in cognitive function, Davies, et al. [<xref ref-type="bibr" rid="B304-brainsci-08-00154">304</xref>] assessed the performance of 39, XO mice, where the X chromosome was either paternally (39, X<sup>p</sup>O) or maternally (39, X<sup>m</sup>O) inherited, in various cognitive tasks. 39, X<sup>m</sup>O mice exhibited deficits in reversal learning, a measure of impulsive and compulsive behaviour [<xref ref-type="bibr" rid="B305-brainsci-08-00154">305</xref>]. Furthermore, a novel imprinted gene candidate, <italic>Xlr3b</italic>, which is maternally expressed in the 39, X<sup>m</sup>O mouse prefrontal and orbitofrontal cortex and hippocampus, was identified as mediator of the inflexible reversal learning. Together, these findings indicate that X-linked imprinted genes expressed in a parent of origin-dependent manner could influence sexually dimorphic phenotypes in brain function and may confer vulnerability to neurodevelopmental disorders such as autism and ADHD.</p>
</sec>
<sec id="sec4dot2dot3-brainsci-08-00154">
<title>4.2.3. Y-Chromosome Effects </title>
<p>The Y chromosome is passed only from father to son, indicating that any Y-linked traits are only present in males. Males possess genes on the Y chromosome that have no homologous sequences on the X chromosome, suggesting that genes encoded on the Y chromosome may contribute to biological sex differences [<xref ref-type="bibr" rid="B306-brainsci-08-00154">306</xref>,<xref ref-type="bibr" rid="B307-brainsci-08-00154">307</xref>]. Whilst the majority of Y chromosome genes are involved in testis development and spermatogenesis [<xref ref-type="bibr" rid="B308-brainsci-08-00154">308</xref>,<xref ref-type="bibr" rid="B309-brainsci-08-00154">309</xref>,<xref ref-type="bibr" rid="B310-brainsci-08-00154">310</xref>], a significant proportion are expressed in the brain [<xref ref-type="bibr" rid="B225-brainsci-08-00154">225</xref>,<xref ref-type="bibr" rid="B226-brainsci-08-00154">226</xref>]. Thus, Y chromosome-specific genes could contribute to sexual differentiation of the brain indirectly, through influencing gonadal hormone production or directly via cell autonomous actions in the brain [<xref ref-type="bibr" rid="B277-brainsci-08-00154">277</xref>]. Xu and colleagues showed that six Y-chromosome genes, <italic>Ddx3y</italic>, <italic>Ube1y</italic>, <italic>Kdm5d</italic>, <italic>Eif2s3y</italic>, <italic>Uty</italic> and <italic>Usp9y</italic> were expressed in both the developing and adult XY male mouse brain [<xref ref-type="bibr" rid="B226-brainsci-08-00154">226</xref>]. All six genes were also expressed in the brain of XY female mice that lacked the male-sex determining gene <italic>SRY</italic> and testes [<xref ref-type="bibr" rid="B226-brainsci-08-00154">226</xref>]. Another study showed that <italic>Dby</italic> and <italic>Eif2s3y</italic> were expressed in the developing male mouse brain at 10.5 days post coitum, prior to the influence of gonadal hormones [<xref ref-type="bibr" rid="B38-brainsci-08-00154">38</xref>]. Together, these findings indicate that Y-chromosome gene expression in the brain is independent of hormonal influence, suggesting that Y chromosome genes could contribute to sexually dimorphic brain development and function. In support, several clinical studies have reported ADHD diagnosis in 47, XYY and 48, XXYY boys [<xref ref-type="bibr" rid="B299-brainsci-08-00154">299</xref>,<xref ref-type="bibr" rid="B311-brainsci-08-00154">311</xref>,<xref ref-type="bibr" rid="B312-brainsci-08-00154">312</xref>] which suggests that a dosage-effect of Y-chromosome genes may increase the risk of males to neurological disorders. Whilst it is unclear which Y-chromosome gene(s) have a physiological role in the male brain, emerging studies indicate that the male-sex determining gene, <italic>SRY,</italic> is an ideal candidate to investigate [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B280-brainsci-08-00154">280</xref>].</p>
</sec>
<sec id="sec4dot2dot4-brainsci-08-00154">
<title>4.2.4. Y-Chromosome Gene <italic>SRY</italic>
</title>
<p><italic>SRY</italic> (Sex-determining Region on the Y chromosome) encodes is a transcription factor that initiates male-sex determination by directing embryonic bipotential gonads to develop into testes rather than ovaries [<xref ref-type="bibr" rid="B313-brainsci-08-00154">313</xref>,<xref ref-type="bibr" rid="B314-brainsci-08-00154">314</xref>]. Subsequently the testes secrete testosterone, which can act to masculinise the brain during development (‘organisational effects’) or at particular time points leading to reversible neural changes (‘activational effects’). In addition to its ‘indirect’ hormonal effects on the brain, emerging evidence demonstrate that <italic>SRY</italic> can directly exert actions in the adult male brain [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>]. In the mouse brain, <italic>SRY</italic> expression is developmentally regulated, with the circular (untranslatable) form of <italic>SRY</italic> transcripts expressed from embryonic day 11 (E11) through E19 whilst postnatal brain <italic>SRY</italic> transcripts are of the linear (translatable) form [<xref ref-type="bibr" rid="B315-brainsci-08-00154">315</xref>]. In the adult brain, <italic>SRY</italic> mRNA is expressed in regions abundant in catecholamine cell bodies or nerve terminals such as the SNc, ventral tegmental area (VTA), locus coeruleus and hypothalamus [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B316-brainsci-08-00154">316</xref>]. Immunohistochemical studies in human and rodent midbrain sections reveal that <italic>SRY</italic> protein co-localizes with dopaminergic neurons in the SNc and VTA, and with GABAergic neurons in the substantia nigra pars reticulata [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B280-brainsci-08-00154">280</xref>]. In line with the presence of <italic>SRY</italic> in dopamine-neurons, <italic>SRY</italic> regulates dopamine biosynthesis genes in vitro [<xref ref-type="bibr" rid="B280-brainsci-08-00154">280</xref>,<xref ref-type="bibr" rid="B316-brainsci-08-00154">316</xref>,<xref ref-type="bibr" rid="B317-brainsci-08-00154">317</xref>] and dopamine-dependent functions such as voluntary movement [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>] and blood pressure [<xref ref-type="bibr" rid="B318-brainsci-08-00154">318</xref>,<xref ref-type="bibr" rid="B319-brainsci-08-00154">319</xref>] in male rats. Combined, these results suggest that <italic>SRY</italic> exerts a direct male-specific action on adult DA neurons, independent of circulating gonadal hormones.</p>
<p>Given that <italic>SRY</italic> is expressed in brain regions closely associated with pathophysiology of ADHD and autism, abnormal regulation of <italic>SRY</italic> expression during development, and consequently dopamine machinery genes, may contribute to the hyper- or hypo-function of dopamine levels in these disorders. Considering the expression of <italic>SRY</italic> in the human male SNc [<xref ref-type="bibr" rid="B280-brainsci-08-00154">280</xref>], a brain region that degenerates in PD, dysregulation of <italic>SRY</italic> in male dopamine neurons may underlie the male preponderance to PD. Indeed, <italic>SRY</italic> expression is aberrantly elevated in a human cell culture model of PD [<xref ref-type="bibr" rid="B320-brainsci-08-00154">320</xref>]. Whilst other Y-linked genes, such as neuroligin 4, will also need to be examined for their role in male-biased neurodevelopmental disorders [<xref ref-type="bibr" rid="B321-brainsci-08-00154">321</xref>], these results highlight the need to better understand the molecular regulation, function, and targets of <italic>SRY</italic> in the healthy and diseased male brain. This information, alongside identifying novel <italic>SRY</italic> polymorphisms, will be essential for the development of novel therapeutic strategies (e.g., male-specific therapies) for sex-biased neurological disorders. </p>
</sec>
</sec>
</sec>
<sec id="sec5-brainsci-08-00154">
<title>5. Future Directions and Conclusions</title>
<p>Given that sex differences in neurological disorders arises from a combination of hormonal and genetic factors, integrated pre-clinical and clinical research efforts will be needed to distinguish the source of these differences. Animal models in which chromosomal and hormonal factors can be systematically varied, such as the four-core genotype model [<xref ref-type="bibr" rid="B37-brainsci-08-00154">37</xref>] and sex chromosome trisomy model [<xref ref-type="bibr" rid="B322-brainsci-08-00154">322</xref>], have proven to be useful tools in partitioning the effect of sex chromosome complement from the actions of gonadal sex hormones. The use of transgenic or knockout rat technologies and spatiotemporal-restricted gene expression strategies (e.g., brain <italic>SRY</italic> overexpressing transgenic rat) will be vital in identifying the role of sex-linked genes in the healthy and diseased brain. In parallel, genome-wide association and copy-number variation studies in human populations need to stratify disease-associated genetic variants by sex to identify potential interactions between sex and genetic vulnerability. Together, these studies may highlight novel sex-specific protective and risk factors, which should ultimately facilitate improved diagnosis, prognosis and treatment for males and females.</p>
<p>Evidence from numerous clinical studies indicate a promising role for sex-specific hormonal therapies in neurodegenerative and neuropsychiatric disorders. For instance, female-specific therapeutic benefit of estrogen treatment has been demonstrated for cognitive decline in AD [<xref ref-type="bibr" rid="B323-brainsci-08-00154">323</xref>,<xref ref-type="bibr" rid="B324-brainsci-08-00154">324</xref>,<xref ref-type="bibr" rid="B325-brainsci-08-00154">325</xref>,<xref ref-type="bibr" rid="B326-brainsci-08-00154">326</xref>] and MS [<xref ref-type="bibr" rid="B327-brainsci-08-00154">327</xref>], as well as improved efficacy of dopamine agonist medications for female PD patients [<xref ref-type="bibr" rid="B233-brainsci-08-00154">233</xref>]. Similarly, estrogen has shown to be beneficial in women with post-natal depression [<xref ref-type="bibr" rid="B328-brainsci-08-00154">328</xref>] and schizophrenia [<xref ref-type="bibr" rid="B34-brainsci-08-00154">34</xref>]. Conversely, testosterone therapy has shown promising effects on cognitive decline in male patients with AD [<xref ref-type="bibr" rid="B329-brainsci-08-00154">329</xref>] or MS [<xref ref-type="bibr" rid="B330-brainsci-08-00154">330</xref>], and non-motor symptoms of PD [<xref ref-type="bibr" rid="B331-brainsci-08-00154">331</xref>]. Moreover, emerging evidence from animal models and clinical observations also suggest a role for targeting X-linked (e.g., steroid sulfatase) or-Y-linked (<italic>SRY</italic>, neuroligin-4) genes [<xref ref-type="bibr" rid="B26-brainsci-08-00154">26</xref>,<xref ref-type="bibr" rid="B38-brainsci-08-00154">38</xref>,<xref ref-type="bibr" rid="B321-brainsci-08-00154">321</xref>] for male-biased neurodevelopmental disorders such as autism or ADHD. Given the potential therapeutic benefit of gonadal hormones in neuropsychiatric and neurodegenerative disorders, better understanding the sex hormone status of patients have the potential to improve diagnosis and inform treatment selection.</p>
<p>Whilst gender specific medicine still faces many challenges in current healthcare, the recognition that sex affects the pathophysiology and expression of human disease is starting to influence governmental and regulatory bodies. Indeed, National Institutes of Health and Food and Drug Administration are acting to ensure that both sexes are represented in pre-clinical and clinical studies, as well as all the drug development phases. In conclusion, better understanding the biological differences between the male and female brain will not only allow better, and even optimal, treatment of neurological disorders and a reduction in health care expenditure due to the elimination of inadequate treatment or adverse events. </p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We acknowledge the Victorian Government’s Operational Infrastructure Support (OIS) Program.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, J.L.; Investigation, P.P.-G., M.S., A.Z., H.L. and J.L.; Writing—Original Draft Preparation, P.P.-G., M.S. and J.L.; Writing—Review &amp; Editing, P.P.-G. and J.L.; Supervision, J.L.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research received no external funding. </p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest. </p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-brainsci-08-00154">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loke</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Biological factors underlying sex differences in neurological disorders</article-title>
<source/>Int. J. Biochem. Cell. Boil.
          <year>2015</year>
<volume>65</volume>
<fpage>139</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2015.05.024</pub-id>
<pub-id pub-id-type="pmid">26028290</pub-id>
</element-citation>
</ref>
<ref id="B2-brainsci-08-00154">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Pfaff</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Sex differences in neurological and psychiatric disorders</article-title>
<source/>Front. Neuroendocrinol.
          <year>2014</year>
<volume>35</volume>
<fpage>253</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2014.05.005</pub-id>
<pub-id pub-id-type="pmid">24882637</pub-id>
</element-citation>
</ref>
<ref id="B3-brainsci-08-00154">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ngun</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Ghahramani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sánchez</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Bocklandt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vilain</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The genetics of sex differences in brain and behavior</article-title>
<source/>Front. Neuroendocr.
          <year>2011</year>
<volume>32</volume>
<fpage>227</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2010.10.001</pub-id>
<pub-id pub-id-type="pmid">20951723</pub-id>
</element-citation>
</ref>
<ref id="B4-brainsci-08-00154">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarthy</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Blaustein</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>De Vries</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Sex differences in the brain: The not so inconvenient truth</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>2241</fpage>
<lpage>2247</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5372-11.2012</pub-id>
<pub-id pub-id-type="pmid">22396398</pub-id>
</element-citation>
</ref>
<ref id="B5-brainsci-08-00154">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanamsagar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bilbo</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development</article-title>
<source/>J. Steroid Biochem. Mol. Boil.
          <year>2016</year>
<volume>160</volume>
<fpage>127</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1016/j.jsbmb.2015.09.039</pub-id>
<pub-id pub-id-type="pmid">26435451</pub-id>
</element-citation>
</ref>
<ref id="B6-brainsci-08-00154">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosgrove</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Mazure</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Staley</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Evolving knowledge of sex differences in brain structure, function, and chemistry</article-title>
<source/>Biol. Psychiatry
          <year>2007</year>
<volume>62</volume>
<fpage>847</fpage>
<lpage>855</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.03.001</pub-id>
<pub-id pub-id-type="pmid">17544382</pub-id>
</element-citation>
</ref>
<ref id="B7-brainsci-08-00154">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillies</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>McArthur</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines</article-title>
<source/>Pharmacol. Rev.
          <year>2010</year>
<volume>62</volume>
<fpage>155</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1124/pr.109.002071</pub-id>
<pub-id pub-id-type="pmid">20392807</pub-id>
</element-citation>
</ref>
<ref id="B8-brainsci-08-00154">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname>
<given-names>A.-M.</given-names>
</name>
<name>
<surname>Swaab</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Sex differences in the brain, behavior, and neuropsychiatric disorders</article-title>
<source/>Neuroscience
          <year>2010</year>
<volume>16</volume>
<fpage>550</fpage>
<lpage>565</lpage>
<pub-id pub-id-type="doi">10.1177/1073858410377005</pub-id>
<pub-id pub-id-type="pmid">20889965</pub-id>
</element-citation>
</ref>
<ref id="B9-brainsci-08-00154">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>It is not all hormones: Alternative explanations for sexual differentiation of the brain</article-title>
<source/>Brain Res.
          <year>2006</year>
<fpage>36</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2006.09.105</pub-id>
<pub-id pub-id-type="pmid">17101121</pub-id>
</element-citation>
</ref>
<ref id="B10-brainsci-08-00154">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ober</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Loisel</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Gilad</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Sex-specific genetic architecture of human disease</article-title>
<source/>Nat. Rev. Genet.
          <year>2008</year>
<volume>9</volume>
<fpage>911</fpage>
<lpage>922</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2415</pub-id>
<pub-id pub-id-type="pmid">19002143</pub-id>
</element-citation>
</ref>
<ref id="B11-brainsci-08-00154">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>V.M.</given-names>
</name>
</person-group>
<article-title>Why are sex and gender important to basic physiology and translational and individualized medicine?</article-title>
<source/>Am. J. Physiol.-Heart Circ. Physiol.
          <year>2014</year>
<volume>306</volume>
<fpage>H781</fpage>
<lpage>H788</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00994.2013</pub-id>
<pub-id pub-id-type="pmid">24414073</pub-id>
</element-citation>
</ref>
<ref id="B12-brainsci-08-00154">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingalhalikar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Satterthwaite</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Ruparel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gur</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Gur</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Sex differences in the structural connectome of the human brain</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2014</year>
<volume>111</volume>
<fpage>823</fpage>
<lpage>828</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1316909110</pub-id>
<pub-id pub-id-type="pmid">24297904</pub-id>
</element-citation>
</ref>
<ref id="B13-brainsci-08-00154">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewinsohn</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Seeley</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Major depressive disorder in older adolescents: Prevalence, risk factors, and clinical implications</article-title>
<source/>Clin. Psychol. Rev.
          <year>1998</year>
<volume>18</volume>
<fpage>765</fpage>
<lpage>794</lpage>
<pub-id pub-id-type="doi">10.1016/S0272-7358(98)00010-5</pub-id>
<pub-id pub-id-type="pmid">9827321</pub-id>
</element-citation>
</ref>
<ref id="B14-brainsci-08-00154">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biederman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mick</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Braaten</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wilens</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Frazier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic</article-title>
<source/>Am. J. Psychiatry
          <year>2002</year>
<volume>159</volume>
<fpage>36</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.159.1.36</pub-id>
<pub-id pub-id-type="pmid">11772687</pub-id>
</element-citation>
</ref>
<ref id="B15-brainsci-08-00154">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillies</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Pienaar</surname>
<given-names>I.S.</given-names>
</name>
<name>
<surname>Vohra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qamhawi</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Sex differences in parkinson’s disease</article-title>
<source/>Front. Neuroendocr.
          <year>2014</year>
<volume>35</volume>
<fpage>370</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2014.02.002</pub-id>
<pub-id pub-id-type="pmid">24607323</pub-id>
</element-citation>
</ref>
<ref id="B16-brainsci-08-00154">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haaxma</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Bloem</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Borm</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Oyen</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Leenders</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Eshuis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dluzen</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Horstink</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Gender differences in parkinson’s disease</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2007</year>
<volume>78</volume>
<fpage>819</fpage>
<lpage>824</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2006.103788</pub-id>
<pub-id pub-id-type="pmid">17098842</pub-id>
</element-citation>
</ref>
<ref id="B17-brainsci-08-00154">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Den Eeden</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Tanner</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Fross</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Leimpeter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Incidence of parkinson’s disease: Variation by age, gender, and race/ethnicity</article-title>
<source/>Am. J. Epidemiol.
          <year>2003</year>
<volume>157</volume>
<fpage>1015</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="doi">10.1093/aje/kwg068</pub-id>
<pub-id pub-id-type="pmid">12777365</pub-id>
</element-citation>
</ref>
<ref id="B18-brainsci-08-00154">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCombe</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Review article: Effects of gender in amyotrophic lateral sclerosis</article-title>
<source/>Gend. Med.
          <year>2010</year>
<volume>7</volume>
<fpage>557</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1016/j.genm.2010.11.010</pub-id>
<pub-id pub-id-type="pmid">21195356</pub-id>
</element-citation>
</ref>
<ref id="B19-brainsci-08-00154">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Prevalence of amyotrophic lateral sclerosis—United States, 2010–2011</article-title>
<source/>Am. J. Public Health
          <year>2015</year>
<volume>105</volume>
<fpage>e7</fpage>
<lpage>e9</lpage>
</element-citation>
</ref>
<ref id="B20-brainsci-08-00154">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Sex differences in cognitive impairment and Alzheimer’s disease</article-title>
<source/>Front. Neuroendocr.
          <year>2014</year>
<volume>35</volume>
<fpage>385</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2014.01.002</pub-id>
<pub-id pub-id-type="pmid">24434111</pub-id>
</element-citation>
</ref>
<ref id="B21-brainsci-08-00154">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hebert</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Weuve</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Scherr</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Alzheimer disease in the United States (2010–2050) estimated using the 2010 census</article-title>
<source/>Neurology
          <year>2013</year>
<volume>80</volume>
<fpage>1778</fpage>
<lpage>1783</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e31828726f5</pub-id>
<pub-id pub-id-type="pmid">23390181</pub-id>
</element-citation>
</ref>
<ref id="B22-brainsci-08-00154">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beeson</surname>
<given-names>P.B.</given-names>
</name>
</person-group>
<article-title>Age and sex associations of 40 autoimmune diseases</article-title>
<source/>Am. J. Med.
          <year>1994</year>
<volume>96</volume>
<fpage>457</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1016/0002-9343(94)90173-2</pub-id>
<pub-id pub-id-type="pmid">8192178</pub-id>
</element-citation>
</ref>
<ref id="B23-brainsci-08-00154">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hernán</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Temporal trends in the incidence of multiple sclerosis</article-title>
<source/>Neurology
          <year>2008</year>
<volume>71</volume>
<fpage>129</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000316802.35974.34</pub-id>
<pub-id pub-id-type="pmid">18606967</pub-id>
</element-citation>
</ref>
<ref id="B24-brainsci-08-00154">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Hurn</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Woodruff</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Sohrabji</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schiebinger</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wetherington</surname>
<given-names>C.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Considering sex as a biological variable in preclinical research</article-title>
<source/>FASEB J.
          <year>2017</year>
<volume>31</volume>
<fpage>29</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201600781R</pub-id>
<pub-id pub-id-type="pmid">27682203</pub-id>
</element-citation>
</ref>
<ref id="B25-brainsci-08-00154">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarthy</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Reframing sexual differentiation of the brain</article-title>
<source/>Nat. Neurosci.
          <year>2011</year>
<volume>14</volume>
<fpage>677</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2834</pub-id>
<pub-id pub-id-type="pmid">21613996</pub-id>
</element-citation>
</ref>
<ref id="B26-brainsci-08-00154">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dewing</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Sinchak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fernagut</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chesselet</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Micevych</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>V.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct regulation of adult brain function by the male-specific factor <italic>SRY</italic></article-title>
<source/>Curr. Biol.
          <year>2006</year>
<volume>16</volume>
<fpage>415</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2006.01.017</pub-id>
<pub-id pub-id-type="pmid">16488877</pub-id>
</element-citation>
</ref>
<ref id="B27-brainsci-08-00154">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jazin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cahill</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Sex differences in molecular neuroscience: From fruit flies to humans</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2010</year>
<volume>11</volume>
<fpage>9</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2754</pub-id>
<pub-id pub-id-type="pmid">20019686</pub-id>
</element-citation>
</ref>
<ref id="B28-brainsci-08-00154">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McEwen</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Milner</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Understanding the broad influence of sex hormones and sex differences in the brain</article-title>
<source/>J. Neurosci. Res.
          <year>2017</year>
<volume>95</volume>
<fpage>24</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.23809</pub-id>
<pub-id pub-id-type="pmid">27870427</pub-id>
</element-citation>
</ref>
<ref id="B29-brainsci-08-00154">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sisk</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Zehr</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Pubertal hormones organize the adolescent brain and behavior</article-title>
<source/>Front. Neuroendocr.
          <year>2005</year>
<volume>26</volume>
<fpage>163</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2005.10.003</pub-id>
<pub-id pub-id-type="pmid">16309736</pub-id>
</element-citation>
</ref>
<ref id="B30-brainsci-08-00154">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neufang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Specht</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hausmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Güntürkün</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Herpertz-Dahlmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Konrad</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Sex differences and the impact of steroid hormones on the developing human brain</article-title>
<source/>Cereb. Cortex
          <year>2008</year>
<volume>19</volume>
<fpage>464</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhn100</pub-id>
<pub-id pub-id-type="pmid">18550597</pub-id>
</element-citation>
</ref>
<ref id="B31-brainsci-08-00154">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Gorski</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Gonadal steroid induction of structural sex differences in the central nervous system</article-title>
<source/>Annu. Rev. Neurosci.
          <year>1984</year>
<volume>7</volume>
<fpage>413</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.ne.07.030184.002213</pub-id>
<pub-id pub-id-type="pmid">6370082</pub-id>
</element-citation>
</ref>
<ref id="B32-brainsci-08-00154">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dluzen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Horstink</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Estrogen as neuroprotectant of nigrostriatal dopaminergic system: Laboratory and clinical studies</article-title>
<source/>Endocrine
          <year>2003</year>
<volume>21</volume>
<fpage>67</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1385/ENDO:21:1:67</pub-id>
<pub-id pub-id-type="pmid">12777705</pub-id>
</element-citation>
</ref>
<ref id="B33-brainsci-08-00154">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourque</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dluzen</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Di Paolo</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Neuroprotective actions of sex steroids in parkinson’s disease</article-title>
<source/>Front. Neuroendocr.
          <year>2009</year>
<volume>30</volume>
<fpage>142</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2009.04.014</pub-id>
<pub-id pub-id-type="pmid">19410597</pub-id>
</element-citation>
</ref>
<ref id="B34-brainsci-08-00154">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulkarni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>de Castella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Gurvich</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bartholomeusz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Estrogen in severe mental illness: A potential new treatment approach</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2008</year>
<volume>65</volume>
<fpage>955</fpage>
<lpage>960</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.65.8.955</pub-id>
<pub-id pub-id-type="pmid">18678800</pub-id>
</element-citation>
</ref>
<ref id="B35-brainsci-08-00154">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martel</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Gobrogge</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Breedlove</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Nigg</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Masculinized finger-length ratios of boys, but not girls, are associated with attention-deficit/hyperactivity disorder</article-title>
<source/>Behav. Neurosci.
          <year>2008</year>
<volume>122</volume>
<fpage>273</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.122.2.273</pub-id>
<pub-id pub-id-type="pmid">18410167</pub-id>
</element-citation>
</ref>
<ref id="B36-brainsci-08-00154">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Bruin</surname>
<given-names>E.I.</given-names>
</name>
<name>
<surname>Verheij</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wiegman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ferdinand</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Differences in finger length ratio between males with autism, pervasive developmental disorder-not otherwise specified, adhd, and anxiety disorders</article-title>
<source/>Dev. Med. Child. Neurol.
          <year>2006</year>
<volume>48</volume>
<fpage>962</fpage>
<lpage>965</lpage>
<pub-id pub-id-type="doi">10.1017/S0012162206002118</pub-id>
<pub-id pub-id-type="pmid">17109783</pub-id>
</element-citation>
</ref>
<ref id="B37-brainsci-08-00154">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues?</article-title>
<source/>Front. Neuroendocr.
          <year>2009</year>
<volume>30</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2008.11.001</pub-id>
<pub-id pub-id-type="pmid">19028515</pub-id>
</element-citation>
</ref>
<ref id="B38-brainsci-08-00154">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dewing</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vilain</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation</article-title>
<source/>Brain Res. Mol. Brain Res.
          <year>2003</year>
<volume>118</volume>
<fpage>82</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1016/S0169-328X(03)00339-5</pub-id>
<pub-id pub-id-type="pmid">14559357</pub-id>
</element-citation>
</ref>
<ref id="B39-brainsci-08-00154">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wittchen</surname>
<given-names>H.U.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Eaton</surname>
<given-names>W.W.</given-names>
</name>
</person-group>
<article-title>Dsm-III-r generalized anxiety disorder in the national comorbidity survey</article-title>
<source/>Arch. Gen. Psychiatry
          <year>1994</year>
<volume>51</volume>
<fpage>355</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.1994.03950050015002</pub-id>
<pub-id pub-id-type="pmid">8179459</pub-id>
</element-citation>
</ref>
<ref id="B40-brainsci-08-00154">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breslau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Andreski</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults</article-title>
<source/>Boil. Psychiatry
          <year>1996</year>
<volume>39</volume>
<fpage>411</fpage>
<lpage>418</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3223(95)00188-3</pub-id>
</element-citation>
</ref>
<ref id="B41-brainsci-08-00154">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Pharmacotherapy of anxiety disorders: A critical review</article-title>
<source/>Dialogues Clin. Neurosci.
          <year>2011</year>
<volume>13</volume>
<fpage>423</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="pmid">22275848</pub-id>
</element-citation>
</ref>
<ref id="B42-brainsci-08-00154">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altemus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sarvaiya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Neill Epperson</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Sex differences in anxiety and depression clinical perspectives</article-title>
<source/>Front. Neuroendocr.
          <year>2014</year>
<volume>35</volume>
<fpage>320</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2014.05.004</pub-id>
<pub-id pub-id-type="pmid">24887405</pub-id>
</element-citation>
</ref>
<ref id="B43-brainsci-08-00154">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacKinaw-Koons</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Vasey</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Considering sex differences in anxiety and its disorders across the life span: A construct-validation approach</article-title>
<source/>Appl. Prev. Psychol.
          <year>2000</year>
<volume>9</volume>
<fpage>191</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1016/S0962-1849(05)80004-6</pub-id>
</element-citation>
</ref>
<ref id="B44-brainsci-08-00154">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bekker</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>Agoraphobia and gender: A review</article-title>
<source/>Clin. Psychol. Rev.
          <year>1996</year>
<volume>16</volume>
<fpage>129</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="doi">10.1016/0272-7358(96)00012-8</pub-id>
</element-citation>
</ref>
<ref id="B45-brainsci-08-00154">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bekker</surname>
<given-names>M.H.J.</given-names>
</name>
</person-group>
<article-title>Anxiety disorders: Sex differences in prevalence, degree, and background, but gender-neutral treatment</article-title>
<source/>Gend. Med.
          <year>2007</year>
<volume>4</volume>
<fpage>S178</fpage>
<lpage>S193</lpage>
<pub-id pub-id-type="doi">10.1016/S1550-8579(07)80057-X</pub-id>
<pub-id pub-id-type="pmid">18156102</pub-id>
</element-citation>
</ref>
<ref id="B46-brainsci-08-00154">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Bevilaqua</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>da Fonseca</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Nardi</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Thuret</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>G.P.</given-names>
</name>
</person-group>
<article-title>Gender differences in the neurobiology of anxiety: Focus on adult hippocampal neurogenesis</article-title>
<source/>Neural. Plast.
          <year>2016</year>
<fpage>5026713</fpage>
<pub-id pub-id-type="doi">10.1155/2016/5026713</pub-id>
<pub-id pub-id-type="pmid">26885403</pub-id>
</element-citation>
</ref>
<ref id="B47-brainsci-08-00154">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cover</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Maeng</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Lebron-Milad</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Milad</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Mechanisms of estradiol in fear circuitry: Implications for sex differences in psychopathology</article-title>
<source/>Transl. Psychiatry
          <year>2014</year>
<volume>4</volume>
<fpage>e422</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2014.67</pub-id>
<pub-id pub-id-type="pmid">25093600</pub-id>
</element-citation>
</ref>
<ref id="B48-brainsci-08-00154">
<label>48.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Health Organisation</collab>
</person-group>
<source/>Depression and Other Common Mental Disorders: Global Health Estimates
          <publisher-name>WHO</publisher-name>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<year>2017</year>
</element-citation>
</ref>
<ref id="B49-brainsci-08-00154">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Global mortality, disability, and the contribution of risk factors: Global burden of disease study</article-title>
<source/>Lancet
          <year>1997</year>
<volume>349</volume>
<fpage>1436</fpage>
<lpage>1442</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(96)07495-8</pub-id>
<pub-id pub-id-type="pmid">9164317</pub-id>
</element-citation>
</ref>
<ref id="B50-brainsci-08-00154">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammen</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Padesky</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Sex differences in the expression of depressive responses on the beck depression inventory</article-title>
<source/>J. Abnorm. Psychol.
          <year>1977</year>
<volume>86</volume>
<fpage>609</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1037/0021-843X.86.6.609</pub-id>
<pub-id pub-id-type="pmid">599211</pub-id>
</element-citation>
</ref>
<ref id="B51-brainsci-08-00154">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steer</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Sex differences on the revised beck depression inventory for outpatients with affective disorders</article-title>
<source/>J. Pers. Assess.
          <year>1989</year>
<volume>53</volume>
<fpage>693</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1207/s15327752jpa5304_6</pub-id>
<pub-id pub-id-type="pmid">2607401</pub-id>
</element-citation>
</ref>
<ref id="B52-brainsci-08-00154">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kornstein</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Thase</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Yonkers</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>McCullough</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Keitner</surname>
<given-names>G.I.</given-names>
</name>
<name>
<surname>Gelenberg</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gender differences in chronic major and double depression</article-title>
<source/>J. Affect. Disord.
          <year>2000</year>
<volume>60</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0327(99)00158-5</pub-id>
<pub-id pub-id-type="pmid">10940442</pub-id>
</element-citation>
</ref>
<ref id="B53-brainsci-08-00154">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ressler</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Nemeroff</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders</article-title>
<source/>Depression Anxiety
          <year>2000</year>
<volume>12</volume>
<issue>Suppl. 1</issue>
<fpage>2</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1002/1520-6394(2000)12:1+&lt;2::AID-DA2&gt;3.0.CO;2-4</pub-id>
<pub-id pub-id-type="pmid">11098410</pub-id>
</element-citation>
</ref>
<ref id="B54-brainsci-08-00154">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Gliogenesis and glial pathology in depression</article-title>
<source/>CNS Neurol. Disord. Drug Targets
          <year>2007</year>
<volume>6</volume>
<fpage>219</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.2174/187152707780619326</pub-id>
<pub-id pub-id-type="pmid">17511618</pub-id>
</element-citation>
</ref>
<ref id="B55-brainsci-08-00154">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdallah</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>De Feyter</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Fasula</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krystal</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Rothman</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Sanacora</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Glutamate metabolism in major depressive disorder</article-title>
<source/>Am. J. Psychiatry
          <year>2014</year>
<volume>171</volume>
<fpage>1320</fpage>
<lpage>1327</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2014.14010067</pub-id>
<pub-id pub-id-type="pmid">25073688</pub-id>
</element-citation>
</ref>
<ref id="B56-brainsci-08-00154">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeRubeis</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Siegle</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Hollon</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Cognitive therapy vs. Medications for depression: Treatment outcomes and neural mechanisms</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2008</year>
<volume>9</volume>
<fpage>788</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2345</pub-id>
<pub-id pub-id-type="pmid">18784657</pub-id>
</element-citation>
</ref>
<ref id="B57-brainsci-08-00154">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kessler</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>McGonagle</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Swartz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blazer</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Sex and depression in the national comorbidity survey. II: Cohort effects</article-title>
<source/>J. Affect. Disord.
          <year>1994</year>
<volume>30</volume>
<fpage>15</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/0165-0327(94)90147-3</pub-id>
<pub-id pub-id-type="pmid">8151045</pub-id>
</element-citation>
</ref>
<ref id="B58-brainsci-08-00154">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kessler</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>McGonagle</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Swartz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blazer</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Sex and depression in the national comorbidity survey. I: Lifetime prevalence, chronicity and recurrence</article-title>
<source/>J. Affect. Disord.
          <year>1993</year>
<volume>29</volume>
<fpage>85</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/0165-0327(93)90026-G</pub-id>
<pub-id pub-id-type="pmid">8300981</pub-id>
</element-citation>
</ref>
<ref id="B59-brainsci-08-00154">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Mirowsky</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Explaining the social patterns of depression: Control and problem solving—Or support and talking?</article-title>
<source/>J. Health Soc. Behav.
          <year>1989</year>
<volume>30</volume>
<fpage>206</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="doi">10.2307/2137014</pub-id>
<pub-id pub-id-type="pmid">2738367</pub-id>
</element-citation>
</ref>
<ref id="B60-brainsci-08-00154">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noble</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Depression in women</article-title>
<source/>Metab. Clin. Exp.
          <year>2005</year>
<volume>54</volume>
<fpage>49</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2005.01.014</pub-id>
<pub-id pub-id-type="pmid">15877314</pub-id>
</element-citation>
</ref>
<ref id="B61-brainsci-08-00154">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seeman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kapur</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Schizophrenia: More dopamine, more d(2) receptors</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2000</year>
<volume>97</volume>
<fpage>7673</fpage>
<lpage>7675</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.97.14.7673</pub-id>
<pub-id pub-id-type="pmid">10884398</pub-id>
</element-citation>
</ref>
<ref id="B62-brainsci-08-00154">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldstein</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Cherkerzian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsuang</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Petryshen</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>Sex differences in the genetic risk for schizophrenia: History of the evidence for sex-specific and sex-dependent effects</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2013</year>
<volume>162B</volume>
<fpage>698</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32159</pub-id>
<pub-id pub-id-type="pmid">24132902</pub-id>
</element-citation>
</ref>
<ref id="B63-brainsci-08-00154">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Kosten</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.Y.</given-names>
</name>
</person-group>
<article-title>Free radicals, antioxidant defense systems, and schizophrenia</article-title>
<source/>Prog. Neuro-Psychopharmacol. Boil. Psychiatry
          <year>2013</year>
<volume>46</volume>
<fpage>200</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.02.015</pub-id>
<pub-id pub-id-type="pmid">23470289</pub-id>
</element-citation>
</ref>
<ref id="B64-brainsci-08-00154">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>The neuropathology of schizophrenia. A critical review of the data and their interpretation</article-title>
<source/>Brain A J. Neurol.
          <year>1999</year>
<volume>122 Pt 4</volume>
<fpage>593</fpage>
<lpage>624</lpage>
<pub-id pub-id-type="doi">10.1093/brain/122.4.593</pub-id>
</element-citation>
</ref>
<ref id="B65-brainsci-08-00154">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howes</surname>
<given-names>O.D.</given-names>
</name>
<name>
<surname>Kapur</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The dopamine hypothesis of schizophrenia: Version III—the final common pathway</article-title>
<source/>Schizophr. Bull.
          <year>2009</year>
<volume>35</volume>
<fpage>549</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1093/schbul/sbp006</pub-id>
<pub-id pub-id-type="pmid">19325164</pub-id>
</element-citation>
</ref>
<ref id="B66-brainsci-08-00154">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aghajanian</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Marek</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Serotonin and hallucinogens</article-title>
<source/>Neuropsychopharmacology
          <year>1999</year>
<volume>21</volume>
<fpage>16S</fpage>
<lpage>23S</lpage>
<pub-id pub-id-type="doi">10.1016/S0893-133X(98)00135-3</pub-id>
<pub-id pub-id-type="pmid">10432484</pub-id>
</element-citation>
</ref>
<ref id="B67-brainsci-08-00154">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goff</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Coyle</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>The emerging role of glutamate in the pathophysiology and treatment of schizophrenia</article-title>
<source/>Am. J. Psychiatry
          <year>2001</year>
<volume>158</volume>
<fpage>1367</fpage>
<lpage>1377</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.158.9.1367</pub-id>
<pub-id pub-id-type="pmid">11532718</pub-id>
</element-citation>
</ref>
<ref id="B68-brainsci-08-00154">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laruelle</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1996</year>
<volume>93</volume>
<fpage>9235</fpage>
<lpage>9240</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.93.17.9235</pub-id>
<pub-id pub-id-type="pmid">8799184</pub-id>
</element-citation>
</ref>
<ref id="B69-brainsci-08-00154">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joyce</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Linking the family of d2 receptors to neuronal circuits in human brain: Insights into schizophrenia</article-title>
<source/>Neuropsychopharmacology
          <year>1997</year>
<volume>16</volume>
<fpage>375</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1016/S0893-133X(96)00276-X</pub-id>
<pub-id pub-id-type="pmid">9165493</pub-id>
</element-citation>
</ref>
<ref id="B70-brainsci-08-00154">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapur</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Arenovich</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Agid</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zipursky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lindborg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Evidence for onset of antipsychotic effects within the first 24 h of treatment</article-title>
<source/>Am. J. Psychiatry
          <year>2005</year>
<volume>162</volume>
<fpage>939</fpage>
<lpage>946</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.162.5.939</pub-id>
<pub-id pub-id-type="pmid">15863796</pub-id>
</element-citation>
</ref>
<ref id="B71-brainsci-08-00154">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seeman</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Seeman</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Is schizophrenia a dopamine supersensitivity psychotic reaction?</article-title>
<source/>Prog. Neuro-Psychopharmacol. Boil. Psychiatry
          <year>2014</year>
<volume>48</volume>
<fpage>155</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.10.003</pub-id>
<pub-id pub-id-type="pmid">24128684</pub-id>
</element-citation>
</ref>
<ref id="B72-brainsci-08-00154">
<label>72.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Lavrestsky</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>History of Schizophrenia as a Psychiatric Disorder</article-title>
<source/>Clinical Handbook of Schizophrenia
          <publisher-name>Guilford Publications</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2008</year>
</element-citation>
</ref>
<ref id="B73-brainsci-08-00154">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochoa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Usall</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cobo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Labad</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review</article-title>
<source/>Schizophr. Res. Treat.
          <year>2012</year>
<fpage>916198</fpage>
<pub-id pub-id-type="doi">10.1155/2012/916198</pub-id>
<pub-id pub-id-type="pmid">22966451</pub-id>
</element-citation>
</ref>
<ref id="B74-brainsci-08-00154">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kendell</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Diagnosis and classification of functional psychoses</article-title>
<source/>Br. Med Bull.
          <year>1987</year>
<volume>43</volume>
<fpage>499</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.bmb.a072198</pub-id>
<pub-id pub-id-type="pmid">3322482</pub-id>
</element-citation>
</ref>
<ref id="B75-brainsci-08-00154">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shtasel</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Gur</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Gallacher</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Heimberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gur</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>Gender differences in the clinical expression of schizophrenia</article-title>
<source/>Schizophr. Res.
          <year>1992</year>
<volume>7</volume>
<fpage>225</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1016/0920-9964(92)90016-X</pub-id>
<pub-id pub-id-type="pmid">1390401</pub-id>
</element-citation>
</ref>
<ref id="B76-brainsci-08-00154">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Castle</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Jablensky</surname>
<given-names>A.V.</given-names>
</name>
</person-group>
<article-title>Do women express and experience psychosis differently from men? Epidemiological evidence from the australian national study of low prevalence (psychotic) disorders</article-title>
<source/>Aust. N. Z. J. Psychiatry
          <year>2008</year>
<volume>42</volume>
<fpage>74</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1080/00048670701732699</pub-id>
<pub-id pub-id-type="pmid">18058447</pub-id>
</element-citation>
</ref>
<ref id="B77-brainsci-08-00154">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGlashan</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Bardenstein</surname>
<given-names>K.K.</given-names>
</name>
</person-group>
<article-title>Gender differences in affective, schizoaffective, and schizophrenic disorders</article-title>
<source/>Schizophr. Bull.
          <year>1990</year>
<volume>16</volume>
<fpage>319</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1093/schbul/16.2.319</pub-id>
<pub-id pub-id-type="pmid">2374887</pub-id>
</element-citation>
</ref>
<ref id="B78-brainsci-08-00154">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayeux</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Epidemiology of Alzheimer disease</article-title>
<source/>Cold Spring Harbor Perspect. Med.
          <year>2012</year>
<volume>2</volume>
<fpage>1</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a006239</pub-id>
<pub-id pub-id-type="pmid">22908189</pub-id>
</element-citation>
</ref>
<ref id="B79-brainsci-08-00154">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mielke</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Vemuri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rocca</surname>
<given-names>W.A.</given-names>
</name>
</person-group>
<article-title>Clinical epidemiology of Alzheimer’s disease: Assessing sex and gender differences</article-title>
<source/>Clin. Epidemiol.
          <year>2014</year>
<volume>6</volume>
<fpage>37</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.2147/CLEP.S37929</pub-id>
<pub-id pub-id-type="pmid">24470773</pub-id>
</element-citation>
</ref>
<ref id="B80-brainsci-08-00154">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitehouse</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Coyle</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>DeLong</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis</article-title>
<source/>Ann. Neurol. Off. J. Am. Neurol. Assoc. Child. Neurol. Soc.
          <year>1981</year>
<volume>10</volume>
<fpage>122</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410100203</pub-id>
<pub-id pub-id-type="pmid">7283399</pub-id>
</element-citation>
</ref>
<ref id="B81-brainsci-08-00154">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>The molecular pathology of alzheimer’s disease</article-title>
<source/>Neuron
          <year>1991</year>
<volume>6</volume>
<fpage>487</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(91)90052-2</pub-id>
<pub-id pub-id-type="pmid">1673054</pub-id>
</element-citation>
</ref>
<ref id="B82-brainsci-08-00154">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glenner</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>1984</year>
<volume>120</volume>
<fpage>885</fpage>
<lpage>890</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-291X(84)80190-4</pub-id>
<pub-id pub-id-type="pmid">6375662</pub-id>
</element-citation>
</ref>
<ref id="B83-brainsci-08-00154">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coyle</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Delong</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease: A disorder of cortical cholinergic innervation</article-title>
<source/>Science
          <year>1983</year>
<volume>219</volume>
<fpage>1184</fpage>
<lpage>1190</lpage>
<pub-id pub-id-type="doi">10.1126/science.6338589</pub-id>
<pub-id pub-id-type="pmid">6338589</pub-id>
</element-citation>
</ref>
<ref id="B84-brainsci-08-00154">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perl</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>Neuropathology of alzheimer’s disease</article-title>
<source/>Mount Sinai J. Med. J. Transl. Personalized Med. J. Transl. Pers. Med.
          <year>2010</year>
<volume>77</volume>
<fpage>32</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1002/msj.20157</pub-id>
<pub-id pub-id-type="pmid">20101720</pub-id>
</element-citation>
</ref>
<ref id="B85-brainsci-08-00154">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Neuropathological stageing of alzheimer-related changes</article-title>
<source/>Acta Neuropathol.
          <year>1991</year>
<volume>82</volume>
<fpage>239</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1007/BF00308809</pub-id>
<pub-id pub-id-type="pmid">1759558</pub-id>
</element-citation>
</ref>
<ref id="B86-brainsci-08-00154">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wenk</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>Neuropathologic changes in alzheimer’s disease</article-title>
<source/>J. Clin. Psychiatry
          <year>2003</year>
<volume>64</volume>
<fpage>7</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">12934968</pub-id>
</element-citation>
</ref>
<ref id="B87-brainsci-08-00154">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Alzheimer’s Association</collab>
</person-group>
<article-title>2017 Alzheimer’s disease facts and figures</article-title>
<source/>Alzheimers Dement.
          <year>2017</year>
<volume>13</volume>
<fpage>325</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2017.02.001</pub-id>
</element-citation>
</ref>
<ref id="B88-brainsci-08-00154">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Launer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fratiglioni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Di Carlo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Breteler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dartigues</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jagger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martinez-Lage</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Prevalence of dementia and major subtypes in europe: A collaborative study of population-based cohorts</article-title>
<source/>Neurology
          <year>2000</year>
<volume>54</volume>
<fpage>S4</fpage>
<lpage>S9</lpage>
<pub-id pub-id-type="pmid">10854354</pub-id>
</element-citation>
</ref>
<ref id="B89-brainsci-08-00154">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zandi</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Plassman</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Welsh-Bohmer</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Steffens</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Breitner</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Investigators</surname>
<given-names>C.C.M.S.</given-names>
</name>
</person-group>
<article-title>Hormone replacement therapy and incidence of alzheimer disease in older women: The cache county study</article-title>
<source/>JAMA
          <year>2002</year>
<volume>288</volume>
<fpage>2123</fpage>
<lpage>2129</lpage>
<pub-id pub-id-type="doi">10.1001/jama.288.17.2123</pub-id>
<pub-id pub-id-type="pmid">12413371</pub-id>
</element-citation>
</ref>
<ref id="B90-brainsci-08-00154">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Resnick</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Mallampalli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kalbarczyk</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Sex and gender differences in alzheimer’s disease: Recommendations for future research</article-title>
<source/>J. Womens Health
          <year>2012</year>
<volume>21</volume>
<fpage>1018</fpage>
<lpage>1023</lpage>
<pub-id pub-id-type="doi">10.1089/jwh.2012.3789</pub-id>
<pub-id pub-id-type="pmid">22917473</pub-id>
</element-citation>
</ref>
<ref id="B91-brainsci-08-00154">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seshadri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beiser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kelly-Hayes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kase</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kannel</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>The lifetime risk of stroke: Estimates from the framingham study</article-title>
<source/>Stroke J. Cereb. Circ.
          <year>2006</year>
<volume>37</volume>
<fpage>345</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.0000199613.38911.b2</pub-id>
<pub-id pub-id-type="pmid">16397184</pub-id>
</element-citation>
</ref>
<ref id="B92-brainsci-08-00154">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaffe</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Toran-Allerand</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Greengard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gandy</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Estrogen regulates metabolism of alzheimer amyloid beta precursor protein</article-title>
<source/>J. Biol. Chem.
          <year>1994</year>
<volume>269</volume>
<fpage>13065</fpage>
<lpage>13068</lpage>
<pub-id pub-id-type="pmid">8175728</pub-id>
</element-citation>
</ref>
<ref id="B93-brainsci-08-00154">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plassman</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Langa</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Heeringa</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Ofstedal</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>W.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of dementia in the united states: The aging, demographics, and memory study</article-title>
<source/>Neuroepidemiology
          <year>2007</year>
<volume>29</volume>
<fpage>125</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1159/000109998</pub-id>
<pub-id pub-id-type="pmid">17975326</pub-id>
</element-citation>
</ref>
<ref id="B94-brainsci-08-00154">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Bienias</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Sex differences in the clinical manifestations of alzheimer disease pathology</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2005</year>
<volume>62</volume>
<fpage>685</fpage>
<lpage>691</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.62.6.685</pub-id>
<pub-id pub-id-type="pmid">15939846</pub-id>
</element-citation>
</ref>
<ref id="B95-brainsci-08-00154">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ardekani</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Convit</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bachman</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Analysis of the miriad data shows sex differences in hippocampal atrophy progression</article-title>
<source/>J. Alzheimers Disease JAD
          <year>2016</year>
<volume>50</volume>
<fpage>847</fpage>
<lpage>857</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-150780</pub-id>
<pub-id pub-id-type="pmid">26836168</pub-id>
</element-citation>
</ref>
<ref id="B96-brainsci-08-00154">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tschanz</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Corcoran</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Treiber</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Norton</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Mielke</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Piercy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rabins</surname>
<given-names>P.V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with alzheimer dementia: The cache county dementia progression study</article-title>
<source/>Am. J. Geriatr. Psychiatry Off. J. Am. Assoc. Geriatr. Psychiatry
          <year>2011</year>
<volume>19</volume>
<fpage>532</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1097/JGP.0b013e3181faec23</pub-id>
<pub-id pub-id-type="pmid">21606896</pub-id>
</element-citation>
</ref>
<ref id="B97-brainsci-08-00154">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinforiani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Citterio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zucchella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bono</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Corbetta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Merlo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mauri</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Impact of gender differences on the outcome of alzheimer’s disease</article-title>
<source/>Dement. Geriatr. Cogn. Disorders
          <year>2010</year>
<volume>30</volume>
<fpage>147</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1159/000318842</pub-id>
<pub-id pub-id-type="pmid">20733307</pub-id>
</element-citation>
</ref>
<ref id="B98-brainsci-08-00154">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henderson</surname>
<given-names>V.W.</given-names>
</name>
<name>
<surname>Buckwalter</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>Cognitive deficits of men and women with alzheimer’s disease</article-title>
<source/>Neurology
          <year>1994</year>
<volume>44</volume>
<fpage>90</fpage>
<pub-id pub-id-type="doi">10.1212/WNL.44.1.90</pub-id>
<pub-id pub-id-type="pmid">8290098</pub-id>
</element-citation>
</ref>
<ref id="B99-brainsci-08-00154">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Read</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Gatz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vuoksimaa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Malmberg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McClearn</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>Sex differences after all those years? Heritability of cognitive abilities in old age</article-title>
<source/>J. Gerontol. Ser. B Psychol. Sci. Soc. Sci.
          <year>2006</year>
<volume>61</volume>
<fpage>P137</fpage>
<lpage>P143</lpage>
<pub-id pub-id-type="doi">10.1093/geronb/61.3.P137</pub-id>
<pub-id pub-id-type="pmid">16670182</pub-id>
</element-citation>
</ref>
<ref id="B100-brainsci-08-00154">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proust-Lima</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Amieva</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Letenneur</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Orgogozo</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Jacqmin-Gadda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dartigues</surname>
<given-names>J.-F.</given-names>
</name>
</person-group>
<article-title>Gender and education impact on brain aging: A general cognitive factor approach</article-title>
<source/>Psychol. Aging
          <year>2008</year>
<volume>23</volume>
<fpage>608</fpage>
<lpage>620</lpage>
<pub-id pub-id-type="doi">10.1037/a0012838</pub-id>
<pub-id pub-id-type="pmid">18808250</pub-id>
</element-citation>
</ref>
<ref id="B101-brainsci-08-00154">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laws</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Irvine</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gale</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>Sex differences in cognitive impairment in alzheimer’s disease</article-title>
<source/>World J. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>54</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.5498/wjp.v6.i1.54</pub-id>
<pub-id pub-id-type="pmid">27014598</pub-id>
</element-citation>
</ref>
<ref id="B102-brainsci-08-00154">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scacchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gambina</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Broggio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Corbo Rosa</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Sex and esr1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with alzheimer’s disease</article-title>
<source/>Int. J. Geriatr. Psychiatry
          <year>2013</year>
<volume>29</volume>
<fpage>610</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1002/gps.4043</pub-id>
<pub-id pub-id-type="pmid">24150894</pub-id>
</element-citation>
</ref>
<ref id="B103-brainsci-08-00154">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Bejar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Weinstock</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats</article-title>
<source/>Neuropharmacology
          <year>2000</year>
<volume>39</volume>
<fpage>497</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/S0028-3908(99)00157-4</pub-id>
<pub-id pub-id-type="pmid">10698015</pub-id>
</element-citation>
</ref>
<ref id="B104-brainsci-08-00154">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canevelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Quarata</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Remiddi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lucchini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lacorte</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vanacore</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cesari</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Sex and gender differences in the treatment of alzheimer’s disease: A systematic review of randomized controlled trials</article-title>
<source/>Pharmacol. Res.
          <year>2017</year>
<volume>115</volume>
<fpage>218</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2016.11.035</pub-id>
<pub-id pub-id-type="pmid">27913252</pub-id>
</element-citation>
</ref>
<ref id="B105-brainsci-08-00154">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sospedra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Immunology of multiple sclerosis</article-title>
<source/>Annu. Rev. Immunol.
          <year>2004</year>
<volume>23</volume>
<fpage>683</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115707</pub-id>
<pub-id pub-id-type="pmid">15771584</pub-id>
</element-citation>
</ref>
<ref id="B106-brainsci-08-00154">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuhlmann</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Relapsing–remitting and primary progressive ms have the same cause(s)—The neuropathologist’s view: 2</article-title>
<source/>Mult. Scler. J.
          <year>2013</year>
<volume>19</volume>
<fpage>268</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1177/1352458513476563</pub-id>
<pub-id pub-id-type="pmid">23426170</pub-id>
</element-citation>
</ref>
<ref id="B107-brainsci-08-00154">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raffel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wakerley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nicholas</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis</article-title>
<source/>Medicine
          <year>2016</year>
<volume>44</volume>
<fpage>537</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1016/j.mpmed.2016.06.005</pub-id>
</element-citation>
</ref>
<ref id="B108-brainsci-08-00154">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sánchez</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Nieto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barroso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Martín</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hernández</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing–remitting multiple sclerosis</article-title>
<source/>Eur. J. Neurol.
          <year>2008</year>
<volume>15</volume>
<fpage>1091</fpage>
<lpage>1099</lpage>
<pub-id pub-id-type="doi">10.1111/j.1468-1331.2008.02259.x</pub-id>
<pub-id pub-id-type="pmid">18727673</pub-id>
</element-citation>
</ref>
<ref id="B109-brainsci-08-00154">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizvi</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Agius</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Current approved options for treating patients with multiple sclerosis</article-title>
<source/>Neurology
          <year>2004</year>
<volume>63</volume>
<fpage>S8</fpage>
<lpage>S14</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.63.12_suppl_6.S8</pub-id>
<pub-id pub-id-type="pmid">15623672</pub-id>
</element-citation>
</ref>
<ref id="B110-brainsci-08-00154">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebers</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Sadovnick</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Dyment</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>I.M.L.</given-names>
</name>
<name>
<surname>Willer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Risch</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Parent-of-origin effect in multiple sclerosis: Observations in half-siblings</article-title>
<source/>Lancet
          <year>2004</year>
<volume>363</volume>
<fpage>1773</fpage>
<lpage>1774</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(04)16304-6</pub-id>
<pub-id pub-id-type="pmid">15172777</pub-id>
</element-citation>
</ref>
<ref id="B111-brainsci-08-00154">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glad</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Nyland</surname>
<given-names>H.I.</given-names>
</name>
<name>
<surname>Aarseth</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Riise</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Myhr</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Long-term follow-up of benign multiple sclerosis in hordaland county, western norway</article-title>
<source/>Mult. Scler.
          <year>2009</year>
<volume>15</volume>
<fpage>942</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="doi">10.1177/1352458509106511</pub-id>
<pub-id pub-id-type="pmid">19570821</pub-id>
</element-citation>
</ref>
<ref id="B112-brainsci-08-00154">
<label>112.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Bergamaschi</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Prognostic factors in multiple sclerosis</article-title>
<source/>International Review of Neurobiology
          <publisher-name>Academic Press</publisher-name>
<publisher-loc>Cambridge, MA, USA</publisher-loc>
<year>2007</year>
<volume>Volume 79</volume>
<fpage>423</fpage>
<lpage>447</lpage>
</element-citation>
</ref>
<ref id="B113-brainsci-08-00154">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinshenker</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>G.P.A.</given-names>
</name>
<name>
<surname>Noseworthy</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Carriere</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Baskerville</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ebers</surname>
<given-names>G.C.</given-names>
</name>
</person-group>
<article-title>The natural history of multiple sclerosis: A geographically based study3. Multivariate analysis of predictive factors and models of outcome</article-title>
<source/>Brain
          <year>1991</year>
<volume>114</volume>
<fpage>1045</fpage>
<lpage>1056</lpage>
<pub-id pub-id-type="doi">10.1093/brain/114.2.1045</pub-id>
<pub-id pub-id-type="pmid">2043940</pub-id>
</element-citation>
</ref>
<ref id="B114-brainsci-08-00154">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pozzilli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tomassini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Marinelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Paolillo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gasperini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bastianello</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>‘Gender gap’ in multiple sclerosis: Magnetic resonance imaging evidence</article-title>
<source/>Eur. J. Neurol.
          <year>2003</year>
<volume>10</volume>
<fpage>95</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1046/j.1468-1331.2003.00519.x</pub-id>
<pub-id pub-id-type="pmid">12535003</pub-id>
</element-citation>
</ref>
<ref id="B115-brainsci-08-00154">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greer</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Csurhes</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Pender</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>McCombe</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls</article-title>
<source/>J. Autoimmun.
          <year>2004</year>
<volume>22</volume>
<fpage>345</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2004.03.004</pub-id>
<pub-id pub-id-type="pmid">15120759</pub-id>
</element-citation>
</ref>
<ref id="B116-brainsci-08-00154">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luchetti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van Eden</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Schuurman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>van Strien</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Swaab</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Huitinga</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Gender differences in multiple sclerosis: Induction of estrogen signaling in male and progesterone signaling in female lesions</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>2014</year>
<volume>73</volume>
<fpage>123</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1097/NEN.0000000000000037</pub-id>
<pub-id pub-id-type="pmid">24423637</pub-id>
</element-citation>
</ref>
<ref id="B117-brainsci-08-00154">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname>
<given-names>T.-P.</given-names>
</name>
<name>
<surname>Landsborough</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hsi</surname>
<given-names>M.-S.</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis amongst Chinese in Taiwan</article-title>
<source/>J. Neurol. Sci.
          <year>1976</year>
<volume>27</volume>
<fpage>459</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1016/0022-510X(76)90214-8</pub-id>
<pub-id pub-id-type="pmid">1262905</pub-id>
</element-citation>
</ref>
<ref id="B118-brainsci-08-00154">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kira</surname>
<given-names>J.-I.</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis in the Japanese population</article-title>
<source/>Lancet Neurol.
          <year>2003</year>
<volume>2</volume>
<fpage>117</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(03)00308-9</pub-id>
<pub-id pub-id-type="pmid">12849268</pub-id>
</element-citation>
</ref>
<ref id="B119-brainsci-08-00154">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orton</surname>
<given-names>S.-M.</given-names>
</name>
<name>
<surname>Herrera</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Valdar</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ramagopalan</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Sadovnick</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Ebers</surname>
<given-names>G.C.</given-names>
</name>
</person-group>
<article-title>Sex ratio of multiple sclerosis in Canada: A longitudinal study</article-title>
<source/>Lancet Neurol.
          <year>2006</year>
<volume>5</volume>
<fpage>932</fpage>
<lpage>936</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(06)70581-6</pub-id>
<pub-id pub-id-type="pmid">17052660</pub-id>
</element-citation>
</ref>
<ref id="B120-brainsci-08-00154">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maghzi</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Ghazavi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ahsan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Etemadifar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mousavi</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Khorvash</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Minagar</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Increasing female preponderance of multiple sclerosis in Isfahan, Iran: A population-based study</article-title>
<source/>Mult. Scler. J.
          <year>2010</year>
<volume>16</volume>
<fpage>359</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1177/1352458509358092</pub-id>
<pub-id pub-id-type="pmid">20086021</pub-id>
</element-citation>
</ref>
<ref id="B121-brainsci-08-00154">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ingram</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pickersgill</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Swingler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Compston</surname>
<given-names>D.A.S.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>N.P.</given-names>
</name>
</person-group>
<article-title>Increasing prevalence and incidence of multiple sclerosis in south east wales</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2009</year>
<volume>80</volume>
<fpage>386</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2008.144667</pub-id>
<pub-id pub-id-type="pmid">18931003</pub-id>
</element-citation>
</ref>
<ref id="B122-brainsci-08-00154">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celius</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Smestad</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades</article-title>
<source/>Acta Neurol. Scand. Suppl.
          <year>2009</year>
<fpage>27</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0404.2009.01208.x</pub-id>
<pub-id pub-id-type="pmid">19566494</pub-id>
</element-citation>
</ref>
<ref id="B123-brainsci-08-00154">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sidhom</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hizem</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nasri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kacem</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Djebara</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Gargouri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gouider</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A prospective study on the prognosis of multiple sclerosis in tunisia: Do we really have a distinct disease course in north africa?</article-title>
<source/>Mult. Scler. Relat. Disord.
          <year>2014</year>
<volume>3</volume>
<fpage>740</fpage>
<lpage>741</lpage>
<pub-id pub-id-type="doi">10.1016/j.msard.2014.09.157</pub-id>
</element-citation>
</ref>
<ref id="B124-brainsci-08-00154">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Autism: Many genes, common pathways?</article-title>
<source/>Cell
          <year>2008</year>
<volume>135</volume>
<fpage>391</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.10.016</pub-id>
<pub-id pub-id-type="pmid">18984147</pub-id>
</element-citation>
</ref>
<ref id="B125-brainsci-08-00154">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Autism</article-title>
<source/>Lancet
          <year>2014</year>
<volume>383</volume>
<fpage>896</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id>
<pub-id pub-id-type="pmid">24074734</pub-id>
</element-citation>
</ref>
<ref id="B126-brainsci-08-00154">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webb</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Early identification of autism: Early characteristics, onset of symptoms, and diagnostic stability</article-title>
<source/>Infants Young Child.
          <year>2009</year>
<volume>22</volume>
<fpage>100</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1097/IYC.0b013e3181a02f7f</pub-id>
<pub-id pub-id-type="pmid">28090148</pub-id>
</element-citation>
</ref>
<ref id="B127-brainsci-08-00154">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bespalova</surname>
<given-names>I.N.</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Disease susceptibility genes for autism</article-title>
<source/>Ann. Med.
          <year>2003</year>
<volume>35</volume>
<fpage>274</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.1080/07853890310005966</pub-id>
<pub-id pub-id-type="pmid">12846270</pub-id>
</element-citation>
</ref>
<ref id="B128-brainsci-08-00154">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kassebaum</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Bhutta</surname>
<given-names>Z.A.</given-names>
</name>
<name>
<surname>Dandona</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gething</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Kinfu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>S.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global, regional, and national levels of maternal mortality, 1990–2015: A systematic analysis for the global burden of disease study 2015</article-title>
<source/>Lancet
          <year>2016</year>
<volume>388</volume>
<fpage>1775</fpage>
<lpage>1812</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(16)31470-2</pub-id>
<pub-id pub-id-type="pmid">27733286</pub-id>
</element-citation>
</ref>
<ref id="B129-brainsci-08-00154">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wiggins</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Maenner</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kurzius-Spencer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zahorodny</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Robinson Rosenberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, united states, 2014</article-title>
<source/>MMWR Surveill. Summ.
          <year>2018</year>
<volume>67</volume>
<fpage>1</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.15585/mmwr.ss6706a1</pub-id>
<pub-id pub-id-type="pmid">29701730</pub-id>
</element-citation>
</ref>
<ref id="B130-brainsci-08-00154">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newschaffer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Giarelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Pinto-Martin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Reaven</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The epidemiology of autism spectrum disorders</article-title>
<source/>Annu. Rev. Public Health
          <year>2007</year>
<volume>28</volume>
<fpage>235</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.publhealth.28.021406.144007</pub-id>
<pub-id pub-id-type="pmid">17367287</pub-id>
</element-citation>
</ref>
<ref id="B131-brainsci-08-00154">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chugani</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Muzik</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rothermel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Behen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mangner</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Chugani</surname>
<given-names>H.T.</given-names>
</name>
</person-group>
<article-title>Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys</article-title>
<source/>Ann. Neurol.
          <year>1997</year>
<volume>42</volume>
<fpage>666</fpage>
<lpage>669</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410420420</pub-id>
<pub-id pub-id-type="pmid">9382481</pub-id>
</element-citation>
</ref>
<ref id="B132-brainsci-08-00154">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chugani</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Muzik</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Behen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rothermel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Janisse</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chugani</surname>
<given-names>H.T.</given-names>
</name>
</person-group>
<article-title>Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children</article-title>
<source/>Ann. Neurol.
          <year>1999</year>
<volume>45</volume>
<fpage>287</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="doi">10.1002/1531-8249(199903)45:3&lt;287::AID-ANA3&gt;3.0.CO;2-9</pub-id>
<pub-id pub-id-type="pmid">10072042</pub-id>
</element-citation>
</ref>
<ref id="B133-brainsci-08-00154">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachevalier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Loveland</surname>
<given-names>K.A.</given-names>
</name>
</person-group>
<article-title>The orbitofrontal–amygdala circuit and self-regulation of social–emotional behavior in autism</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2006</year>
<volume>30</volume>
<fpage>97</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2005.07.002</pub-id>
<pub-id pub-id-type="pmid">16157377</pub-id>
</element-citation>
</ref>
<ref id="B134-brainsci-08-00154">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ring</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Bullmore</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Wheelwright</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ashwin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>S.C.R.</given-names>
</name>
</person-group>
<article-title>The amygdala theory of autism</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2000</year>
<volume>24</volume>
<fpage>355</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1016/S0149-7634(00)00011-7</pub-id>
<pub-id pub-id-type="pmid">10781695</pub-id>
</element-citation>
</ref>
<ref id="B135-brainsci-08-00154">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saemundsen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Georgsdottir</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Egilsson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rafnsson</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Prevalence of autism spectrum disorders in an icelandic birth cohort</article-title>
<source/>BMJ Open
          <year>2013</year>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1136/bmjopen-2013-002748</pub-id>
<pub-id pub-id-type="pmid">23788511</pub-id>
</element-citation>
</ref>
<ref id="B136-brainsci-08-00154">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Laska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Cheon</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of autism spectrum disorders in a total population sample</article-title>
<source/>Am. J. Psychiatry
          <year>2011</year>
<volume>168</volume>
<fpage>904</fpage>
<lpage>912</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10101532</pub-id>
<pub-id pub-id-type="pmid">21558103</pub-id>
</element-citation>
</ref>
<ref id="B137-brainsci-08-00154">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halladay</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Constantino</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Koenig</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Messinger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pelphrey</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>A.T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex and gender differences in autism spectrum disorder: Summarizing evidence gaps and identifying emerging areas of priority</article-title>
<source/>Mol. Autism
          <year>2015</year>
<volume>6</volume>
<fpage>36</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0019-y</pub-id>
<pub-id pub-id-type="pmid">26075049</pub-id>
</element-citation>
</ref>
<ref id="B138-brainsci-08-00154">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cederlund</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lamberg</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zeijlon</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Brief report: “The autism epidemic”. The registered prevalence of autism in a swedish urban area</article-title>
<source/>J. Autism Dev. Disord.
          <year>2006</year>
<volume>36</volume>
<fpage>429</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-006-0081-6</pub-id>
<pub-id pub-id-type="pmid">16568356</pub-id>
</element-citation>
</ref>
<ref id="B139-brainsci-08-00154">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Auyeung</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Sex/gender differences and autism: Setting the scene for future research</article-title>
<source/>J. Am. Acad. Child. Adolesc. Psychiatry
          <year>2015</year>
<volume>54</volume>
<fpage>11</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaac.2014.10.003</pub-id>
<pub-id pub-id-type="pmid">25524786</pub-id>
</element-citation>
</ref>
<ref id="B140-brainsci-08-00154">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frazier</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Georgiades</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Hardan</surname>
<given-names>A.Y.</given-names>
</name>
</person-group>
<article-title>Behavioral and cognitive characteristics of females and males with autism in the simons simplex collection</article-title>
<source/>J. Am. Acad. Child. Adolesc. Psychiatry
          <year>2014</year>
<volume>53</volume>
<fpage>329</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaac.2013.12.004</pub-id>
<pub-id pub-id-type="pmid">24565360</pub-id>
</element-citation>
</ref>
<ref id="B141-brainsci-08-00154">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zwaigenbaum</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bryson</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Vaillancourt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Roncadin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Sex differences in children with autism spectrum disorder identified within a high-risk infant cohort</article-title>
<source/>J. Autism Dev. Disord.
          <year>2012</year>
<volume>42</volume>
<fpage>2585</fpage>
<lpage>2596</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-012-1515-y</pub-id>
<pub-id pub-id-type="pmid">22453928</pub-id>
</element-citation>
</ref>
<ref id="B142-brainsci-08-00154">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gockley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Constantino</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>The female protective effect in autism spectrum disorder is not mediated by a single genetic locus</article-title>
<source/>Mol. Autism
          <year>2015</year>
<volume>6</volume>
<fpage>25</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0014-3</pub-id>
<pub-id pub-id-type="pmid">25973162</pub-id>
</element-citation>
</ref>
<ref id="B143-brainsci-08-00154">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Understanding autism in the light of sex/gender</article-title>
<source/>Mol. Autism
          <year>2015</year>
<volume>6</volume>
<fpage>24</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0021-4</pub-id>
<pub-id pub-id-type="pmid">25973161</pub-id>
</element-citation>
</ref>
<ref id="B144-brainsci-08-00154">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The extreme male brain theory of autism</article-title>
<source/>Trends Cogn. Sci.
          <year>2002</year>
<volume>6</volume>
<fpage>248</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/S1364-6613(02)01904-6</pub-id>
<pub-id pub-id-type="pmid">12039606</pub-id>
</element-citation>
</ref>
<ref id="B145-brainsci-08-00154">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polanczyk</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>de Lima</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Horta</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>The worldwide prevalence of ADHD: A systematic review and metaregression analysis</article-title>
<source/>Am. J. Psychiatry
          <year>2007</year>
<volume>164</volume>
<fpage>942</fpage>
<lpage>948</lpage>
<pub-id pub-id-type="doi">10.1176/ajp.2007.164.6.942</pub-id>
<pub-id pub-id-type="pmid">17541055</pub-id>
</element-citation>
</ref>
<ref id="B146-brainsci-08-00154">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biederman</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Attention-deficit hyperactivity disorder</article-title>
<source/>Lancet
          <year>2005</year>
<volume>366</volume>
<fpage>237</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(05)66915-2</pub-id>
<pub-id pub-id-type="pmid">16023516</pub-id>
</element-citation>
</ref>
<ref id="B147-brainsci-08-00154">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pliszka</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>The neuropsychopharmacology of attention-deficit/hyperactivity disorder</article-title>
<source/>Biol. Psychiatry
          <year>2005</year>
<volume>57</volume>
<fpage>1385</fpage>
<lpage>1390</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2004.08.026</pub-id>
<pub-id pub-id-type="pmid">15950012</pub-id>
</element-citation>
</ref>
<ref id="B148-brainsci-08-00154">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Couture</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)</article-title>
<source/>Ann. Pharmacother.
          <year>2014</year>
<volume>48</volume>
<fpage>209</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1177/1060028013510699</pub-id>
<pub-id pub-id-type="pmid">24259638</pub-id>
</element-citation>
</ref>
<ref id="B149-brainsci-08-00154">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnsten</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Pliszka</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders</article-title>
<source/>Pharmacol. Biochem. Behav.
          <year>2011</year>
<volume>99</volume>
<fpage>211</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2011.01.020</pub-id>
<pub-id pub-id-type="pmid">21295057</pub-id>
</element-citation>
</ref>
<ref id="B150-brainsci-08-00154">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biederman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arnsten</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Wilens</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Safren</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Culpepper</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>New developments in the treatment of adhd</article-title>
<source/>J. Clin. Psychiatry
          <year>2006</year>
<volume>67</volume>
<fpage>148</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="pmid">16426101</pub-id>
</element-citation>
</ref>
<ref id="B151-brainsci-08-00154">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solanto</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Wasserstein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Abikoff</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Alvir</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Kofman</surname>
<given-names>M.D.</given-names>
</name>
</person-group>
<article-title>Efficacy of meta-cognitive therapy for adult adhd</article-title>
<source/>Am. J. Psychiatry
          <year>2010</year>
<volume>167</volume>
<fpage>958</fpage>
<lpage>968</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2009.09081123</pub-id>
<pub-id pub-id-type="pmid">20231319</pub-id>
</element-citation>
</ref>
<ref id="B152-brainsci-08-00154">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balint</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Czobor</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Komlosi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meszaros</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bitter</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Attention deficit hyperactivity disorder (ADHD): Gender- and age-related differences in neurocognition</article-title>
<source/>Psychol. Med.
          <year>2009</year>
<volume>39</volume>
<fpage>1337</fpage>
<lpage>1345</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291708004236</pub-id>
<pub-id pub-id-type="pmid">18713489</pub-id>
</element-citation>
</ref>
<ref id="B153-brainsci-08-00154">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biederman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wilens</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder</article-title>
<source/>Int. J. Neuropsychopharmacol. Off. Sci. J. Coll. Int. Neuropsychopharmacol. (CINP)
          <year>2004</year>
<volume>7</volume>
<fpage>77</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1017/S1461145703003973</pub-id>
<pub-id pub-id-type="pmid">14733627</pub-id>
</element-citation>
</ref>
<ref id="B154-brainsci-08-00154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaub</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>C.L.</given-names>
</name>
</person-group>
<article-title>Gender differences in adhd: A meta-analysis and critical review</article-title>
<source/>J. Am. Acad. Child. Adolesc. Psychiatry
          <year>1997</year>
<volume>36</volume>
<fpage>1036</fpage>
<lpage>1045</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199708000-00011</pub-id>
<pub-id pub-id-type="pmid">9256583</pub-id>
</element-citation>
</ref>
<ref id="B155-brainsci-08-00154">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graetz</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Sawyer</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Baghurst</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Gender differences among children with DSM-IV ADHD in Australia</article-title>
<source/>J. Am. Acad Child. Adolesc Psychiatry
          <year>2005</year>
<volume>44</volume>
<fpage>159</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-200502000-00008</pub-id>
<pub-id pub-id-type="pmid">15689729</pub-id>
</element-citation>
</ref>
<ref id="B156-brainsci-08-00154">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rucklidge</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Gender differences in ADHD: Implications for psychosocial treatments</article-title>
<source/>Expert Rev. Neurother.
          <year>2008</year>
<volume>8</volume>
<fpage>643</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="doi">10.1586/14737175.8.4.643</pub-id>
<pub-id pub-id-type="pmid">18416665</pub-id>
</element-citation>
</ref>
<ref id="B157-brainsci-08-00154">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willcutt</surname>
<given-names>E.G.</given-names>
</name>
</person-group>
<article-title>The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review</article-title>
<source/>Neurotherapeutics
          <year>2012</year>
<volume>9</volume>
<fpage>490</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-012-0135-8</pub-id>
<pub-id pub-id-type="pmid">22976615</pub-id>
</element-citation>
</ref>
<ref id="B158-brainsci-08-00154">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnett</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Willcutt</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>DeFries</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>R.K.</given-names>
</name>
</person-group>
<article-title>Sex differences in ADHD symptom severity</article-title>
<source/>J. Child. Psychol. Psychiatry
          <year>2015</year>
<volume>56</volume>
<fpage>632</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1111/jcpp.12337</pub-id>
<pub-id pub-id-type="pmid">25283790</pub-id>
</element-citation>
</ref>
<ref id="B159-brainsci-08-00154">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Sex differences in attention deficit hyperactivity disorder: Candidate genetic and endocrine mechanisms</article-title>
<source/>Front. Neuroendocrinol.
          <year>2014</year>
<volume>35</volume>
<fpage>331</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2014.03.003</pub-id>
<pub-id pub-id-type="pmid">24680800</pub-id>
</element-citation>
</ref>
<ref id="B160-brainsci-08-00154">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahey</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Applegate</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McBurnett</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Greenhill</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hynd</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Barkley</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Newcorn</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Richters</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents</article-title>
<source/>Am. J. Psychiatry
          <year>1994</year>
<volume>151</volume>
<fpage>1673</fpage>
<lpage>1685</lpage>
<pub-id pub-id-type="pmid">7943460</pub-id>
</element-citation>
</ref>
<ref id="B161-brainsci-08-00154">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willcutt</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Nigg</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Solanto</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Tannock</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Loo</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>McBurnett</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lahey</surname>
<given-names>B.B.</given-names>
</name>
</person-group>
<article-title>Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes</article-title>
<source/>J. Abnorm. Psychol.
          <year>2012</year>
<volume>121</volume>
<fpage>991</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="doi">10.1037/a0027347</pub-id>
<pub-id pub-id-type="pmid">22612200</pub-id>
</element-citation>
</ref>
<ref id="B162-brainsci-08-00154">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barry</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Selikowitz</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Age and gender effects in EEG coherence: III. Girls with attention-deficit/hyperactivity disorder</article-title>
<source/>Clin. Neurophysiol.
          <year>2006</year>
<volume>117</volume>
<fpage>243</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinph.2005.09.026</pub-id>
<pub-id pub-id-type="pmid">16376608</pub-id>
</element-citation>
</ref>
<ref id="B163-brainsci-08-00154">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hermens</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Soei</surname>
<given-names>E.X.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Kohn</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Resting EEG theta activity predicts cognitive performance in attention-deficit hyperactivity disorder</article-title>
<source/>Pediatr. Neurol.
          <year>2005</year>
<volume>32</volume>
<fpage>248</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2004.11.009</pub-id>
<pub-id pub-id-type="pmid">15797181</pub-id>
</element-citation>
</ref>
<ref id="B164-brainsci-08-00154">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hermens</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Lazzaro</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Whitmont</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Melkonian</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Sex differences in adult ADHD: A double dissociation in brain activity and autonomic arousal</article-title>
<source/>Biol. Psychol.
          <year>2004</year>
<volume>66</volume>
<fpage>221</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsycho.2003.10.006</pub-id>
<pub-id pub-id-type="pmid">15099695</pub-id>
</element-citation>
</ref>
<ref id="B165-brainsci-08-00154">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Demontis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mattheisen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brikell</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ghirardi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lichtenstein</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A genetic investigation of sex bias in the prevalence of attention-deficit/hyperactivity disorder</article-title>
<source/>Biol. Psychiatry
          <year>2018</year>
<volume>83</volume>
<fpage>1044</fpage>
<lpage>1053</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.11.026</pub-id>
<pub-id pub-id-type="pmid">29325848</pub-id>
</element-citation>
</ref>
<ref id="B166-brainsci-08-00154">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albin</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Mink</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Recent advances in tourette syndrome research</article-title>
<source/>Trends Neurosci.
          <year>2006</year>
<volume>29</volume>
<fpage>175</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2006.01.001</pub-id>
<pub-id pub-id-type="pmid">16430974</pub-id>
</element-citation>
</ref>
<ref id="B167-brainsci-08-00154">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Gilles de la tourette syndrome: The complexities of phenotype and treatment</article-title>
<source/>Br. J. Hosp. Med.
          <year>2011</year>
<volume>72</volume>
<fpage>100</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.12968/hmed.2011.72.2.100</pub-id>
</element-citation>
</ref>
<ref id="B168-brainsci-08-00154">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Walkup</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment</article-title>
<source/>Medicine
          <year>1991</year>
<volume>70</volume>
<fpage>15</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1097/00005792-199101000-00002</pub-id>
<pub-id pub-id-type="pmid">1988764</pub-id>
</element-citation>
</ref>
<ref id="B169-brainsci-08-00154">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghanizadeh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mosallaei</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Psychiatric disorders and behavioral problems in children and adolescents with tourette syndrome</article-title>
<source/>Brain Dev.
          <year>2009</year>
<volume>31</volume>
<fpage>15</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1016/j.braindev.2008.03.010</pub-id>
<pub-id pub-id-type="pmid">18558469</pub-id>
</element-citation>
</ref>
<ref id="B170-brainsci-08-00154">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Piedad</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rickards</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cavanna</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>The role of impulse control disorders in tourette syndrome: An exploratory study</article-title>
<source/>J. Neurol. Sci.
          <year>2011</year>
<volume>310</volume>
<fpage>276</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2011.06.032</pub-id>
<pub-id pub-id-type="pmid">21741055</pub-id>
</element-citation>
</ref>
<ref id="B171-brainsci-08-00154">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stern</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Silbersweig</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Chee</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Trimble</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Frith</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Frackowiak</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Dolan</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>A functional neuroanatomy of tics in tourette syndrome</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2000</year>
<volume>57</volume>
<fpage>741</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.57.8.741</pub-id>
<pub-id pub-id-type="pmid">10920461</pub-id>
</element-citation>
</ref>
<ref id="B172-brainsci-08-00154">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minzer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Increased prefrontal d2 protein in tourette syndrome: A postmortem analysis of frontal cortex and striatum</article-title>
<source/>J. Neurol. Sci.
          <year>2004</year>
<volume>219</volume>
<fpage>55</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2003.12.006</pub-id>
<pub-id pub-id-type="pmid">15050438</pub-id>
</element-citation>
</ref>
<ref id="B173-brainsci-08-00154">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Christian</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Gelfand</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mantil</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sallee</surname>
<given-names>F.R.</given-names>
</name>
</person-group>
<article-title>Altered mesolimbocortical and thalamic dopamine in tourette syndrome</article-title>
<source/>Neurology
          <year>2006</year>
<volume>67</volume>
<fpage>1695</fpage>
<lpage>1697</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000242733.18534.2c</pub-id>
<pub-id pub-id-type="pmid">17101911</pub-id>
</element-citation>
</ref>
<ref id="B174-brainsci-08-00154">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steeves</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Kideckel</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Rusjan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Houle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sandor</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Strafella</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Extrastriatal dopaminergic dysfunction in tourette syndrome</article-title>
<source/>Ann. Neurol.
          <year>2010</year>
<volume>67</volume>
<fpage>170</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21809</pub-id>
<pub-id pub-id-type="pmid">20225192</pub-id>
</element-citation>
</ref>
<ref id="B175-brainsci-08-00154">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buse</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schoenefeld</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Munchau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roessner</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Neuromodulation in tourette syndrome: Dopamine and beyond</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2013</year>
<volume>37</volume>
<fpage>1069</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.10.004</pub-id>
<pub-id pub-id-type="pmid">23085211</pub-id>
</element-citation>
</ref>
<ref id="B176-brainsci-08-00154">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>Z.A.</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Tics and tourette syndrome</article-title>
<source/>Psychiatr. Clin. N. Am.
          <year>2014</year>
<volume>37</volume>
<fpage>269</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1016/j.psc.2014.05.001</pub-id>
<pub-id pub-id-type="pmid">25150562</pub-id>
</element-citation>
</ref>
<ref id="B177-brainsci-08-00154">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egolf</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Current pharmacotherapeutic approaches for the treatment of tourette syndrome</article-title>
<source/>Drugs Today
          <year>2014</year>
<volume>50</volume>
<fpage>159</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1358/dot.2014.50.2.2097801</pub-id>
<pub-id pub-id-type="pmid">24619591</pub-id>
</element-citation>
</ref>
<ref id="B178-brainsci-08-00154">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutta</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cavanna</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>The effectiveness of habit reversal therapy in the treatment of tourette syndrome and other chronic tic disorders: A systematic review</article-title>
<source/>Funct. Neurol.
          <year>2013</year>
<volume>28</volume>
<fpage>7</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">23731910</pub-id>
</element-citation>
</ref>
<ref id="B179-brainsci-08-00154">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wile</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Pringsheim</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>Behavior therapy for tourette syndrome: A systematic review and meta-analysis</article-title>
<source/>Curr. Treat. Opt. Neurol.
          <year>2013</year>
<volume>15</volume>
<fpage>385</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="doi">10.1007/s11940-013-0238-5</pub-id>
<pub-id pub-id-type="pmid">23645295</pub-id>
</element-citation>
</ref>
<ref id="B180-brainsci-08-00154">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jankovic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kurlan</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Tourette syndrome: Evolving concepts</article-title>
<source/>Mov. Disord. Off. J. Mov. Disord. Soc.
          <year>2011</year>
<volume>26</volume>
<fpage>1149</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="doi">10.1002/mds.23618</pub-id>
<pub-id pub-id-type="pmid">21484868</pub-id>
</element-citation>
</ref>
<ref id="B181-brainsci-08-00154">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santangelo</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Pauls</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Tsuang</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Leckman</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Tourette’s syndrome: What are the influences of gender and comorbid obsessive-compulsive disorder?</article-title>
<source/>J. Am. Acad. Child. Adolesc. Psychiatry
          <year>1994</year>
<volume>33</volume>
<fpage>795</fpage>
<lpage>804</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199407000-00004</pub-id>
<pub-id pub-id-type="pmid">8083136</pub-id>
</element-citation>
</ref>
<ref id="B182-brainsci-08-00154">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baumgardner</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Denckla</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Abrams</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Colli</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Corpus callosum morphology in children with tourette syndrome and attention deficit hyperactivity disorder</article-title>
<source/>Neurology
          <year>1996</year>
<volume>47</volume>
<fpage>477</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.47.2.477</pub-id>
<pub-id pub-id-type="pmid">8757024</pub-id>
</element-citation>
</ref>
<ref id="B183-brainsci-08-00154">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mostofsky</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Wendlandt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cutting</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Denckla</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Corpus callosum measurements in girls with tourette syndrome</article-title>
<source/>Neurology
          <year>1999</year>
<volume>53</volume>
<fpage>1345</fpage>
<lpage>1347</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.53.6.1345</pub-id>
<pub-id pub-id-type="pmid">10522898</pub-id>
</element-citation>
</ref>
<ref id="B184-brainsci-08-00154">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lyttelton</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arnaoutelis</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sandor</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Brandner</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatosensory-motor bodily representation cortical thinning in tourette: Effects of tic severity, age and gender</article-title>
<source/>Cortex
          <year>2010</year>
<volume>46</volume>
<fpage>750</fpage>
<lpage>760</lpage>
<pub-id pub-id-type="doi">10.1016/j.cortex.2009.06.008</pub-id>
<pub-id pub-id-type="pmid">19733347</pub-id>
</element-citation>
</ref>
<ref id="B185-brainsci-08-00154">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lichter</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Finnegan</surname>
<given-names>S.G.</given-names>
</name>
</person-group>
<article-title>Influence of gender on tourette syndrome beyond adolescence</article-title>
<source/>Eur. Psychiatry J. Assoc. Eur. Psychiatry
          <year>2015</year>
<volume>30</volume>
<fpage>334</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1016/j.eurpsy.2014.07.003</pub-id>
<pub-id pub-id-type="pmid">25193042</pub-id>
</element-citation>
</ref>
<ref id="B186-brainsci-08-00154">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGrath</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Welham</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>El Saadi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>MacCauley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chant</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology</article-title>
<source/>BMC Med.
          <year>2004</year>
<volume>2</volume>
<elocation-id>13</elocation-id>
<pub-id pub-id-type="doi">10.1186/1741-7015-2-13</pub-id>
<pub-id pub-id-type="pmid">15115547</pub-id>
</element-citation>
</ref>
<ref id="B187-brainsci-08-00154">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castle</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Wessely</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Sex and schizophrenia: Effects of diagnostic stringency, and associations with and premorbid variables</article-title>
<source/>Br. J. Psychiatry
          <year>1993</year>
<volume>162</volume>
<fpage>658</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.162.5.658</pub-id>
<pub-id pub-id-type="pmid">8149118</pub-id>
</element-citation>
</ref>
<ref id="B188-brainsci-08-00154">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGrath</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chant</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Welham</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Schizophrenia: A concise overview of incidence, prevalence, and mortality</article-title>
<source/>Epidemiol. Rev.
          <year>2008</year>
<volume>30</volume>
<fpage>67</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1093/epirev/mxn001</pub-id>
<pub-id pub-id-type="pmid">18480098</pub-id>
</element-citation>
</ref>
<ref id="B189-brainsci-08-00154">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Werf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kohler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verkaaik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Verhey</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>van Winkel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Os</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Allardyce</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Systematic review and collaborative recalculation of 133,693 incident cases of schizophrenia</article-title>
<source/>Psychol. Med.
          <year>2014</year>
<volume>44</volume>
<fpage>9</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291712002796</pub-id>
<pub-id pub-id-type="pmid">23244442</pub-id>
</element-citation>
</ref>
<ref id="B190-brainsci-08-00154">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lang</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Lozano</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Parkinson’s disease. First of two parts</article-title>
<source/>N. Engl. J. Med.
          <year>1998</year>
<volume>339</volume>
<fpage>1044</fpage>
<lpage>1053</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199810083391506</pub-id>
<pub-id pub-id-type="pmid">9761807</pub-id>
</element-citation>
</ref>
<ref id="B191-brainsci-08-00154">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dauer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Przedborski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Parkinson’s disease: Mechanisms and models</article-title>
<source/>Neuron
          <year>2003</year>
<volume>39</volume>
<fpage>889</fpage>
<lpage>909</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(03)00568-3</pub-id>
<pub-id pub-id-type="pmid">12971891</pub-id>
</element-citation>
</ref>
<ref id="B192-brainsci-08-00154">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brotchie</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Venderova</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Levodopa-induced dyskinesia in parkinson’s disease</article-title>
<source/>J. Neural Transm.
          <year>2005</year>
<volume>112</volume>
<fpage>359</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="doi">10.1007/s00702-004-0251-7</pub-id>
<pub-id pub-id-type="pmid">15614429</pub-id>
</element-citation>
</ref>
<ref id="B193-brainsci-08-00154">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalia</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>Parkinson’s disease</article-title>
<source/>Lancet
          <year>2015</year>
<volume>386</volume>
<fpage>896</fpage>
<lpage>912</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(14)61393-3</pub-id>
<pub-id pub-id-type="pmid">25904081</pub-id>
</element-citation>
</ref>
<ref id="B194-brainsci-08-00154">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ascherio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schwarzschild</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>The epidemiology of parkinson’s disease: Risk factors and prevention</article-title>
<source/>Lancet Neurol.
          <year>2016</year>
<volume>15</volume>
<fpage>1257</fpage>
<lpage>1272</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(16)30230-7</pub-id>
<pub-id pub-id-type="pmid">27751556</pub-id>
</element-citation>
</ref>
<ref id="B195-brainsci-08-00154">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lesage</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brice</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Parkinson’s disease: From monogenic forms to genetic susceptibility factors</article-title>
<source/>Hum. Mol. Genet.
          <year>2009</year>
<volume>18</volume>
<fpage>R48</fpage>
<lpage>R59</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp012</pub-id>
<pub-id pub-id-type="pmid">19297401</pub-id>
</element-citation>
</ref>
<ref id="B196-brainsci-08-00154">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Lau</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Breteler</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Epidemiology of parkinson’s disease</article-title>
<source/>Lancet Neurol.
          <year>2006</year>
<volume>5</volume>
<fpage>525</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(06)70471-9</pub-id>
<pub-id pub-id-type="pmid">16713924</pub-id>
</element-citation>
</ref>
<ref id="B197-brainsci-08-00154">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldereschi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Di Carlo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rocca</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Vanni</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maggi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Perissinotto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grigoletto</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Amaducci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Inzitari</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men. Ilsa working group. Italian longitudinal study on aging</article-title>
<source/>Neurology
          <year>2000</year>
<volume>55</volume>
<fpage>1358</fpage>
<lpage>1363</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.55.9.1358</pub-id>
<pub-id pub-id-type="pmid">11087781</pub-id>
</element-citation>
</ref>
<ref id="B198-brainsci-08-00154">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wooten</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Currie</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Bovbjerg</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Patrie</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Are men at greater risk for parkinson’s disease than women?</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2004</year>
<volume>75</volume>
<fpage>637</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2003.020982</pub-id>
<pub-id pub-id-type="pmid">15026515</pub-id>
</element-citation>
</ref>
<ref id="B199-brainsci-08-00154">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>McArthur</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Razvi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Datla</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Dexter</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Gillies</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: Differential actions of estrogen in males and females</article-title>
<source/>Neuroscience
          <year>2003</year>
<volume>116</volume>
<fpage>213</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(02)00578-X</pub-id>
<pub-id pub-id-type="pmid">12535954</pub-id>
</element-citation>
</ref>
<ref id="B200-brainsci-08-00154">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leranth</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Elsworth</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Naftolin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Redmond</surname>
<given-names>D.E.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group>
<article-title>Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for parkinson’s disease and memory</article-title>
<source/>J. Neurosci.
          <year>2000</year>
<volume>20</volume>
<fpage>8604</fpage>
<lpage>8609</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-23-08604.2000</pub-id>
<pub-id pub-id-type="pmid">11102464</pub-id>
</element-citation>
</ref>
<ref id="B201-brainsci-08-00154">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cantuti-Castelvetri</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Keller-McGandy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bouzou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Asteris</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Frosch</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Standaert</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Effects of gender on nigral gene expression and parkinson disease</article-title>
<source/>Neurobiol. Dis.
          <year>2007</year>
<volume>26</volume>
<fpage>606</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2007.02.009</pub-id>
<pub-id pub-id-type="pmid">17412603</pub-id>
</element-citation>
</ref>
<ref id="B202-brainsci-08-00154">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pohjalainen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rinne</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Någren</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Syvälahti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hietala</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Sex differences in the striatal dopamine d2 receptor binding characteristics in vivo</article-title>
<source/>Am. J. Psychiatry
          <year>1998</year>
<volume>155</volume>
<fpage>768</fpage>
<lpage>773</lpage>
<pub-id pub-id-type="pmid">9619148</pub-id>
</element-citation>
</ref>
<ref id="B203-brainsci-08-00154">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huisman</surname>
<given-names>M.H.B.</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>van Doormaal</surname>
<given-names>P.T.C.</given-names>
</name>
<name>
<surname>Weinreich</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Schelhaas</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>van der Kooi</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>de Visser</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Veldink</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>Population based epidemiology of amyotrophic lateral sclerosis using capture–recapture methodology</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2011</year>
<volume>82</volume>
<fpage>1165</fpage>
<lpage>1170</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2011.244939</pub-id>
<pub-id pub-id-type="pmid">21622937</pub-id>
</element-citation>
</ref>
<ref id="B204-brainsci-08-00154">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Es</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Hardiman</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Chio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Al-Chalabi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pasterkamp</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Veldink</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>Amyotrophic lateral sclerosis</article-title>
<source/>Lancet
          <year>2017</year>
<volume>390</volume>
<fpage>2084</fpage>
<lpage>2098</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(17)31287-4</pub-id>
<pub-id pub-id-type="pmid">28552366</pub-id>
</element-citation>
</ref>
<ref id="B205-brainsci-08-00154">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Harrich</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>García-Martínez</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Gaynor</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Cloning and characterization of a novel cellular protein, tdp-43, that binds to human immunodeficiency virus type 1 tar DNA sequence motifs</article-title>
<source/>J. Virol.
          <year>1995</year>
<volume>69</volume>
<fpage>3584</fpage>
<lpage>3596</lpage>
<pub-id pub-id-type="pmid">7745706</pub-id>
</element-citation>
</ref>
<ref id="B206-brainsci-08-00154">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buratti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Baralle</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Multiple roles of tdp-43 in gene expression, splicing regulation, and human disease</article-title>
<source/>Front. Biosci.
          <year>2008</year>
<volume>13</volume>
<fpage>867</fpage>
<lpage>878</lpage>
<pub-id pub-id-type="doi">10.2741/2727</pub-id>
<pub-id pub-id-type="pmid">17981595</pub-id>
</element-citation>
</ref>
<ref id="B207-brainsci-08-00154">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sampathu</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Truax</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Micsenyi</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Bruce</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schuck</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Grossman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>C.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ubiquitinated tdp-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title>
<source/>Science
          <year>2006</year>
<volume>314</volume>
<fpage>130</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1126/science.1134108</pub-id>
<pub-id pub-id-type="pmid">17023659</pub-id>
</element-citation>
</ref>
<ref id="B208-brainsci-08-00154">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akiyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashizume</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Tdp-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2006</year>
<volume>351</volume>
<fpage>602</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2006.10.093</pub-id>
<pub-id pub-id-type="pmid">17084815</pub-id>
</element-citation>
</ref>
<ref id="B209-brainsci-08-00154">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buratti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Baralle</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>The molecular links between tdp-43 dysfunction and neurodegeneration</article-title>
<source/>Adv. Genet.
          <year>2009</year>
<volume>66</volume>
<fpage>1</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">19737636</pub-id>
</element-citation>
</ref>
<ref id="B210-brainsci-08-00154">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravits</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>La Spada</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Als motor phenotype heterogeneity, focality, and spread</article-title>
<source/>Neurology
          <year>2009</year>
<volume>73</volume>
<fpage>805</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b6bbbd</pub-id>
<pub-id pub-id-type="pmid">19738176</pub-id>
</element-citation>
</ref>
<ref id="B211-brainsci-08-00154">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wirdefeldt</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ronnevi</surname>
<given-names>L.-O.</given-names>
</name>
<name>
<surname>Al-Chalabi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Kamel</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e29749</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0029749</pub-id>
<pub-id pub-id-type="pmid">22216353</pub-id>
</element-citation>
</ref>
<ref id="B212-brainsci-08-00154">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Logroscino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Traynor</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Hardiman</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Chiò</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Swingler</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Millul</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Benn</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Beghi</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Incidence of amyotrophic lateral sclerosis in Europe</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2009</year>
<volume>81</volume>
<fpage>385</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.2009.183525</pub-id>
<pub-id pub-id-type="pmid">19710046</pub-id>
</element-citation>
</ref>
<ref id="B213-brainsci-08-00154">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worms</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>The epidemiology of motor neuron diseases: A review of recent studies</article-title>
<source/>J. Neurol. Sci.
          <year>2001</year>
<volume>191</volume>
<fpage>3</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-510X(01)00630-X</pub-id>
<pub-id pub-id-type="pmid">11676986</pub-id>
</element-citation>
</ref>
<ref id="B214-brainsci-08-00154">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haverkamp</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Appel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Appel</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Natural history of amyotrophic lateral sclerosis in a database population validation of a scoring system and a model for survival prediction</article-title>
<source/>Brain
          <year>1995</year>
<volume>118</volume>
<fpage>707</fpage>
<lpage>719</lpage>
<pub-id pub-id-type="doi">10.1093/brain/118.3.707</pub-id>
<pub-id pub-id-type="pmid">7600088</pub-id>
</element-citation>
</ref>
<ref id="B215-brainsci-08-00154">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manjaly</surname>
<given-names>Z.R.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Abhinav</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wijesekera</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ganesalingam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Willey</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>The sex ratio in amyotrophic lateral sclerosis: A population based study</article-title>
<source/>Amyotroph. Lateral Scler.
          <year>2010</year>
<volume>11</volume>
<fpage>439</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.3109/17482961003610853</pub-id>
<pub-id pub-id-type="pmid">20225930</pub-id>
</element-citation>
</ref>
<ref id="B216-brainsci-08-00154">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traynor</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Codd</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Corr</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Forde</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hardiman</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Incidence and prevalence of als in ireland, 1995–1997 a population-based study</article-title>
<source/>Neurology
          <year>1999</year>
<volume>52</volume>
<fpage>504</fpage>
<pub-id pub-id-type="doi">10.1212/WNL.52.3.504</pub-id>
<pub-id pub-id-type="pmid">10025778</pub-id>
</element-citation>
</ref>
<ref id="B217-brainsci-08-00154">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abhinav</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hardstaff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Orrell</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sakel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ampong</surname>
<given-names>M.-A.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Amyotrophic lateral sclerosis in south-east england: A population-based study</article-title>
<source/>Neuroepidemiology
          <year>2007</year>
<volume>29</volume>
<fpage>44</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1159/000108917</pub-id>
<pub-id pub-id-type="pmid">17898523</pub-id>
</element-citation>
</ref>
<ref id="B218-brainsci-08-00154">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meineri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tribolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schiffer</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Risk factors in motor neuron disease: A case-control study</article-title>
<source/>Neuroepidemiology
          <year>1991</year>
<volume>10</volume>
<fpage>174</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1159/000110267</pub-id>
<pub-id pub-id-type="pmid">1745327</pub-id>
</element-citation>
</ref>
<ref id="B219-brainsci-08-00154">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Breedlove</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Sexual differentiation of the vertebrate nervous system</article-title>
<source/>Nat. Neurosci.
          <year>2004</year>
<volume>7</volume>
<fpage>1034</fpage>
<lpage>1039</lpage>
<pub-id pub-id-type="doi">10.1038/nn1325</pub-id>
<pub-id pub-id-type="pmid">15452574</pub-id>
</element-citation>
</ref>
<ref id="B220-brainsci-08-00154">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berchtold</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Cribbs</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Head</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Beach</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Troncoso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
</person-group>
<article-title>Gene expression changes in the course of normal brain aging are sexually dimorphic</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>15605</fpage>
<lpage>15610</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0806883105</pub-id>
<pub-id pub-id-type="pmid">18832152</pub-id>
</element-citation>
</ref>
<ref id="B221-brainsci-08-00154">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blekhman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Zumbo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gilad</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Sex-specific and lineage-specific alternative splicing in primates</article-title>
<source/>Genome Res.
          <year>2010</year>
<volume>20</volume>
<fpage>180</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="doi">10.1101/gr.099226.109</pub-id>
<pub-id pub-id-type="pmid">20009012</pub-id>
</element-citation>
</ref>
<ref id="B222-brainsci-08-00154">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahr</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Maxson</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Just</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pilgrim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reisert</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Transcription of the y chromosomal gene, sry, in adult mouse brain</article-title>
<source/>Mol. Brain Res.
          <year>1995</year>
<volume>33</volume>
<fpage>179</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1016/0169-328X(95)00136-G</pub-id>
<pub-id pub-id-type="pmid">8774960</pub-id>
</element-citation>
</ref>
<ref id="B223-brainsci-08-00154">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lahr</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Swaab</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Pilgrim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reisert</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>The y-chromosomal genes sry and zfy are transcribed in adult human brain</article-title>
<source/>Neurogenetics
          <year>1998</year>
<volume>1</volume>
<fpage>281</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1007/s100480050042</pub-id>
<pub-id pub-id-type="pmid">10732804</pub-id>
</element-citation>
</ref>
<ref id="B224-brainsci-08-00154">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reinius</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Saetre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Blekhman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Merino-Martinez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gilad</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jazin</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>An evolutionarily conserved sexual signature in the primate brain</article-title>
<source/>PLoS Genet.
          <year>2008</year>
<volume>4</volume>
<elocation-id>e1000100</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000100</pub-id>
<pub-id pub-id-type="pmid">18566661</pub-id>
</element-citation>
</ref>
<ref id="B225-brainsci-08-00154">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vawter</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Choudary</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Molnar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Gender-specific gene expression in post-mortem human brain: Localization to sex chromosomes</article-title>
<source/>Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol.
          <year>2004</year>
<volume>29</volume>
<fpage>373</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300337</pub-id>
<pub-id pub-id-type="pmid">14583743</pub-id>
</element-citation>
</ref>
<ref id="B226-brainsci-08-00154">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Burgoyne</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Sex differences in sex chromosome gene expression in mouse brain</article-title>
<source/>Hum. Mol. Genet.
          <year>2002</year>
<volume>11</volume>
<fpage>1409</fpage>
<lpage>1419</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/11.12.1409</pub-id>
<pub-id pub-id-type="pmid">12023983</pub-id>
</element-citation>
</ref>
<ref id="B227-brainsci-08-00154">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Schadt</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Ingram-Drake</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Drake</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Lusis</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Tissue-specific expression and regulation of sexually dimorphic genes in mice</article-title>
<source/>Genome Res.
          <year>2006</year>
<volume>16</volume>
<fpage>995</fpage>
<lpage>1004</lpage>
<pub-id pub-id-type="doi">10.1101/gr.5217506</pub-id>
<pub-id pub-id-type="pmid">16825664</pub-id>
</element-citation>
</ref>
<ref id="B228-brainsci-08-00154">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galfalvy</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Erraji-Benchekroun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Smyrniotopoulos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pavlidis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Sibille</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Arango</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Sex genes for genomic analysis in human brain: Internal controls for comparison of probe level data extraction</article-title>
<source/>BMC Bioinform.
          <year>2003</year>
<volume>4</volume>
<fpage>37</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-4-37</pub-id>
<pub-id pub-id-type="pmid">12962547</pub-id>
</element-citation>
</ref>
<ref id="B229-brainsci-08-00154">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinn</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Marsden</surname>
<given-names>C.D.</given-names>
</name>
</person-group>
<article-title>Menstrual-related fluctuations in parkinson’s disease</article-title>
<source/>Mov. Disord.
          <year>1986</year>
<volume>1</volume>
<fpage>85</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1002/mds.870010112</pub-id>
<pub-id pub-id-type="pmid">3504235</pub-id>
</element-citation>
</ref>
<ref id="B230-brainsci-08-00154">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitacre</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Reingold</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Looney</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>A gender gap in autoimmunity</article-title>
<source/>Science
          <year>1999</year>
<volume>283</volume>
<fpage>1277</fpage>
<lpage>1278</lpage>
<pub-id pub-id-type="doi">10.1126/science.283.5406.1277</pub-id>
<pub-id pub-id-type="pmid">10084932</pub-id>
</element-citation>
</ref>
<ref id="B231-brainsci-08-00154">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merlo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spampinato</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Sortino</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Estrogen and alzheimer’s disease: Still an attractive topic despite disappointment from early clinical results</article-title>
<source/>Eur. J. Pharmacol.
          <year>2017</year>
<volume>817</volume>
<fpage>51</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2017.05.059</pub-id>
<pub-id pub-id-type="pmid">28577965</pub-id>
</element-citation>
</ref>
<ref id="B232-brainsci-08-00154">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Currie</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Trugman</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Wooten</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Postmenopausal estrogen use affects risk for parkinson disease</article-title>
<source/>Arch. Neurol.
          <year>2004</year>
<volume>61</volume>
<fpage>886</fpage>
<lpage>888</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.61.6.886</pub-id>
<pub-id pub-id-type="pmid">15210525</pub-id>
</element-citation>
</ref>
<ref id="B233-brainsci-08-00154">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsang</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations</article-title>
<source/>Neurology
          <year>2000</year>
<volume>54</volume>
<fpage>2292</fpage>
<lpage>2298</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.54.12.2292</pub-id>
<pub-id pub-id-type="pmid">10881255</pub-id>
</element-citation>
</ref>
<ref id="B234-brainsci-08-00154">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders-Pullman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gordon-Elliott</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Parides</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fahn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Bressman</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The effect of estrogen replacement on early parkinson’s disease</article-title>
<source/>Neurology
          <year>1999</year>
<volume>52</volume>
<fpage>1417</fpage>
<lpage>1421</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.52.7.1417</pub-id>
<pub-id pub-id-type="pmid">10227628</pub-id>
</element-citation>
</ref>
<ref id="B235-brainsci-08-00154">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finkelsztejn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paschoal</surname>
<given-names>F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Fragoso</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature</article-title>
<source/>BJOG Int. J. Obstet. Gynaecol.
          <year>2011</year>
<volume>118</volume>
<fpage>790</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-0528.2011.02931.x</pub-id>
<pub-id pub-id-type="pmid">21401856</pub-id>
</element-citation>
</ref>
<ref id="B236-brainsci-08-00154">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillies</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Dexter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McArthur</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of parkinson’s disease</article-title>
<source/>Pharmacol. Biochem. Behav.
          <year>2004</year>
<volume>78</volume>
<fpage>513</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2004.04.022</pub-id>
<pub-id pub-id-type="pmid">15251260</pub-id>
</element-citation>
</ref>
<ref id="B237-brainsci-08-00154">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bebo</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Fyfe-Johnson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adlard</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Beam</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Vandenbark</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Offner</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains</article-title>
<source/>J. Immunol.
          <year>2001</year>
<volume>166</volume>
<fpage>2080</fpage>
<lpage>2089</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.166.3.2080</pub-id>
<pub-id pub-id-type="pmid">11160259</pub-id>
</element-citation>
</ref>
<ref id="B238-brainsci-08-00154">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carroll</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Rosario</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stanczyk</surname>
<given-names>F.Z.</given-names>
</name>
<name>
<surname>Oddo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>LaFerla</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Pike</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Progesterone and estrogen regulate alzheimer-like neuropathology in female 3xtg-ad mice</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<fpage>13357</fpage>
<lpage>13365</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2718-07.2007</pub-id>
<pub-id pub-id-type="pmid">18045930</pub-id>
</element-citation>
</ref>
<ref id="B239-brainsci-08-00154">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Uljon</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gaynor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lafrancois</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Simpkins</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Refolo</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Petanceska</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of a(beta) peptides by estrogen in mouse models</article-title>
<source/>J. Neurochem.
          <year>2002</year>
<volume>80</volume>
<fpage>191</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1046/j.0022-3042.2001.00690.x</pub-id>
<pub-id pub-id-type="pmid">11796757</pub-id>
</element-citation>
</ref>
<ref id="B240-brainsci-08-00154">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function</article-title>
<source/>BMC Neurosci.
          <year>2006</year>
<volume>7</volume>
<fpage>74</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2202-7-74</pub-id>
<pub-id pub-id-type="pmid">17083736</pub-id>
</element-citation>
</ref>
<ref id="B241-brainsci-08-00154">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Gridley</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Simpkins</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Estradiol protects against β-amyloid (25–35)-induced toxicity in sk-n-sh human neuroblastoma cells</article-title>
<source/>Neurosci. Lett.
          <year>1996</year>
<volume>218</volume>
<fpage>165</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(96)13148-7</pub-id>
<pub-id pub-id-type="pmid">8945754</pub-id>
</element-citation>
</ref>
<ref id="B242-brainsci-08-00154">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hickey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bryant</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Judd</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Evaluation and management of depressive and anxiety symptoms in midlife</article-title>
<source/>Climacteric J. Int. Menopause Soc.
          <year>2012</year>
<volume>15</volume>
<fpage>3</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.3109/13697137.2011.620188</pub-id>
<pub-id pub-id-type="pmid">22132727</pub-id>
</element-citation>
</ref>
<ref id="B243-brainsci-08-00154">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pigott</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Anxiety disorders in women</article-title>
<source/>Psychiatr. Clin. N. Am.
          <year>2003</year>
<volume>26</volume>
<fpage>621</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1016/S0193-953X(03)00040-6</pub-id>
</element-citation>
</ref>
<ref id="B244-brainsci-08-00154">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Anxiety disorders during pregnancy and the postpartum period: A systematic review</article-title>
<source/>J. Clin. Psychiatry
          <year>2006</year>
<volume>67</volume>
<fpage>1285</fpage>
<lpage>1298</lpage>
<pub-id pub-id-type="doi">10.4088/JCP.v67n0818</pub-id>
<pub-id pub-id-type="pmid">16965210</pub-id>
</element-citation>
</ref>
<ref id="B245-brainsci-08-00154">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Veen</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Jonker</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>van Vliet</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Zitman</surname>
<given-names>F.G.</given-names>
</name>
</person-group>
<article-title>The effects of female reproductive hormones in generalized social anxiety disorder</article-title>
<source/>Int. J. Psychiatry Med.
          <year>2009</year>
<volume>39</volume>
<fpage>283</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="doi">10.2190/PM.39.3.e</pub-id>
<pub-id pub-id-type="pmid">19967900</pub-id>
</element-citation>
</ref>
<ref id="B246-brainsci-08-00154">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vesga-Lopez</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Blanco</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Keyes</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Olfson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Hasin</surname>
<given-names>D.S.</given-names>
</name>
</person-group>
<article-title>Psychiatric disorders in pregnant and postpartum women in the united states</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2008</year>
<volume>65</volume>
<fpage>805</fpage>
<lpage>815</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.65.7.805</pub-id>
<pub-id pub-id-type="pmid">18606953</pub-id>
</element-citation>
</ref>
<ref id="B247-brainsci-08-00154">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walf</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior</article-title>
<source/>Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol.
          <year>2006</year>
<volume>31</volume>
<fpage>1097</fpage>
<lpage>1111</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301067</pub-id>
<pub-id pub-id-type="pmid">16554740</pub-id>
</element-citation>
</ref>
<ref id="B248-brainsci-08-00154">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weissman</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Treatment of depression: Men and women are different?</article-title>
<source/>Am. J. Psychiatry
          <year>2014</year>
<volume>171</volume>
<fpage>384</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2013.13121668</pub-id>
<pub-id pub-id-type="pmid">24687191</pub-id>
</element-citation>
</ref>
<ref id="B249-brainsci-08-00154">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riecher Rossler</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Can estradiol modulate schizophrenic symptomatology?</article-title>
<source/>Schizophr. Bull.
          <year>1994</year>
<volume>20</volume>
<fpage>203</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1093/schbul/20.1.203</pub-id>
<pub-id pub-id-type="pmid">8197416</pub-id>
</element-citation>
</ref>
<ref id="B250-brainsci-08-00154">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gattaz</surname>
<given-names>W.F.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Riecher-Rössler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Soddu</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Influence of the menstrual cycle phase on the therapeutic response in schizophrenia</article-title>
<source/>Biol. Psychiatry
          <year>1994</year>
<volume>36</volume>
<fpage>137</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3223(94)91195-9</pub-id>
<pub-id pub-id-type="pmid">7948447</pub-id>
</element-citation>
</ref>
<ref id="B251-brainsci-08-00154">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallonquist</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Seeman</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rector</surname>
<given-names>N.A.</given-names>
</name>
</person-group>
<article-title>Variation in symptom severity over the menstrual cycle of schizophrenics</article-title>
<source/>Biol. Psychiatry
          <year>1993</year>
<volume>33</volume>
<fpage>207</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3223(93)90141-Y</pub-id>
<pub-id pub-id-type="pmid">8448269</pub-id>
</element-citation>
</ref>
<ref id="B252-brainsci-08-00154">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulkarni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Riedel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Castella</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Rolfe</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Taffe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Estrogen—A potential treatment for schizophrenia</article-title>
<source/>Schizophr. Res.
          <year>2001</year>
<volume>48</volume>
<fpage>137</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/S0920-9964(00)00088-8</pub-id>
<pub-id pub-id-type="pmid">11278160</pub-id>
</element-citation>
</ref>
<ref id="B253-brainsci-08-00154">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riecher-Rossler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Estrogens and gonadal function in schizophrenia and related psychoses</article-title>
<source/>Curr. Top. Behav. Neurosci.
          <year>2011</year>
<volume>8</volume>
<fpage>155</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="pmid">21643901</pub-id>
</element-citation>
</ref>
<ref id="B254-brainsci-08-00154">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Österlund</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>J.-A.K.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>Y.L.</given-names>
</name>
</person-group>
<article-title>Estrogen receptor β (erβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: Distinct distribution pattern to erα mRNA</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>2000</year>
<volume>85</volume>
<fpage>3840</fpage>
<lpage>3846</lpage>
<pub-id pub-id-type="pmid">11061547</pub-id>
</element-citation>
</ref>
<ref id="B255-brainsci-08-00154">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Österlund</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>Y.L.</given-names>
</name>
</person-group>
<article-title>Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders</article-title>
<source/>Prog. Neurobiol.
          <year>2001</year>
<volume>64</volume>
<fpage>251</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1016/S0301-0082(00)00059-9</pub-id>
<pub-id pub-id-type="pmid">11240308</pub-id>
</element-citation>
</ref>
<ref id="B256-brainsci-08-00154">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Östlund</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>Y.L.</given-names>
</name>
</person-group>
<article-title>Estrogen receptor gene expression in relation to neuropsychiatric disorders</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2003</year>
<fpage>54</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1196/annals.1286.006</pub-id>
</element-citation>
</ref>
<ref id="B257-brainsci-08-00154">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rissman</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Heck</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Shupnik</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>J.-Å.</given-names>
</name>
</person-group>
<article-title>Disruption of estrogen receptor β gene impairs spatial learning in female mice</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2002</year>
<volume>99</volume>
<fpage>3996</fpage>
<lpage>4001</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.012032699</pub-id>
<pub-id pub-id-type="pmid">11891272</pub-id>
</element-citation>
</ref>
<ref id="B258-brainsci-08-00154">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rissman</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Wersinger</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Fugger</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Sex with knockout models: Behavioral studies of estrogen receptor α1</article-title>
<source/>Brain Res.
          <year>1999</year>
<volume>835</volume>
<fpage>80</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(99)01452-3</pub-id>
<pub-id pub-id-type="pmid">10448199</pub-id>
</element-citation>
</ref>
<ref id="B259-brainsci-08-00154">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muniz</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Bitran</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Revilla-Sanchez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grauer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pulito</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory</article-title>
<source/>Nat. Neurosci.
          <year>2008</year>
<volume>11</volume>
<fpage>334</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1038/nn2057</pub-id>
<pub-id pub-id-type="pmid">18297067</pub-id>
</element-citation>
</ref>
<ref id="B260-brainsci-08-00154">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Astous</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morissette</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Di Paolo</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Effect of estrogen receptor agonists treatment in mptp mice: Evidence of neuroprotection by an er alpha agonist</article-title>
<source/>Neuropharmacology
          <year>2004</year>
<volume>47</volume>
<fpage>1180</fpage>
<lpage>1188</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.08.020</pub-id>
<pub-id pub-id-type="pmid">15567427</pub-id>
</element-citation>
</ref>
<ref id="B261-brainsci-08-00154">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morissette</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jourdain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Al Sweidi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Menniti</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Di Paolo</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Role of estrogen receptors in neuroprotection by estradiol against mptp toxicity</article-title>
<source/>Neuropharmacology
          <year>2007</year>
<volume>52</volume>
<fpage>1509</fpage>
<lpage>1520</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2007.02.004</pub-id>
<pub-id pub-id-type="pmid">17420033</pub-id>
</element-citation>
</ref>
<ref id="B262-brainsci-08-00154">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsumoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Alteration in sex-specific behaviors in male mice lacking the aromatase gene</article-title>
<source/>Neuroendocrinology
          <year>2003</year>
<volume>77</volume>
<fpage>416</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1159/000071313</pub-id>
<pub-id pub-id-type="pmid">12845227</pub-id>
</element-citation>
</ref>
<ref id="B263-brainsci-08-00154">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Uematsu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sekine</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Aihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Krust</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain masculinization requires androgen receptor function</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>1673</fpage>
<lpage>1678</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0305303101</pub-id>
<pub-id pub-id-type="pmid">14747651</pub-id>
</element-citation>
</ref>
<ref id="B264-brainsci-08-00154">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hines</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Early androgen influences on human neural and behavioural development</article-title>
<source/>Early Hum. Dev.
          <year>2008</year>
<volume>84</volume>
<fpage>805</fpage>
<lpage>807</lpage>
<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2008.09.006</pub-id>
<pub-id pub-id-type="pmid">18938049</pub-id>
</element-citation>
</ref>
<ref id="B265-brainsci-08-00154">
<label>265.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Auyeung</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ashwin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Knickmeyer</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Why are autism spectrum conditions more prevalent in males?</article-title>
<source/>PLoS Biol.
          <year>2011</year>
<volume>9</volume>
<elocation-id>e1001081</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1001081</pub-id>
<pub-id pub-id-type="pmid">21695109</pub-id>
</element-citation>
</ref>
<ref id="B266-brainsci-08-00154">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auyeung</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ashwin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Knickmeyer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hackett</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hines</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Fetal testosterone predicts sexually differentiated childhood behavior in girls and in boys</article-title>
<source/>Psychol. Sci.
          <year>2009</year>
<volume>20</volume>
<fpage>144</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1111/j.1467-9280.2009.02279.x</pub-id>
<pub-id pub-id-type="pmid">19175758</pub-id>
</element-citation>
</ref>
<ref id="B267-brainsci-08-00154">
<label>267.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auyeung</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ashwin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Knickmeyer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hackett</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Fetal testosterone and autistic traits</article-title>
<source/>Br. J. Psychol.
          <year>2009</year>
<volume>100</volume>
<fpage>1</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1348/000712608X311731</pub-id>
<pub-id pub-id-type="pmid">18547459</pub-id>
</element-citation>
</ref>
<ref id="B268-brainsci-08-00154">
<label>268.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Scutt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lewis-Jones</surname>
<given-names>D.I.</given-names>
</name>
</person-group>
<article-title>The ratio of 2nd to 4th digit length: A predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen</article-title>
<source/>Hum. Reprod.
          <year>1998</year>
<volume>13</volume>
<fpage>3000</fpage>
<lpage>3004</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/13.11.3000</pub-id>
<pub-id pub-id-type="pmid">9853845</pub-id>
</element-citation>
</ref>
<ref id="B269-brainsci-08-00154">
<label>269.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Koonce</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Edinger</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Walf</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice</article-title>
<source/>Horm. Behav.
          <year>2008</year>
<volume>54</volume>
<fpage>726</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2008.07.013</pub-id>
<pub-id pub-id-type="pmid">18775724</pub-id>
</element-citation>
</ref>
<ref id="B270-brainsci-08-00154">
<label>270.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodosy</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zelmanova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Majzunova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Filova</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Malinova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ostatnikova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Celec</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The anxiolytic effect of testosterone in the rat is mediated via the androgen receptor</article-title>
<source/>Pharmacol. Biochem. Behav.
          <year>2012</year>
<volume>102</volume>
<fpage>191</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2012.04.005</pub-id>
<pub-id pub-id-type="pmid">22546276</pub-id>
</element-citation>
</ref>
<ref id="B271-brainsci-08-00154">
<label>271.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDermott</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schrader</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Role of gonadal hormones in anxiety and fear memory formation and inhibition in male mice</article-title>
<source/>Physiol. Behav.
          <year>2012</year>
<volume>105</volume>
<fpage>1168</fpage>
<lpage>1174</lpage>
<pub-id pub-id-type="doi">10.1016/j.physbeh.2011.12.016</pub-id>
<pub-id pub-id-type="pmid">22226989</pub-id>
</element-citation>
</ref>
<ref id="B272-brainsci-08-00154">
<label>272.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leckman</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Scahill</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Possible exacerbation of tics by androgenic steroids</article-title>
<source/>N. Engl. J. Med.
          <year>1990</year>
<volume>322</volume>
<fpage>1674</fpage>
<pub-id pub-id-type="doi">10.1056/NEJM199006073222314</pub-id>
<pub-id pub-id-type="pmid">2342531</pub-id>
</element-citation>
</ref>
<ref id="B273-brainsci-08-00154">
<label>273.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muroni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Puligheddu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marrosu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bortolato</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A preliminary study of finasteride in tourette syndrome</article-title>
<source/>Mov. Disord. Off. J. Mov. Disord. Soc.
          <year>2011</year>
<volume>26</volume>
<fpage>2146</fpage>
<lpage>2147</lpage>
<pub-id pub-id-type="doi">10.1002/mds.23810</pub-id>
<pub-id pub-id-type="pmid">21618612</pub-id>
</element-citation>
</ref>
<ref id="B274-brainsci-08-00154">
<label>274.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bebo</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Zelinka-Vincent</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Adamus</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Amundson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vandenbark</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Offner</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Gonadal hormones influence the immune response to plp 139–151 and the clinical course of relapsing experimental autoimmmune encephalomyelitis</article-title>
<source/>J. Neuroimmunol.
          <year>1998</year>
<volume>84</volume>
<fpage>122</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-5728(97)00214-2</pub-id>
<pub-id pub-id-type="pmid">9628453</pub-id>
</element-citation>
</ref>
<ref id="B275-brainsci-08-00154">
<label>275.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khasnavis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pahan</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Castration induces parkinson disease pathologies in young male mice via inducible nitric-oxide synthase</article-title>
<source/>J. Biol. Chem.
          <year>2013</year>
<volume>288</volume>
<fpage>20843</fpage>
<lpage>20855</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.443556</pub-id>
<pub-id pub-id-type="pmid">23744073</pub-id>
</element-citation>
</ref>
<ref id="B276-brainsci-08-00154">
<label>276.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Isles</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>Imprinted gene expression in the brain</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2005</year>
<volume>29</volume>
<fpage>421</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2004.11.007</pub-id>
<pub-id pub-id-type="pmid">15820547</pub-id>
</element-citation>
</ref>
<ref id="B277-brainsci-08-00154">
<label>277.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kopsida</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stergiakouli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>The role of the y chromosome in brain function</article-title>
<source/>Open Neuroendocrinol. J.
          <year>2009</year>
<volume>2</volume>
<fpage>20</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.2174/1876528900902010020</pub-id>
<pub-id pub-id-type="pmid">20396406</pub-id>
</element-citation>
</ref>
<ref id="B278-brainsci-08-00154">
<label>278.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.F.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Q.J.</given-names>
</name>
</person-group>
<article-title>Interactions between maoa and syp polymorphisms were associated with symptoms of attention-deficit/hyperactivity disorder in chinese han subjects</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2015</year>
<volume>168B</volume>
<fpage>45</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32273</pub-id>
<pub-id pub-id-type="pmid">25487813</pub-id>
</element-citation>
</ref>
<ref id="B279-brainsci-08-00154">
<label>279.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carriere</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ancelin</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Involvement of gpr50 polymorphisms in depression: Independent replication in a prospective elderly cohort</article-title>
<source/>Brain Behav.
          <year>2015</year>
<volume>5</volume>
<fpage>e00313</fpage>
<pub-id pub-id-type="doi">10.1002/brb3.313</pub-id>
<pub-id pub-id-type="pmid">25798330</pub-id>
</element-citation>
</ref>
<ref id="B280-brainsci-08-00154">
<label>280.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czech</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Parish</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Vilain</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>V.R.</given-names>
</name>
</person-group>
<article-title>The human testis-determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism</article-title>
<source/>J. Neurochem.
          <year>2012</year>
<volume>122</volume>
<fpage>260</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07782.x</pub-id>
<pub-id pub-id-type="pmid">22568433</pub-id>
</element-citation>
</ref>
<ref id="B281-brainsci-08-00154">
<label>281.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hamdan</surname>
<given-names>F.F.</given-names>
</name>
<name>
<surname>Lafreniere</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Henrion</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Laurent</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Noreau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thibodeau</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Karemera</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systematic resequencing of x-chromosome synaptic genes in autism spectrum disorder and schizophrenia</article-title>
<source/>Mol. Psychiatry
          <year>2011</year>
<volume>16</volume>
<fpage>867</fpage>
<lpage>880</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2010.54</pub-id>
<pub-id pub-id-type="pmid">20479760</pub-id>
</element-citation>
</ref>
<ref id="B282-brainsci-08-00154">
<label>282.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Rijn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Swaab</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Executive dysfunction and the relation with behavioral problems in children with 47,xxy and 47,xxx</article-title>
<source/>Genes Brain Behav.
          <year>2015</year>
<volume>14</volume>
<fpage>200</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1111/gbb.12203</pub-id>
<pub-id pub-id-type="pmid">25684214</pub-id>
</element-citation>
</ref>
<ref id="B283-brainsci-08-00154">
<label>283.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyon</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Gene action in the x-chromosome of the mouse (mus musculus l.)</article-title>
<source/>Nature
          <year>1961</year>
<volume>190</volume>
<fpage>372</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1038/190372a0</pub-id>
<pub-id pub-id-type="pmid">13764598</pub-id>
</element-citation>
</ref>
<ref id="B284-brainsci-08-00154">
<label>284.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Willard</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title>X-inactivation profile reveals extensive variability in x-linked gene expression in females</article-title>
<source/>Nature
          <year>2005</year>
<volume>434</volume>
<fpage>400</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="doi">10.1038/nature03479</pub-id>
<pub-id pub-id-type="pmid">15772666</pub-id>
</element-citation>
</ref>
<ref id="B285-brainsci-08-00154">
<label>285.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Taya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kaibuchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Sexually dimorphic expression of usp9x is related to sex chromosome complement in adult mouse brain</article-title>
<source/>Eur. J. Neurosci.
          <year>2005</year>
<volume>21</volume>
<fpage>3017</fpage>
<lpage>3022</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04134.x</pub-id>
<pub-id pub-id-type="pmid">15978012</pub-id>
</element-citation>
</ref>
<ref id="B286-brainsci-08-00154">
<label>286.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Disteche</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Sex-specific differences in expression of histone demethylases utx and uty in mouse brain and neurons</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>4521</fpage>
<lpage>4527</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5382-07.2008</pub-id>
<pub-id pub-id-type="pmid">18434530</pub-id>
</element-citation>
</ref>
<ref id="B287-brainsci-08-00154">
<label>287.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Wallis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mazzocco</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Moshang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zackai</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zinn</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Muenke</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Increased prevalence of adhd in turner syndrome with no evidence of imprinting effects</article-title>
<source/>J. Pediatr. Psychol.
          <year>2006</year>
<volume>31</volume>
<fpage>945</fpage>
<lpage>955</lpage>
<pub-id pub-id-type="doi">10.1093/jpepsy/jsj106</pub-id>
<pub-id pub-id-type="pmid">16524959</pub-id>
</element-citation>
</ref>
<ref id="B288-brainsci-08-00154">
<label>288.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skuse</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Imprinting, the x-chromosome, and the male brain: Explaining sex differences in the liability to autism</article-title>
<source/>Pediatr. Res.
          <year>2000</year>
<volume>47</volume>
<fpage>9</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1203/00006450-200001000-00006</pub-id>
<pub-id pub-id-type="pmid">10625077</pub-id>
</element-citation>
</ref>
<ref id="B289-brainsci-08-00154">
<label>289.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prior</surname>
<given-names>T.I.</given-names>
</name>
<name>
<surname>Chue</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Tibbo</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Investigation of turner syndrome in schizophrenia</article-title>
<source/>Am. J. Med. Genet.
          <year>2000</year>
<volume>96</volume>
<fpage>373</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1002/1096-8628(20000612)96:3&lt;373::AID-AJMG26&gt;3.0.CO;2-Z</pub-id>
<pub-id pub-id-type="pmid">10898917</pub-id>
</element-citation>
</ref>
<ref id="B290-brainsci-08-00154">
<label>290.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Humby</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Isles</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Burgoyne</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>X-monosomy effects on visuospatial attention in mice: A candidate gene and implications for turner syndrome and attention deficit hyperactivity disorder</article-title>
<source/>Biol. Psychiatry
          <year>2007</year>
<volume>61</volume>
<fpage>1351</fpage>
<lpage>1360</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.08.011</pub-id>
<pub-id pub-id-type="pmid">17161381</pub-id>
</element-citation>
</ref>
<ref id="B291-brainsci-08-00154">
<label>291.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laumonnier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bonnet-Brilhault</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gomot</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blanc</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moizard</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Raynaud</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ronce</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lemonnier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Calvas</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>X-linked mental retardation and autism are associated with a mutation in the nlgn4 gene, a member of the neuroligin family</article-title>
<source/>Am. J. Hum. Genet.
          <year>2004</year>
<volume>74</volume>
<fpage>552</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="doi">10.1086/382137</pub-id>
<pub-id pub-id-type="pmid">14963808</pub-id>
</element-citation>
</ref>
<ref id="B292-brainsci-08-00154">
<label>292.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Quach</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Betancur</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rastam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Colineaux</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>I.C.</given-names>
</name>
<name>
<surname>Soderstrom</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Giros</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations of the x-linked genes encoding neuroligins nlgn3 and nlgn4 are associated with autism</article-title>
<source/>Nat. Genet.
          <year>2003</year>
<volume>34</volume>
<fpage>27</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<pub-id pub-id-type="pmid">12669065</pub-id>
</element-citation>
</ref>
<ref id="B293-brainsci-08-00154">
<label>293.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaafsma</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Pfaff</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Etiologies underlying sex differences in autism spectrum disorders</article-title>
<source/>Front. Neuroendocrinol.
          <year>2014</year>
<volume>35</volume>
<fpage>255</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2014.03.006</pub-id>
<pub-id pub-id-type="pmid">24705124</pub-id>
</element-citation>
</ref>
<ref id="B294-brainsci-08-00154">
<label>294.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>I.L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Schutz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Holden</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Association of autism severity with a monoamine oxidase a functional polymorphism</article-title>
<source/>Clin. Genet.
          <year>2003</year>
<volume>64</volume>
<fpage>190</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-0004.2003.00115.x</pub-id>
<pub-id pub-id-type="pmid">12919132</pub-id>
</element-citation>
</ref>
<ref id="B295-brainsci-08-00154">
<label>295.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>I.L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Chudley</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forster-Gibson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Holden</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Autism severity is associated with child and maternal maoa genotypes</article-title>
<source/>Clin. Genet.
          <year>2011</year>
<volume>79</volume>
<fpage>355</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2010.01471.x</pub-id>
<pub-id pub-id-type="pmid">20573161</pub-id>
</element-citation>
</ref>
<ref id="B296-brainsci-08-00154">
<label>296.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tassone</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Pessah</surname>
<given-names>I.N.</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Maoa, dbh, and slc6a4 variants in charge: A case-control study of autism spectrum disorders</article-title>
<source/>Autism Res. Off. J. Int. Soc. Autism Res.
          <year>2011</year>
<volume>4</volume>
<fpage>250</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1002/aur.196</pub-id>
<pub-id pub-id-type="pmid">21538940</pub-id>
</element-citation>
</ref>
<ref id="B297-brainsci-08-00154">
<label>297.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhowmik</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chattopadhyay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chaudhuri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Maoa promoter polymorphism and attention deficit hyperactivity disorder (adhd) in indian children</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
          <year>2006</year>
<volume>141B</volume>
<fpage>637</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30385</pub-id>
<pub-id pub-id-type="pmid">16856146</pub-id>
</element-citation>
</ref>
<ref id="B298-brainsci-08-00154">
<label>298.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warwick</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Doody</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Lawrie</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kestelman</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Best</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Johnstone</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>1999</year>
<volume>66</volume>
<fpage>628</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.66.5.628</pub-id>
<pub-id pub-id-type="pmid">10209175</pub-id>
</element-citation>
</ref>
<ref id="B299-brainsci-08-00154">
<label>299.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tartaglia</surname>
<given-names>N.R.</given-names>
</name>
<name>
<surname>Ayari</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hutaff-Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Boada</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Attention-deficit hyperactivity disorder symptoms in children and adolescents with sex chromosome aneuploidy: Xxy, xxx, xyy, and xxyy</article-title>
<source/>J. Dev. Behav. Pediatr. JDBP
          <year>2012</year>
<volume>33</volume>
<fpage>309</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="doi">10.1097/DBP.0b013e31824501c8</pub-id>
<pub-id pub-id-type="pmid">22333574</pub-id>
</element-citation>
</ref>
<ref id="B300-brainsci-08-00154">
<label>300.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynn</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>The 39,xo mouse as a model for the neurobiology of turner syndrome and sex-biased neuropsychiatric disorders</article-title>
<source/>Behav. Brain Res.
          <year>2007</year>
<volume>179</volume>
<fpage>173</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2007.02.013</pub-id>
<pub-id pub-id-type="pmid">17367875</pub-id>
</element-citation>
</ref>
<ref id="B301-brainsci-08-00154">
<label>301.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reik</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Genomic imprinting: Parental influence on the genome</article-title>
<source/>Nat. Rev. Genet.
          <year>2001</year>
<volume>2</volume>
<fpage>21</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1038/35047554</pub-id>
<pub-id pub-id-type="pmid">11253064</pub-id>
</element-citation>
</ref>
<ref id="B302-brainsci-08-00154">
<label>302.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skuse</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Coppin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dalton</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Aamodt-Leeper</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bacarese-Hamilton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Creswell</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>McGurk</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Evidence from turner’s syndrome of an imprinted x-linked locus affecting cognitive function</article-title>
<source/>Nature
          <year>1997</year>
<volume>387</volume>
<fpage>705</fpage>
<lpage>708</lpage>
<pub-id pub-id-type="doi">10.1038/42706</pub-id>
<pub-id pub-id-type="pmid">9192895</pub-id>
</element-citation>
</ref>
<ref id="B303-brainsci-08-00154">
<label>303.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bishop</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Canning</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Elgar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Skuse</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Distinctive patterns of memory function in subgroups of females with turner syndrome: Evidence for imprinted loci on the x-chromosome affecting neurodevelopment</article-title>
<source/>Neuropsychologia
          <year>2000</year>
<volume>38</volume>
<fpage>712</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="doi">10.1016/S0028-3932(99)00118-9</pub-id>
<pub-id pub-id-type="pmid">10689047</pub-id>
</element-citation>
</ref>
<ref id="B304-brainsci-08-00154">
<label>304.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Isles</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Karunadasa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Burrmann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Humby</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ojarikre</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Biggin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Skuse</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Burgoyne</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Xlr3b is a new imprinted candidate for x-linked parent-of-origin effects on cognitive function in mice</article-title>
<source/>Nat. Genet.
          <year>2005</year>
<volume>37</volume>
<fpage>625</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="doi">10.1038/ng1577</pub-id>
<pub-id pub-id-type="pmid">15908950</pub-id>
</element-citation>
</ref>
<ref id="B305-brainsci-08-00154">
<label>305.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izquierdo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jentsch</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Reversal learning as a measure of impulsive and compulsive behavior in addictions</article-title>
<source/>Psychopharmacology
          <year>2012</year>
<volume>219</volume>
<fpage>607</fpage>
<lpage>620</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-011-2579-7</pub-id>
<pub-id pub-id-type="pmid">22134477</pub-id>
</element-citation>
</ref>
<ref id="B306-brainsci-08-00154">
<label>306.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jobling</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Tyler-Smith</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The human y chromosome: An evolutionary marker comes of age</article-title>
<source/>Nat. Rev. Genet.
          <year>2003</year>
<volume>4</volume>
<fpage>598</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1038/nrg1124</pub-id>
<pub-id pub-id-type="pmid">12897772</pub-id>
</element-citation>
</ref>
<ref id="B307-brainsci-08-00154">
<label>307.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Y chromosome’s roles in sex differences in disease</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2017</year>
<volume>114</volume>
<fpage>3787</fpage>
<lpage>3789</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1702161114</pub-id>
<pub-id pub-id-type="pmid">28360199</pub-id>
</element-citation>
</ref>
<ref id="B308-brainsci-08-00154">
<label>308.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgoyne</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>The role of the mammalian y chromosome in spermatogenesis</article-title>
<source/>Development
          <year>1987</year>
<volume>101</volume>
<fpage>133</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">3503711</pub-id>
</element-citation>
</ref>
<ref id="B309-brainsci-08-00154">
<label>309.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodfellow</surname>
<given-names>P.N.</given-names>
</name>
<name>
<surname>Lovell-Badge</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Sry and sex determination in mammals</article-title>
<source/>Annu. Rev. Genet.
          <year>1993</year>
<volume>27</volume>
<fpage>71</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.ge.27.120193.000443</pub-id>
<pub-id pub-id-type="pmid">8122913</pub-id>
</element-citation>
</ref>
<ref id="B310-brainsci-08-00154">
<label>310.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahn</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Functional coherence of the human y chromosome</article-title>
<source/>Science
          <year>1997</year>
<volume>278</volume>
<fpage>675</fpage>
<lpage>680</lpage>
<pub-id pub-id-type="doi">10.1126/science.278.5338.675</pub-id>
<pub-id pub-id-type="pmid">9381176</pub-id>
</element-citation>
</ref>
<ref id="B311-brainsci-08-00154">
<label>311.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Zeger</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Kushner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zinn</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Roeltgen</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>An extra x or y chromosome: Contrasting the cognitive and motor phenotypes in childhood in boys with 47,xyy syndrome or 47,xxy klinefelter syndrome</article-title>
<source/>Dev. Disabil. Res. Rev.
          <year>2009</year>
<volume>15</volume>
<fpage>309</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1002/ddrr.85</pub-id>
<pub-id pub-id-type="pmid">20014371</pub-id>
</element-citation>
</ref>
<ref id="B312-brainsci-08-00154">
<label>312.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arnesen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stray</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Vildalen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vesterhus</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Stimulant medication in 47,xyy syndrome: A report of two cases</article-title>
<source/>Dev. Med. Child Neurol.
          <year>2005</year>
<volume>47</volume>
<fpage>559</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1017/S001216220500109X</pub-id>
<pub-id pub-id-type="pmid">16108458</pub-id>
</element-citation>
</ref>
<ref id="B313-brainsci-08-00154">
<label>313.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinclair</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Berta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Frischauf</surname>
<given-names>A.-M.</given-names>
</name>
<name>
<surname>Lovell-Badge</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goodfellow</surname>
<given-names>P.N.</given-names>
</name>
</person-group>
<article-title>A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif</article-title>
<source/>Nature
          <year>1990</year>
<volume>346</volume>
<fpage>240</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1038/346240a0</pub-id>
<pub-id pub-id-type="pmid">1695712</pub-id>
</element-citation>
</ref>
<ref id="B314-brainsci-08-00154">
<label>314.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koopman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Munsterberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Capel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Vivian</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lovell-Badge</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Expression of a candidate sex-determining gene during mouse testis differentiation</article-title>
<source/>Nature
          <year>1990</year>
<volume>348</volume>
<fpage>450</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1038/348450a0</pub-id>
<pub-id pub-id-type="pmid">2247150</pub-id>
</element-citation>
</ref>
<ref id="B315-brainsci-08-00154">
<label>315.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mosler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Just</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pilgrim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reisert</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Developmental profile of sry transcripts in mouse brain</article-title>
<source/>Neurogenetics
          <year>2000</year>
<volume>3</volume>
<fpage>25</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1007/s100480000093</pub-id>
<pub-id pub-id-type="pmid">11085593</pub-id>
</element-citation>
</ref>
<ref id="B316-brainsci-08-00154">
<label>316.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milsted</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Serova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sabban</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Dunphy</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Ely</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Regulation of tyrosine hydroxylase gene transcription by SRY</article-title>
<source/>Neurosci. Lett.
          <year>2004</year>
<volume>369</volume>
<fpage>203</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2004.07.052</pub-id>
<pub-id pub-id-type="pmid">15464265</pub-id>
</element-citation>
</ref>
<ref id="B317-brainsci-08-00154">
<label>317.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>Y.-F.C.</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Regulation of monoamine oxidase a by the sry gene on the y chromosome</article-title>
<source/>FASEB J.
          <year>2009</year>
<volume>23</volume>
<fpage>4029</fpage>
<lpage>4038</lpage>
<pub-id pub-id-type="doi">10.1096/fj.09-139097</pub-id>
<pub-id pub-id-type="pmid">19661285</pub-id>
</element-citation>
</ref>
<ref id="B318-brainsci-08-00154">
<label>318.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ely</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Underwood</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dunphy</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Boehme</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Milsted</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Review of the y chromosome, sry and hypertension</article-title>
<source/>Steroids
          <year>2010</year>
<volume>75</volume>
<fpage>747</fpage>
<lpage>753</lpage>
<pub-id pub-id-type="doi">10.1016/j.steroids.2009.10.015</pub-id>
<pub-id pub-id-type="pmid">19914267</pub-id>
</element-citation>
</ref>
<ref id="B319-brainsci-08-00154">
<label>319.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Farkas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dunmire</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ely</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Milsted</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Which SRY locus is the hypertensive y chromosome locus?</article-title>
<source/>Hypertension
          <year>2009</year>
<volume>53</volume>
<fpage>430</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.108.124131</pub-id>
<pub-id pub-id-type="pmid">19075093</pub-id>
</element-citation>
</ref>
<ref id="B320-brainsci-08-00154">
<label>320.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czech</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Loke</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vilain</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>V.R.</given-names>
</name>
</person-group>
<article-title>Transient neuroprotection by sry up-regulation in dopamine cells following injury in males</article-title>
<source/>Endocrinology
          <year>2014</year>
<fpage>2602</fpage>
<lpage>2612</lpage>
<pub-id pub-id-type="doi">10.1210/en.2013-2158</pub-id>
<pub-id pub-id-type="pmid">24708242</pub-id>
</element-citation>
</ref>
<ref id="B321-brainsci-08-00154">
<label>321.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Merry</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Dalva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zinn</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Behavioral phenotypes in males with xyy and possible role of increased nlgn4y expression in autism features</article-title>
<source/>Genes Brain Behav.
          <year>2015</year>
<volume>14</volume>
<fpage>137</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1111/gbb.12200</pub-id>
<pub-id pub-id-type="pmid">25558953</pub-id>
</element-citation>
</ref>
<ref id="B322-brainsci-08-00154">
<label>322.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Williams-Burris</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>McClusky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ngun</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Ghahramani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Barseghyan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Reue</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vilain</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>The sex chromosome trisomy mouse model of xxy and xyy: Metabolism and motor performance</article-title>
<source/>Biol. Sex. Differ.
          <year>2013</year>
<volume>4</volume>
<fpage>15</fpage>
<pub-id pub-id-type="doi">10.1186/2042-6410-4-15</pub-id>
<pub-id pub-id-type="pmid">23926958</pub-id>
</element-citation>
</ref>
<ref id="B323-brainsci-08-00154">
<label>323.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fillit</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weinreb</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cholst</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Luine</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Amador</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zabriskie</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Observations in a preliminary open trial of estradiol therapy for senile dementia-alzheimer’s type</article-title>
<source/>Psychoneuroendocrinology
          <year>1986</year>
<volume>11</volume>
<fpage>337</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4530(86)90019-3</pub-id>
<pub-id pub-id-type="pmid">3786638</pub-id>
</element-citation>
</ref>
<ref id="B324-brainsci-08-00154">
<label>324.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohkura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Isse</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Akazawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hamamoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yaoi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hagino</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Evaluation of estrogen treatment in female patients with dementia of the alzheimer type</article-title>
<source/>Endocr. J.
          <year>1994</year>
<volume>41</volume>
<fpage>361</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="doi">10.1507/endocrj.41.361</pub-id>
<pub-id pub-id-type="pmid">8528351</pub-id>
</element-citation>
</ref>
<ref id="B325-brainsci-08-00154">
<label>325.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asthana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Craft</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Raskind</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Lofgreen</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Veith</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Plymate</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with alzheimer’s disease: Results of a placebo-controlled, double-blind, pilot study</article-title>
<source/>Psychoneuroendocrinology
          <year>1999</year>
<volume>24</volume>
<fpage>657</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4530(99)00020-7</pub-id>
<pub-id pub-id-type="pmid">10399774</pub-id>
</element-citation>
</ref>
<ref id="B326-brainsci-08-00154">
<label>326.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>M.-X.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Marder</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schofield</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gurland</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mayeux</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Effect of oestrogen during menopause on risk and age at onset of alzheimer’s disease</article-title>
<source/>Lancet
          <year>1996</year>
<volume>348</volume>
<fpage>429</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(96)03356-9</pub-id>
<pub-id pub-id-type="pmid">8709781</pub-id>
</element-citation>
</ref>
<ref id="B327-brainsci-08-00154">
<label>327.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sicotte</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Liva</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Klutch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bouvier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Odesa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Voskuhl</surname>
<given-names>R.R.</given-names>
</name>
</person-group>
<article-title>Treatment of multiple sclerosis with the pregnancy hormone estriol</article-title>
<source/>Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc.
          <year>2002</year>
<volume>52</volume>
<fpage>421</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10301</pub-id>
<pub-id pub-id-type="pmid">12325070</pub-id>
</element-citation>
</ref>
<ref id="B328-brainsci-08-00154">
<label>328.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregoire</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Everitt</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Studd</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Transdermal oestrogen for treatment of severe postnatal depression</article-title>
<source/>Lancet
          <year>1996</year>
<volume>347</volume>
<fpage>930</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(96)91414-2</pub-id>
<pub-id pub-id-type="pmid">8598756</pub-id>
</element-citation>
</ref>
<ref id="B329-brainsci-08-00154">
<label>329.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A pilot study on the effects of testosterone in hypogonadal aging male patients with alzheimer’s disease</article-title>
<source/>Aging Male
          <year>2003</year>
<volume>6</volume>
<fpage>13</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1080/tam.6.1.13.17</pub-id>
<pub-id pub-id-type="pmid">12809076</pub-id>
</element-citation>
</ref>
<ref id="B330-brainsci-08-00154">
<label>330.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sicotte</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Giesser</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Tandon</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Klutch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Drain</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Shattuck</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Elashoff</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Testosterone treatment in multiple sclerosis: A pilot study</article-title>
<source/>Arch. Neurol.
          <year>2007</year>
<volume>64</volume>
<fpage>683</fpage>
<lpage>688</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.64.5.683</pub-id>
<pub-id pub-id-type="pmid">17502467</pub-id>
</element-citation>
</ref>
<ref id="B331-brainsci-08-00154">
<label>331.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Tenover</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Juncos</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>DeLong</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Beneficial effects of testosterone replacement for the nonmotor symptoms of parkinson disease</article-title>
<source/>Arch. Neurol.
          <year>2002</year>
<volume>59</volume>
<fpage>1750</fpage>
<lpage>1753</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.59.11.1750</pub-id>
<pub-id pub-id-type="pmid">12433262</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="brainsci-08-00154-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Sex differences in the prevalence of neurodegenerative and neuropsychiatric disorders. Abbreviations: ADHD, Attention-deficit hyperactivity disorder.</p>
</caption>
<graphic xlink:href="brainsci-08-00154-g001"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>